Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - AEROJET ROCKETDYNE HOLDINGS, INC.exhibit3212015a.htm
EX-31.2 - EXHIBIT 31.2 - AEROJET ROCKETDYNE HOLDINGS, INC.exhibit3122015a.htm
EX-31.1 - EXHIBIT 31.1 - AEROJET ROCKETDYNE HOLDINGS, INC.exhibit3112015a.htm
EX-23.1 - EXHIBIT 23.1 - AEROJET ROCKETDYNE HOLDINGS, INC.exhibit2312015a.htm


UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 FORM 10-K/A
Amendment No. 1
ý
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the fiscal year ended: November 30, 2015
or
¨
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
For the transition period from                      to                      
Commission File Number 1-01520
  Aerojet Rocketdyne Holdings, Inc.
(Exact name of registrant as specified in its charter)
Delaware
 
34-0244000
(State of Incorporation)
 
(I.R.S. Employer
Identification No.)
2001 Aerojet Road
Rancho Cordova, California
 
95742
(Address of Principal Executive Offices)
 
(Zip Code)
Registrant’s telephone number, including area code
(916) 355-4000
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
 
Name of each exchange on which registered
 
Common Stock, $0.10 par value per share
 
New York Stock Exchange and
Chicago Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes ý   No  ¨
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes ¨   No  ý
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý      No  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes  ý      No  ¨
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.    ý
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer  ý Accelerated filer ¨ Non-accelerated filer ¨ Smaller reporting company ¨
 
 
(Do not check if a smaller reporting company)
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act.)    Yes  ¨      No ý
The aggregate market value of the voting common equity held by nonaffiliates of the registrant as of May 31, 2015 was approximately $1.3 billion.
As of January 15, 2016, there were 64.4 million outstanding shares of the Company’s Common Stock, including redeemable common stock and unvested common shares, $0.10 par value.
Portions of the 2016 Proxy Statement of Aerojet Rocketdyne Holdings, Inc. relating to its annual meeting of stockholders scheduled to be held on April 27, 2016 are incorporated by reference into Part III of this Report.





Explanatory Note
In this Amendment No. 1 to the Annual Report on Form 10-K/A (the “Amended Filing”) for the year ended November 30, 2015, Aerojet Rocketdyne Holdings, Inc. (the “Company”) is updating the Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on February 16, 2016 (the “Original Filing”) to (i) reflect a revision to the disclosure on our assessment of internal controls over financial reporting in Item 9A and (ii) update Item 8 to reflect the revised “Report of Independent Registered Certified Public Accounting Firm” of PricewaterhouseCoopers LLP. These updates are a result of identifying an additional material weakness in the Company’s internal control over financial reporting related to the completeness and accuracy of the Company's accounting for income taxes. Except for the inclusion of new certifications required by Rule 13a-14 under the Securities Exchange Act of 1934, as amended (“Exchange Act”), a revised report and new consent of the independent registered public accounting firm (and related amendment to the Exhibit Index to reflect the addition of such certifications and consent), and as required to reflect the change in Item 9A, this Amended Filing speaks only as of the date of the Original Filing and does not modify or update any other disclosures contained in our Original Filing. This Amended Filing should be read in conjunction with the Original Filing and reports filed with the SEC subsequent to the Original Filing.
PART II




Item 8.
Consolidated Financial Statements and Supplementary Data
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of Aerojet Rocketdyne Holdings, Inc.:
In our opinion, the accompanying consolidated balance sheets and the related consolidated statements of operations, of comprehensive (loss) income, of stockholders’ (deficit) equity, and of cash flows present fairly, in all material respects, the financial position of Aerojet Rocketdyne Holdings, Inc. and its subsidiaries as of November 30, 2015 and 2014, and the results of their operations and their cash flows for each of the three years in the period ended November 30, 2015 in conformity with accounting principles generally accepted in the United States of America. Management and we previously concluded that the Company did not maintain effective internal control over financial reporting as of November 30, 2015 because of the material weaknesses related to (a) the purchase accounting considerations for long-term customer contracts acquired as part of a business combination, and (b) the integration of the Company’s accounting policies, practices and controls applicable to the acquired Rocketdyne Business, including those over the segmentation criteria applicable to long-term contracts. However, management has subsequently determined that a material weakness in internal control over financial reporting related to the preparation and review of the financial information used in the calculation of the Company’s annual and quarterly income tax provision also existed as of November 30, 2015. Accordingly, Management’s Report on Internal Control over Financial Reporting and our opinion on the effectiveness of internal control over financial reporting has been restated to include this additional material weakness. Also in our opinion, the Company did not maintain, in all material respects, effective internal control over financial reporting as of November 30, 2015, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) because material weaknesses in internal control over financial reporting related to ineffective controls over (a) the purchase accounting considerations for long-term customer contracts acquired as part of a business combination, (b) the integration of the Company’s accounting policies, practices and controls applicable to the acquired Rocketdyne Business, including those over the segmentation criteria applicable to long-term contracts, and (c) the completeness and accuracy of the Company’s accounting for income taxes, including the income tax provision and related tax assets and liabilities. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. The material weaknesses referred to above are described in Management's Report on Internal Control over Financial Reporting appearing under Item 9A. We considered these material weaknesses in determining the nature, timing, and extent of audit tests applied in our audit of the 2015 consolidated financial statements, and our opinion regarding the effectiveness of the Company’s internal control over financial reporting does not affect our opinion on those consolidated financial statements. The Company's management is responsible for these financial statements, for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in management's report referred to above. Our responsibility is to express opinions on these financial statements and on the Company's internal control over financial reporting based on our integrated audits. We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement and whether effective internal control over financial reporting was maintained in all material respects. Our audits of the financial statements included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
As discussed in Note 2 to the consolidated financial statements, the Company has restated its 2014 and 2013 consolidated financial statements to correct for errors.
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to
permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

3



Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ PricewaterhouseCoopers LLP
Sacramento, California
February 16, 2016, except with respect to our opinion on internal control over financial reporting insofar as it relates to the effects of the matter described in the penultimate paragraph of Management’s Report on Internal Control over Financial Reporting, as to which the date is August 16, 2016


4




Aerojet Rocketdyne Holdings, Inc.
Consolidated Statements of Operations
 
Year Ended
 
2015
 
2014
 
2013
 
 
 
As Restated
 
As Restated
 
(In millions, except per share amounts)
Net sales
$
1,708.3

 
$
1,602.2

 
$
1,378.1

Operating costs and expenses:
 
 
 
 
 
Cost of sales (exclusive of items shown separately below)
1,459.5

 
1,406.2

 
1,234.3

AR1 research and development (see Note 1)
32.1

 

 

Selling, general and administrative
49.0

 
38.2

 
53.6

Depreciation and amortization
65.1

 
63.7

 
43.5

Other expense, net:
 
 
 
 
 
Loss on debt repurchased
1.9

 
60.6

 
5.0

Legal settlement
50.0

 

 

Other
17.4

 
13.9

 
28.9

Total operating costs and expenses
1,675.0

 
1,582.6

 
1,365.3

Operating income
33.3

 
19.6

 
12.8

Non-operating (income) expense:
 
 
 
 
 
Interest income
(0.3
)
 
(0.1
)
 
(0.2
)
Interest expense
50.4

 
52.7

 
48.7

Total non-operating expense, net
50.1

 
52.6

 
48.5

Loss from continuing operations before income taxes
(16.8
)
 
(33.0
)
 
(35.7
)
Income tax provision (benefit)
0.3

 
16.3

 
(198.4
)
(Loss) income from continuing operations
(17.1
)
 
(49.3
)
 
162.7

Income (loss) from discontinued operations, net of income taxes
0.9

 
(0.7
)
 
0.2

Net (loss) income
$
(16.2
)
 
$
(50.0
)
 
$
162.9

(Loss) income per share of common stock
 
 
 
 
 
Basic:
 
 
 
 
 
(Loss) income per share from continuing operations
$
(0.28
)
 
$
(0.85
)
 
$
2.68

Income (loss) per share from discontinued operations, net of income taxes
0.01

 
(0.01
)
 

Net (loss) income per share
$
(0.27
)
 
$
(0.86
)
 
$
2.68

Diluted:
 
 
 
 
 
(Loss) income per share from continuing operations
$
(0.28
)
 
$
(0.85
)
 
$
2.05

Income (loss) per share from discontinued operations, net of income taxes
0.01

 
(0.01
)
 

Net (loss) income per share
$
(0.27
)
 
$
(0.86
)
 
$
2.05

Weighted average shares of common stock outstanding, basic
61.1

 
57.9

 
59.6

Weighted average shares of common stock outstanding, diluted
61.1

 
57.9

 
81.9

See Notes to Consolidated Financial Statements.

5



Aerojet Rocketdyne Holdings, Inc.
Consolidated Statements of Comprehensive (Loss) Income

 
Year Ended
 
2015
 
2014
 
2013
 
 
 
As Restated
 
As Restated
 
(In millions)
Net (loss) income
$
(16.2
)
 
$
(50.0
)
 
$
162.9

Other comprehensive (loss) income:
 
 
 
 
 
Amortization of net actuarial losses, net of $31.3 million, $20.4 million, and $1.2 million of income taxes in fiscal 2015, 2014, and 2013, respectively
49.4

 
31.1

 
91.3

Actuarial (losses) gains, net of $36.9 million, $89.8 million, and $1.1 million of income taxes in fiscal 2015, 2014, and 2013, respectively
(56.6
)
 
(136.0
)
 
167.6

Amortization of prior service credits, net of $0.4 million, $0.4 million and $0.1 million of income taxes in fiscal 2015, 2014, and 2013, respectively
(0.8
)
 
(0.5
)
 
(0.9
)
Comprehensive (loss) income
$
(24.2
)
 
$
(155.4
)
 
$
420.9


See Notes to Consolidated Financial Statements.

6



Aerojet Rocketdyne Holdings, Inc.
Consolidated Balance Sheets
 
As of November 30,
 
2015
 
2014
 
 
 
As Restated
 
(In millions, except per share amounts)
ASSETS
Current Assets
 
 
 
Cash and cash equivalents
$
211.1

 
$
265.9

Accounts receivable
171.5

 
170.5

Inventories
157.5

 
138.0

Recoverable from the U.S. government and other third parties for environmental remediation costs
24.0

 
19.4

Receivable from Northrop Grumman Corporation (“Northrop”)
6.0

 
6.0

Other current assets, net
61.5

 
38.6

Income taxes
2.9

 
2.1

Deferred income taxes
28.1

 
19.9

Total Current Assets
662.6

 
660.4

Noncurrent Assets
 
 
 
Property, plant and equipment, net
365.8

 
366.5

Real estate held for entitlement and leasing
86.2

 
94.4

Recoverable from the U.S. government and other third parties for environmental remediation costs
210.4

 
87.2

Receivable from Northrop
62.7

 
68.8

Deferred income taxes
286.7

 
261.4

Goodwill
158.1

 
158.1

Intangible assets
108.8

 
122.2

Income taxes
7.9

 
6.6

Other noncurrent assets, net
85.7

 
93.0

Total Noncurrent Assets
1,372.3

 
1,258.2

Total Assets
$
2,034.9

 
$
1,918.6

LIABILITIES, REDEEMABLE COMMON STOCK, AND STOCKHOLDERS’ DEFICIT
Current Liabilities
 
 
 
Short-term borrowings and current portion of long-term debt
$
5.3

 
$
5.3

Accounts payable
105.2

 
104.0

Reserves for environmental remediation costs
32.6

 
31.9

Postretirement medical and life insurance benefits
6.0

 
6.4

Advance payments on contracts
203.7

 
197.4

Other current liabilities
201.3

 
221.4

Total Current Liabilities
554.1

 
566.4

Noncurrent Liabilities
 
 
 
Senior debt
88.8

 
93.8

Second-priority senior notes
460.0

 
460.0

Convertible subordinated notes
84.8

 
133.8

Other debt
13.1

 
89.3

Reserves for environmental remediation costs
273.5

 
134.1

Pension benefits
566.2

 
482.8

Postretirement medical and life insurance benefits
45.5

 
51.7

Other noncurrent liabilities
94.4

 
80.6

Total Noncurrent Liabilities
1,626.3

 
1,526.1

Total Liabilities
2,180.4

 
2,092.5

Commitments and contingencies (Note 9)

 

Redeemable common stock, par value of $0.10; 0.1 million shares issued and outstanding as of November 30, 2015 and 2014
0.9

 
1.6

Stockholders’ Deficit
 
 
 
Preference stock, par value of $1.00; 15.0 million shares authorized; none issued or outstanding

 

Common stock, par value of $0.10; 150.0 million shares authorized; 62.9 million shares issued and outstanding as of November 30, 2015; 56.9 million shares issued and outstanding as of November 30, 2014
6.5

 
5.9

Other capital
340.1

 
287.4

Treasury stock at cost, 3.5 million shares as of November 30, 2015 and 2014
(64.5
)
 
(64.5
)
Accumulated deficit
(86.8
)
 
(70.6
)
Accumulated other comprehensive loss, net of income taxes
(341.7
)
 
(333.7
)
Total Stockholders’ Deficit
(146.4
)
 
(175.5
)
Total Liabilities, Redeemable Common Stock and Stockholders’ Deficit
$
2,034.9

 
$
1,918.6

See Notes to Consolidated Financial Statements.

7



Aerojet Rocketdyne Holdings, Inc.
Consolidated Statements of Stockholders’ (Deficit) Equity
 
Common Stock
 
 
 
 
 
 
 
Accumulated Other Comprehensive Loss
 
Total Stockholders' (Deficit) Equity
 
Shares
 
Amount
 
Other Capital
 
Treasury Stock
 
Accumulated Deficit
 
 
 
 
 
 
 
As Restated
 
 
 
As Restated
 
As Restated
 
As Restated
 
(In millions)
November 30, 2012
58.9

 
$
5.9

 
$
269.6

 
$

 
$
(183.5
)
 
$
(486.3
)
 
$
(394.3
)
Net income

 

 

 

 
162.9

 

 
162.9

Amortization of net actuarial losses, net of income taxes

 

 

 

 

 
91.3

 
91.3

Actuarial gains arising during the period, net of income taxes

 

 

 

 

 
167.6

 
167.6

Amortization of prior service credits, net of income taxes

 

 

 

 

 
(0.9
)
 
(0.9
)
Conversion of debt to common stock
0.2

 

 
1.6

 

 

 

 
1.6

Reclassification from redeemable common stock
0.4

 

 
3.7

 

 

 

 
3.7

Stock-based compensation and shares issued under equity plans and other, net
0.4

 

 
5.4

 

 

 

 
5.4

November 30, 2013
59.9

 
5.9

 
280.3

 

 
(20.6
)
 
(228.3
)
 
37.3

Net loss

 

 

 

 
(50.0
)
 

 
(50.0
)
Amortization of net actuarial losses, net of income taxes

 

 

 

 

 
31.1

 
31.1

Actuarial losses arising during the period, net of income taxes

 

 

 

 

 
(136.0
)
 
(136.0
)
Amortization of prior service credits, net of income taxes

 

 

 

 

 
(0.5
)
 
(0.5
)
Reclassification from redeemable common stock
0.1

 

 
(1.4
)
 

 

 

 
(1.4
)
Tax benefit from shares issued under equity plans

 

 
1.3

 

 

 

 
1.3

Purchase of treasury stock
(3.5
)
 

 

 
(64.5
)
 

 

 
(64.5
)
Stock-based compensation and shares issued under equity plans, net
0.4

 

 
7.2

 

 

 

 
7.2

November 30, 2014
56.9

 
5.9

 
287.4

 
(64.5
)
 
(70.6
)
 
(333.7
)
 
(175.5
)
Net loss

 

 

 

 
(16.2
)
 

 
(16.2
)
Amortization of net actuarial losses, net of income taxes

 

 

 

 

 
49.4

 
49.4

Actuarial losses and prior service costs arising during the period, net of income taxes

 

 

 

 

 
(56.6
)
 
(56.6
)
Amortization of prior service credits, net of income taxes

 

 

 

 

 
(0.8
)
 
(0.8
)
Reclassification from redeemable common stock
(0.1
)
 

 
0.7

 

 

 

 
0.7

Tax benefit from shares issued under equity plans

 

 
2.5

 

 

 

 
2.5

Conversion of debt to common stock
5.5

 
0.5

 
48.5

 

 

 

 
49.0

Repurchase of shares to satisfy tax withholding obligations
(0.3
)
 

 
(6.7
)
 

 

 

 
(6.7
)
Stock-based compensation and shares issued under equity plans, net
0.9

 
0.1

 
7.7

 

 

 

 
7.8

November 30, 2015
62.9

 
$
6.5

 
$
340.1

 
$
(64.5
)
 
$
(86.8
)
 
$
(341.7
)
 
$
(146.4
)
See Notes to Consolidated Financial Statements.

8



Aerojet Rocketdyne Holdings, Inc.
Consolidated Statements of Cash Flows
 
Year Ended
 
2015
 
2014
 
2013
 
 
 
As Restated
 
As Restated
 
(In millions)
Operating Activities
 
 
 
 
 
Net (loss) income
$
(16.2
)
 
$
(50.0
)
 
$
162.9

Adjustments to reconcile net (loss) income to net cash provided by operating activities:
 
 
 
 
 
(Income) loss from discontinued operations, net of income taxes
(0.9
)
 
0.7

 
(0.2
)
Depreciation and amortization
65.1

 
63.7

 
43.5

Amortization of financing costs
2.7

 
3.6

 
4.5

Stock-based compensation
8.6

 
5.7

 
14.1

Retirement benefit expense
67.6

 
36.5

 
65.0

Loss on debt repurchased
1.9

 
60.6

 
5.0

Loss on bank amendment

 
0.2

 

Loss on disposal of long-lived assets
0.7

 
2.8

 

Gain on sale of technology
(1.0
)
 
(6.8
)
 

Tax benefit on stock-based awards
(2.5
)
 
(1.3
)
 
(0.2
)
Changes in assets and liabilities, net of effects from acquisition:
 
 
 
 
 
Accounts receivable
(1.0
)
 
28.9

 
(24.0
)
Inventories
(19.5
)
 
(32.0
)
 
(26.4
)
Other current assets, net
(22.8
)
 
(10.8
)
 
(4.4
)
Income tax receivable
(2.9
)
 
3.7

 
(11.8
)
Real estate held for entitlement and leasing
(7.8
)
 
(15.0
)
 
(4.4
)
Receivable from Northrop
6.1

 
(2.8
)
 
3.3

Recoverable from the U.S. government and other third parties for environmental remediation costs
(127.8
)
 
8.5

 
15.1

Other noncurrent assets
11.9

 
(24.1
)
 
(2.0
)
Accounts payable
(5.1
)
 
(18.2
)
 
49.7

Retirement benefits
(4.9
)
 
(5.3
)
 
(5.4
)
Advance payments on contracts
6.3

 
96.9

 
(47.8
)
Other current liabilities
(17.8
)
 
19.8

 
57.8

Deferred income taxes
(27.6
)
 
(7.1
)
 
(199.5
)
Reserves for environmental remediation costs
140.1

 
(5.3
)
 
(18.2
)
Other noncurrent liabilities and other
12.0

 
(0.2
)
 
0.9

Net cash provided by continuing operations
65.2

 
152.7

 
77.5

Net cash used in discontinued operations
(0.1
)
 
(2.1
)
 
(0.1
)
Net Cash Provided by Operating Activities
65.1

 
150.6

 
77.4

Investing Activities
 
 
 
 
 
Purchases of restricted cash investments

 

 
(470.0
)
Sale of restricted cash investments

 

 
470.0

Purchase of Rocketdyne Business

 
0.2

 
(411.2
)
Purchases of investments

 

 
(0.5
)
Proceeds from sale of technology
1.0

 
7.5

 

Capital expenditures
(36.8
)
 
(43.4
)
 
(63.2
)
Net Cash Used in Investing Activities
(35.8
)
 
(35.7
)
 
(474.9
)
Financing Activities
 
 
 
 
 
Proceeds from issuance of debt

 
189.0

 
460.0

Debt issuance costs

 
(4.2
)
 
(14.9
)
Debt repayments/repurchases
(81.2
)
 
(166.3
)
 
(12.8
)
Proceeds from shares issued under equity plans, net
1.3

 
0.2

 
0.7

Repurchase of shares to satisfy tax withholding obligations
(6.7
)
 
(2.1
)
 
(0.2
)
Purchase of treasury stock

 
(64.5
)
 

Tax benefit on stock-based awards
2.5

 
1.3

 
0.2

Net Cash (Used in) Provided by Financing Activities
(84.1
)
 
(46.6
)
 
433.0

Net (Decrease) Increase in Cash and Cash Equivalents
(54.8
)
 
68.3

 
35.5

Cash and Cash Equivalents at Beginning of Period
265.9

 
197.6

 
162.1

Cash and Cash Equivalents at End of Period
$
211.1

 
$
265.9

 
$
197.6

Supplemental disclosures of cash flow information
 
 
 
 
 
Cash paid for interest
$
49.3

 
$
46.9

 
$
33.7

Cash paid for income taxes, net
27.9

 
4.9

 
8.4

Conversion of debt to common stock
49.0

 

 
1.6

See Notes to Consolidated Financial Statements.

9



Aerojet Rocketdyne Holdings, Inc.
Notes to Consolidated Financial Statements
Note 1. Summary of Significant Accounting Policies, (As Restated for fiscal 2014 and 2013)
a.  Basis of Presentation and Nature of Operations
The consolidated financial statements of Aerojet Rocketdyne Holdings, Inc. (“Aerojet Rocketdyne Holdings” or the “Company”) include the accounts of the parent company and its 100% owned and majority owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Certain reclassifications have been made to financial information for prior years to conform to the current year’s presentation.
The Company is a manufacturer of aerospace and defense products and systems with a real estate segment. The Company’s continuing operations are organized into two segments:
Aerospace and Defense — includes the operations of the Company’s wholly-owned subsidiary Aerojet Rocketdyne, Inc. (“Aerojet Rocketdyne”), a leading technology-based designer, developer and manufacturer of aerospace and defense products and systems for the United States (“U.S.”) government, including the Department of Defense (“DoD”), the National Aeronautics and Space Administration (“NASA”), major aerospace and defense prime contractors as well as portions of the commercial sector. Aerojet Rocketdyne is a world-recognized engineering and manufacturing company that specializes in the development and production of propulsion systems for defense and space applications, armament systems for precision tactical systems and munitions, and is considered a domestic market leader in launch propulsion, in-space propulsion, missile defense propulsion, tactical missile propulsion and hypersonic propulsion systems.
Real Estate — includes the activities of the Company’s wholly-owned subsidiary Easton Development Company, LLC (“Easton”) related to the re-zoning, entitlement, sale, and leasing of the Company’s excess real estate assets. The Company owns approximately 11,500 acres of land adjacent to U.S. Highway 50 between Rancho Cordova and Folsom, California east of Sacramento (“Sacramento Land”). The Company is currently in the process of seeking zoning changes and other governmental approvals on a portion of the Sacramento Land to optimize its value.
In July 2012, the Company signed a stock and asset purchase agreement (the “Original Purchase Agreement”) with United Technologies Corporation (“UTC”) to acquire the Pratt & Whitney Rocketdyne division (the “Rocketdyne Business”) from UTC for $550 million (the “Acquisition”). On June 12, 2013, the Company and UTC entered into an amended and restated stock and asset purchase agreement (the “Amended and Restated Purchase Agreement”), which amended and restated the Original Purchase Agreement, as amended. On June 14, 2013, the Company completed the acquisition of substantially all of the Rocketdyne Business pursuant to the Amended and Restated Purchase Agreement. The aggregate consideration to UTC was $411 million which represents the initial purchase price of $550 million reduced by $55 million relating to the potential future acquisition of UTC’s 50% ownership interest of RD Amross, LLC ("RD Amross" a joint venture with NPO Energomash of Khimki, Russia which sells RD-180 engines to RD Amross) and the portion of the UTC business that markets and supports the sale of RD-180 engines (the “RDA Acquisition”). The acquisition of UTC’s 50% ownership interest of RD Amross and UTC’s related business was contingent upon certain conditions including receipt of certain Russian governmental regulatory approvals, which were not obtained. Pursuant to the terms of the Amended and Restated Purchase Agreement, on June 14, 2015, the Company’s obligations to consummate the RDA Acquisition expired. See Note 5 for additional information.
The Company’s fiscal year ends on November 30 of each year. The fiscal year of the Company’s subsidiary, Aerojet Rocketdyne, ends on the last Saturday of November. As a result of the 2013 calendar, Aerojet Rocketdyne had 53 weeks of operations in fiscal 2013 compared to 52 weeks of operations in fiscal 2015 and 2014. The additional week of operations, which occurred in the first quarter of fiscal 2013, accounted for $27.8 million in additional net sales.
On August 31, 2004, the Company completed the sale of its GDX Automotive business. On November 30, 2005, the Company completed the sale of the Fine Chemicals business. The remaining related subsidiaries after the sale of GDX Automotive and the Fine Chemicals business are classified as discontinued operations.
The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires the Company to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.
Restatement
This Annual Report on Form 10-K for the year ended November 30, 2015 (“Form 10-K”) includes the restatement of certain of the Company's previously issued consolidated financial statements and selected financial data. It also amends previously filed management’s discussion and analysis of financial condition and results of operations and other disclosures for the periods presented in this Form 10-K. See Note 2.

10



AR1 Research and Development
Company-sponsored research and development ("R&D") expenses (reported as a component of cost of sales) are generally allocated among all contracts and programs in progress under U.S. government contractual arrangements (see Note 1(r)). The Company's newest large liquid booster engine development project, the AR1, recorded $16.1 million of such costs during fiscal 2015. In the third quarter of fiscal 2015, the Company began separately reporting the portion of the engine development expenses associated with the AR1 project which are currently not allocated across all contracts and programs in progress under U.S. governmental contractual arrangements.  The total of these costs not charged to the U.S. governmental contractual arrangements amounted to $32.1 million in fiscal 2015 bringing the aggregate total AR1 R&D costs incurred during fiscal 2015 to $48.2 million.
b.  Cash and Cash Equivalents
All highly liquid debt instruments purchased with a remaining maturity at the date of purchase of three months or less are considered to be cash equivalents. The Company aggregates its cash balances by bank, and reclassifies any negative balances, if applicable, to accounts payable.

c.  Fair Value of Financial Instruments
The accounting standards use a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. The following are measured at fair value:
 
 
 
Fair value measurement at November 30, 2015
 
Total
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
(In millions)
Money market funds
$
187.2

 
$
187.2

 
$

 
$

 
 
 
Fair value measurement at November 30, 2014
 
Total
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
(In millions)
Money market funds
$
233.4

 
$
233.4

 
$

 
$

As of November 30, 2015, a summary of cash and cash equivalents and the grantor trust by investment type is as follows:
 
Total
 
Cash and
Cash Equivalents
 
Money Market
Funds
 
(In millions)
Cash and cash equivalents
$
211.1

 
$
33.8

 
$
177.3

Grantor trust (included as a component of other current and noncurrent assets)
9.9

 

 
9.9

 
$
221.0

 
$
33.8

 
$
187.2

The carrying amounts of certain of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, accrued compensation, and other accrued liabilities, approximate fair value because of their short maturities.
The estimated fair value and principal amount for the Company’s outstanding debt is presented below:

11



 
Fair Value
 
Principal Amount
 
November 30, 2015
 
November 30, 2014
 
November 30, 2015
 
November 30, 2014
 
(In millions)
Term loan
$
93.8

 
$
98.8

 
$
93.8

 
$
98.8

7.125% Second-Priority Senior Secured Notes (“7 1/8% Notes”)
480.1

 
483.6

 
460.0

 
460.0

4 1/16% Convertible Subordinated Debentures (“4 1/16% Debentures”)
164.0

 
248.2

 
84.6

 
133.6

Delayed draw term loan
13.0

 
89.0

 
13.0

 
89.0

Other debt
0.6

 
0.8

 
0.6

 
0.8

 
$
751.5

 
$
920.4

 
$
652.0

 
$
782.2

The fair values of the 7 1/8% Notes and 4 1/16% Debentures were determined using broker quotes that are based on open markets for the Company’s debt securities as of November 30, 2015 and 2014 (both Level 2 securities), respectively. The fair value of the term loans and other debt was determined to approximate carrying value.
d.  Accounts Receivable
Accounts receivable associated with long-term contracts consist of billed and unbilled amounts. Billed amounts include invoices presented to customers that have not been paid. Unbilled amounts relate to revenues that have been recorded and billings that have not been presented to customers. Amounts for overhead disallowances or billing decrements are reflected in unbilled receivables and primarily represent estimates of potential overhead costs which may not be successfully negotiated and collected.
Other receivables represent amounts billed where revenues were not derived from long-term contracts.
e.  Inventories
Inventories are stated at the lower of cost or market, generally using the average cost method. Costs on long-term contracts and programs in progress represent recoverable costs incurred for production, contract-specific facilities and equipment, allocable operating overhead, advances to suppliers, environmental expenses and, in the case of contracts with the U.S. government, allocable costs deemed allowable under U.S. government procurement regulations for bid and proposal, research and development, and general and administrative expenses. The Company capitalizes costs incurred in advance of contract award or funding in inventories if it determines that contract award or funding is probable. Amounts previously capitalized are expensed when a contract award or funding is no longer probable. Pursuant to contract provisions, agencies of the U.S. government and certain other customers have title to, or a security interest in, inventories related to such contracts as a result of performance-based and progress payments. Such progress payments are reflected as an offset against the related inventory balances.
The acquired Rocketdyne Business inventory was recorded at fair value on the date of Acquisition. The fair value adjustment of $6.3 million was not allocable to the Company’s U.S. government contracts and is being expensed to cost of sales as the inventory is delivered to the customer (see Note 5). The Company expensed $0.3 million, $3.2 million, and $2.2 million to cost of sales in fiscal 2015, 2014, and 2013, respectively, related to the inventory fair value adjustment.
f.  Income Taxes
The Company files a consolidated U.S. federal income tax return with its 100% owned consolidated subsidiaries. The deferred tax assets and/or liabilities are determined by multiplying the differences between the financial reporting and tax reporting bases for assets and liabilities by the enacted tax rates expected to be in effect when such differences are recovered or settled. The effect on deferred taxes of a change in tax rates is recognized in the period of the enactment date of the change.
The carrying value of the Company’s deferred tax assets is dependent upon its ability to generate sufficient taxable income in the future. A valuation allowance is required when it is more likely than not that all or a portion of a deferred tax asset will not be realized. A review of all available positive and negative evidence is considered, including the Company’s past and future performance, the market environment in which it operates, the utilization of tax attributes in the past, the length of carryback and carryforward periods, and evaluation of potential tax planning strategies.
Despite the Company’s belief that its tax return positions are consistent with applicable tax laws, the Company believes that certain positions are likely to be challenged by taxing authorities. Settlement of any challenge can result in no change, a complete disallowance, or some partial adjustment reached through negotiations or litigation. The Company’s tax reserves reflect the difference between the tax benefit claimed on tax returns and the amount recognized in the financial statements. The accounting standards provide guidance for the recognition and measurement in financial statements for uncertain tax positions

12



taken or expected to be taken in a tax return. The evaluation of a tax position is a two-step process, the first step being recognition. The Company determines whether it is more likely than not that a tax position will be sustained upon tax examination, including resolution of any related appeals or litigation, based on only the technical merits of the position. The technical merits of a tax position are derived from both statutory and judicial authority (legislation and statutes, legislative intent, regulations, rulings, and case law) and their applicability to the facts and circumstances of the tax position. If a tax position does not meet the more likely than not recognition threshold, the benefit of that position is not recognized in the financial statements. The second step is measurement. A tax position that meets the more likely than not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate resolution with a taxing authority. As the examination process progresses with tax authorities, adjustments to tax reserves may be necessary to reflect taxes payable upon settlement. Tax reserve adjustments related to positions impacting the effective tax rate affect the provision for income taxes. Tax reserve adjustments related to positions impacting the timing of deductions impact deferred tax assets and liabilities.
g.  Property, Plant and Equipment, net
Property, plant and equipment are recorded at cost. Refurbishment costs are capitalized in the property accounts, whereas ordinary maintenance and repair costs are expensed as incurred. Depreciation is computed principally by accelerated methods based on the following useful lives:  
Buildings and improvements
9 - 40  years
Machinery and equipment
5 - 19  years
Costs related to software acquired, developed or modified solely to meet the Company's internal requirements and for which there are no substantive plans to market are capitalized in accordance with the authoritative guidance on accounting for the costs of computer software developed or obtained for internal use. Only costs incurred after the preliminary planning stage of the project and after management has authorized and committed funds to the project are eligible for capitalization.
The acquired Rocketdyne Business property, plant and equipment were recorded at fair value on the date of Acquisition. The fair value adjustment of $81.9 million is not allocable to the Company’s U.S. government contracts and is being depreciated using a weighted average life of approximately 15 years (see Note 5).
h.  Real Estate Held for Entitlement and Leasing
The Company capitalizes all costs associated with the real estate entitlement and leasing process. The Company classifies activities related to the entitlement, sale, and leasing of its excess real estate assets as operating activities in the consolidated statements of cash flows.
i.  Goodwill
Goodwill represents the excess of the purchase price of an acquired enterprise or assets over the fair values of the identifiable assets acquired and liabilities assumed. Tests for impairment of goodwill are performed on an annual basis, or at any other time if events occur or circumstances indicate that the carrying amount of goodwill may not be recoverable. The Company evaluated goodwill for impairment as of September 1, 2015 and 2014, and determined that goodwill was not impaired.
All of the Company’s recorded goodwill resides in the Aerospace and Defense reporting unit. As of September 1, 2015, the Company evaluated goodwill using a “Step Zero" analysis and determined that it was more likely than not that the fair value of the Aerospace and Defense reporting unit exceeded its carrying amount. As of September 1, 2014, the Company performed a “Step One” analysis to evaluate goodwill impairment and determined that the fair value of the Aerospace and Defense reporting unit exceeded its carrying amount.
To determine the fair value of the Company’s Aerospace and Defense reporting unit, the Company primarily relies upon a discounted cash flow analysis which requires significant assumptions and estimates about future operations, including judgments about expected revenue growth and operating margins, and timing and amounts of expected future cash flows. The cash flows employed in the discounted cash flow analysis are based on five-year financial forecasts developed by management. The analysis also involves discounting the future cash flows to a present value using a discount rate that properly accounts for the risk and nature of the reporting unit cash flows and the rates of return debt and equity holders would require to invest their capital in the Aerospace and Defense reporting unit. In assessing the reasonableness of the Company’s estimated fair value of the Aerospace and Defense reporting unit, the Company evaluates the results of the discounted cash flow analysis in light of what investors are paying for similar interests in comparable aerospace and defense companies as of the valuation date. The Company also ensures that the reporting unit fair value is reasonable given the market value of the entire Company as of the valuation date.

13



The Company evaluates qualitative factors (including macroeconomic conditions, industry and market considerations, cost factors, and overall financial performance) to determine whether it is necessary to perform the first step of the two-step goodwill test. This step is referred to as the “Step Zero" analysis. If it is determined that it is more likely than not (a likelihood of more than 50%) that the fair value of a reporting unit is less than its carrying amount, the Company will need to proceed to the first step (“Step One”) of the two-step goodwill impairment test. In evaluating whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, relevant events and circumstances as discussed below shall be assessed. If, after assessing the totality of events or circumstances, the Company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then the first and second steps of the impairment test are unnecessary.
Circumstances that could trigger an impairment test include but are not limited to: a significant adverse change in the business climate or legal factors; adverse cash flow trends; an adverse action or assessment by a regulator; unanticipated competition; loss of key personnel; decline in stock price; and results of testing for recoverability of a significant asset group within a reporting unit. If the carrying amount of the reporting unit’s goodwill exceeds the implied fair value of that goodwill, an impairment loss is recorded.
There can be no assurance that the Company’s estimates and assumptions made for purposes of its goodwill impairment testing will prove to be accurate predictions of the future. If the Company’s assumptions and estimates are incorrect, the Company may be required to record goodwill impairment charges in future periods.
j.  Intangible Assets
Identifiable intangible assets, such as patents, trademarks, and licenses are recorded at cost or when acquired as part of a business combination at estimated fair value. Identifiable intangible assets are amortized based on when they provide the Company economic benefit, or using the straight-line method, over their estimated useful life. Amortization periods for identifiable intangible assets range from 3 years to 30 years.
k.  Environmental Remediation
The Company expenses, on a current basis, recurring costs associated with managing hazardous substances and contamination in ongoing operations. The Company accrues for costs associated with the remediation of environmental contamination when it becomes probable that a liability has been incurred, and the amount can be reasonably estimated. In most cases only a range of reasonably probable costs can be estimated. In establishing the Company’s reserves, the most probable estimated amount is used when determinable, and the minimum amount is used when no single amount in the range is more probable. The Company’s environmental reserves include the costs of completing remedial investigation and feasibility studies, remedial and corrective actions, regulatory oversight costs, the cost of operation and maintenance of the remedial action plan, and employee compensation costs for employees who are expected to devote a significant amount of time to remediation efforts. Calculation of environmental reserves is based on the evaluation of currently available information with respect to each individual environmental site and considers factors such as existing technology, presently enacted laws and regulations, and prior experience in remediation of contaminated sites. Such estimates are based on the expected costs of investigation and remediation and the likelihood that other potentially responsible parties will be able to fulfill their commitments at sites where the Company may be jointly or severally liable. At the time a liability is recorded for future environmental costs, the Company records an asset for estimated future recoveries that are estimable and probable. Some of the Company’s environmental costs are eligible for future recovery in the pricing of its products and services to the U.S. government and under existing third party agreements. The Company considers the recovery probable based on the Global Settlement Agreement, Northrop Agreement, government contracting regulations, and its long history of receiving reimbursement for such costs (see Notes 9(c) and (d)).
l.  Retirement Benefits
The Company's defined benefit pension plan future benefit accrual was discontinued in fiscal 2009. In addition, the Company provides medical and life insurance benefits (“postretirement benefits”) to certain eligible retired employees, with varied coverage by employee group. Annual charges are made for the cost of the plans, including administrative costs, interest costs on benefit obligations, and net amortization and deferrals, increased or reduced by the return on assets. The Company also sponsors a defined contribution 401(k) plan and participation in the plan is available to substantially all employees (see Note 8).
m.  Conditional Asset Retirement Obligations
Conditional asset retirement obligations (“CAROs”) are legal obligations associated with the retirement of long-lived assets. These liabilities are initially recorded at fair value and the related asset retirement costs are capitalized by increasing the carrying amount of the related assets by the same amount as the liability. Asset retirement costs are subsequently depreciated over the useful lives of the related assets. Subsequent to initial recognition, the Company records period-to-period changes in the CARO liability resulting from the passage of time and revisions to either the timing or the amount of the estimate of the undiscounted cash flows.

14



The Company’s estimate of CAROs associated with owned properties relates to estimated costs necessary for the legally required removal or remediation of various regulated materials, primarily asbestos disposal and radiological decontamination of an ordnance manufacturing facility. For CAROs that are not expected to be retired in the next 15 years, the Company estimated the retirement date of such asset retirement obligations to be 30 years from the date of adoption of the applicable accounting standard. For leased properties, such obligations relate to the estimated cost of contractually required property restoration.
The changes in the carrying amount of CAROs since November 30, 2012 were as follows (in millions):
Balance as of November 30, 2012
$
20.8

Rocketdyne Business Acquisition
1.2

Additions and other, net
(0.6
)
Accretion
1.5

Balance as of November 30, 2013
22.9

Additions and other, net
(0.2
)
Accretion
1.7

Balance as of November 30, 2014
24.4

Additions and other, net
3.0

Accretion
1.9

Balance as of November 30, 2015
$
29.3

n.  Advance Payments on Contracts
The Company receives advances from customers which may exceed costs incurred on certain contracts. Such advances or billings in excess of cost and estimated earnings, other than those reflected as a reduction of inventories as progress payments, are classified as current liabilities.
o.  Loss Contingencies
The Company is currently involved in certain legal proceedings and, as required, has accrued its estimate of the probable costs and recoveries for resolution of these claims. These estimates are based upon an analysis of potential results, assuming a combination of litigation and settlement strategies. It is possible, however, that future results of operations or cash flows for any particular period could be materially affected by changes in estimates or the effectiveness of strategies related to these proceedings.
p.  Warranties
The Company provides product warranties in conjunction with certain product sales. The majority of the Company’s warranties are a one-year standard warranty for parts, workmanship, and compliance with specifications. On occasion, the Company has made commitments beyond the standard warranty obligation. While the Company has contracts with warranty provisions, there is not a history of any significant warranty claims experience. A reserve for warranty exposure is made on a product by product basis when it is both estimable and probable. These costs are included in the program’s estimate at completion and are expensed in accordance with the Company’s revenue recognition methodology as allowed under GAAP for that particular contract.
q.  Revenue Recognition
In the Company’s Aerospace and Defense segment, recognition of profit on long-term contracts requires the use of assumptions and estimates related to the contract value or total contract revenue, the total cost at completion and the measurement of progress towards completion. Due to the nature of the programs, developing the estimated total cost at completion requires the use of significant judgment. Estimates are continually evaluated as work progresses and are revised as necessary. Factors that must be considered in estimating the work to be completed include labor productivity, the nature and technical complexity of the work to be performed, availability and cost volatility of materials, subcontractor and vendor performance, warranty costs, volume assumptions, anticipated labor agreements and inflationary trends, schedule and performance delays, availability of funding from the customer, and the recoverability of costs incurred outside the original contract included in any estimates to complete. The Company reviews contract performance and cost estimates for some contracts at least monthly and for others at least quarterly and more frequently when circumstances significantly change. When a change in estimate is determined to have an impact on contract profit, the Company will record a positive or negative adjustment to the statement of operations. Changes in estimates and assumptions related to the status of certain long-term contracts may have a material effect on the Company’s operating results. The following table summarizes the impact from changes in estimates and assumptions on the statements of operations on contracts, representing 83% of the Company’s

15



aerospace and defense segment net sales over the last three fiscal years, accounted for under the percentage-of-completion method of accounting:
 
Year Ended
 
2015
 
2014
 
2013
 
(In millions, except per share amounts)
Favorable effect of the changes in contract estimates on loss from continuing operations before income taxes
$
41.2

 
$
9.2

 
$
23.2

Favorable effect of the changes in contract estimates on net (loss) income
24.7

 
5.5

 
13.6

Favorable effect of the changes in contract estimates on basic net (loss) income per share
0.40

 
0.10

 
0.22

Favorable effect of the changes in contract estimates on diluted net (loss) income per share
0.40

 
0.10

 
0.16

The fiscal 2015 favorable changes in contract estimates were primarily driven by the following (i) better than expected performance on space launch systems and missile defense programs primarily due to affordability initiatives and lower overhead costs and (ii) unexpected favorable contract performance on close-out activities on the J-2X program. The fiscal 2014 favorable changes in contract estimates were primarily driven by better than expected performance on a space launch system program due to favorable contract negotiations and affordability initiatives partially offset by unanticipated inefficiencies and cost growth on the Antares AJ-26 program. The fiscal 2013 favorable changes in contract estimates were primarily driven by better than expected performance on tactical systems programs due to manufacturing efficiencies and lower overhead costs. The improvements in fiscal 2013 were offset by unexpected cost growth on the Antares AJ-26 program.
The Company considers the nature of the individual underlying contract and the type of products and services provided in determining the proper accounting for a particular contract. Each method is applied consistently to all contracts having similar characteristics, as described below. The Company typically accounts for its contracts using the percentage-of-completion method, and progress is measured on a cost-to-cost or units-of-delivery basis. Sales are recognized using various measures of progress depending on the contractual terms and scope of work of the contract. The Company recognizes revenue on a units-of-delivery basis when contracts require unit deliveries on a frequent and routine basis. Sales using this measure of progress are recognized at the contractually agreed upon unit price. Where the scope of work on contracts principally relates to research and/or development efforts, or the contract is predominantly a development effort with few deliverable units, the Company recognizes revenue on a cost-to-cost basis. In this case, sales are recognized as costs are incurred and include estimated earned fees or profits calculated on the basis of the relationship between costs incurred and total estimated costs at completion. Revenue on service or time and material contracts is recognized when performed. If at any time expected costs exceed the value of the contract, the loss is recognized immediately.
If change orders are in dispute or are unapproved in regard to both scope and price they are evaluated as claims. The Company recognizes revenue on claims when recovery of the claim is probable and the amount can be reasonably estimated. Revenue on claims is recognized only to the extent that contract costs related to the claims have been incurred and when it is probable that the claim will result in a bona fide addition to contract value that can be reliably estimated. No profit is recognized on a claim until final settlement occurs.
Certain government contracts contain cost or performance incentive provisions that provide for increased or decreased fees or profits based upon actual performance against established targets or other criteria. Incentive and award fees, which are generally awarded at the discretion of the customer, are included in estimated contract revenue at the time the amounts can be reasonably determined and are reasonably assured based on historical experience and anticipated performance. The Company continually evaluates its performance and incorporates any anticipated changes in penalties and incentives into its revenue and earnings calculations.
Revenue from real estate asset sales is recognized when a sufficient down-payment has been received, financing has been arranged and title, possession and other attributes of ownership have been transferred to the buyer. The allocation to cost of sales on real estate asset sales is based on a relative fair market value computation of the land sold which includes the basis on the Company’s book value, capitalized entitlement costs, and an estimate of the Company’s continuing financial commitment.
Revenue that is not derived from long-term development and production contracts, or real estate asset transactions, is recognized when persuasive evidence of a final agreement exists, delivery has occurred, the selling price is fixed or determinable and payment from the customer is reasonably assured. Sales are recorded net of provisions for customer pricing allowances.
r.  Research and Development
Company-sponsored R&D expenses were $74.4 million in fiscal 2015, $51.9 million in fiscal 2014, and $42.9 million in fiscal 2013. Company-sponsored R&D expenses include the costs of technical activities that are useful in developing new

16



products, services, processes, or techniques, as well as expenses for technical activities that may significantly improve existing products or processes. These expenses are generally allocated among all contracts and programs in progress under U.S. government contractual arrangements. From time to time, the Company believes it is in its best interests to self-fund and not allocate costs for certain R&D activities to the U.S. government contracts.  In fiscal 2015, Company-sponsored R&D expenses included $48.2 million of AR-1 R&D expenses of which $32.1 million was not allocated to U.S. government contracts.
Customer-sponsored R&D expenditures, which are funded under U.S. government contracts, totaled $485.8 million in fiscal 2015, $481.2 million in fiscal 2014, and $335.9 million in fiscal 2013. Expenditures under customer-sponsored R&D funded government contracts are accounted for as sales and cost of products sold.
s.  Stock-based Compensation
The Company recognizes stock-based compensation in the statements of operations at the grant-date fair value of stock awards issued to employees and directors over the vesting period. The Company also grants Stock Appreciation Rights (“SARS”) awards which are similar to the Company’s employee stock options, but are settled in cash rather than in shares of common stock, and are classified as liability awards. Compensation cost for these awards is determined using a fair-value method and remeasured at each reporting date until the date of settlement. The Company utilizes the short-cut method for determining the historical pool of windfall tax benefits and the tax law ordering approach for purposes of determining whether an excess tax benefit has been realized.
t.  Impairment or Disposal of Long-Lived Assets
Impairment of long-lived assets is recognized when events or circumstances indicate that the carrying amount of the asset, or related groups of assets, may not be recoverable. Circumstances which could trigger a review include, but are not limited to: significant decreases in the market price of the asset; significant adverse changes in the business climate or legal factors; accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset; current period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset; or a current expectation that the asset will more likely than not be sold or disposed of significantly before the end of its estimated useful life. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. If the Company determines that an asset is not recoverable, then the Company would record an impairment charge if the carrying value of the asset exceeds its fair value.
A long-lived asset classified as “held for sale” is initially measured at the lower of its carrying amount or fair value less costs to sell. In the period that the “held for sale” criteria are met, the Company recognizes an impairment charge for any initial adjustment of the long-lived asset amount. Gains or losses not previously recognized resulting from the sale of a long-lived asset are recognized on the date of sale.
u.  Foreign Currency Transactions
Foreign currency transaction gains and (losses) were $0.1 million in fiscal 2015, $0.3 million in fiscal 2014, and ($0.2) million in fiscal 2013, and are reported as a component of discontinued operations. The Company’s foreign currency transactions were associated with the Company’s former GDX business which is classified as discontinued operations in these consolidated financial statements and notes to consolidated financial statements.
v.   Concentrations
Dependence upon government programs and contracts
Sales to the U.S. government and its agencies, including sales to the Company’s significant customers discussed below, were as follows (dollars in millions):
 
U.S. Government
Sales
 
Percentage of Net
Sales
Fiscal 2015
$
1,529.2

 
90
%
Fiscal 2014
1,478.6

 
92
%
Fiscal 2013
1,305.9

 
95
%
The Standard Missile program, which is included in the U.S. government sales, represented 14%, 12%, and 22% of net sales for fiscal 2015, 2014, and 2013, respectively. The Terminal High Altitude Area Defense (“THAAD”) program, which is included in the U.S. government sales, represented 13%, 12%, and 3% of net sales for fiscal 2015, 2014, and 2013, respectively. The demand for certain of the Company’s services and products is directly related to the level of funding of government programs.

17



Major customers
Customers that represented more than 10% of net sales for the fiscal years presented are as follows:
 
Year Ended
 
2015
 
2014
 
2013
Lockheed Martin Corporation ("Lockheed Martin")
29
%
 
28
%
 
23
%
Raytheon Company ("Raytheon")
20

 
17

 
33

United Launch Alliance ("ULA")
19

 
25

 
18

NASA
11

 
11

 
*

__________
*
Less than 10%.
The Company's sales to each of the major customers listed above involve several product lines and programs.
Credit Risk
Aside from investments held in the Company’s defined benefit pension plan, financial instruments that could potentially subject the Company to concentration of credit risk consist primarily of cash, cash equivalents, and trade receivables. The Company’s cash and cash equivalents are held and managed by recognized financial institutions and are subject to the Company’s investment policy. The investment policy outlines minimum acceptable credit ratings for each type of investment and limits the amount of credit exposure to any one security issue. The Company does not believe significant concentration of credit risk exists with respect to these investments.
Customers that represented more than 10% of accounts receivable for the periods presented are as follows:
 
 
As of November 30, 
 
 
2015
 
2014
 
 
 
 
Lockheed Martin
31
%
 
21
%
ULA
23

 
31

Raytheon
18

 
22

NASA
11

 
*

Boeing
*

 
12

_____
* Less than 10%
Dependence on Single Source and Other Third Party Suppliers
The Company uses a significant quantity of raw materials that are highly dependent on market fluctuations and government regulations. Further, as a U.S. government contractor, the Company is often required to procure materials from suppliers capable of meeting rigorous customer and government specifications. As market conditions change for these companies, they often discontinue materials with low sales volumes or profit margins. The Company is often forced to either qualify new materials or pay higher prices to maintain the supply. To-date the Company has been successful in establishing replacement materials and securing customer funding to address specific qualification needs of the programs. Prolonged disruptions in the supply of any of the Company’s key raw materials, difficulty qualifying new sources of supply, implementing use of replacement materials or new sources of supply, and/or a continuing volatility in the prices of raw materials could have a material adverse effect on the Company’s operating results, financial condition, and/or cash flows.
Workforce
As of November 30, 2015, 15% of the Company’s 4,823 employees were covered by collective bargaining agreements.

w.  Related Parties
The chairman of the Company’s board of directors is executive chairman of Steel Partners Holdings L.P. (“Steel Holdings”). Steel Holdings owns 100% of SP Corporate Services LLC ("SP Corporate"). The Company received services of $1.1 million in fiscal 2015 from SP Corporate primarily for the use of an aircraft for business travel. As of November 30, 2015, the Company had a payable due to SP Corporate of $0.5 million.

18



x.  Accounting Pronouncements
Recently Adopted Accounting Pronouncements
In July 2013, the Financial Accounting Standards Board (“FASB”) issued an amendment to the accounting guidance related to the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward exists. The guidance requires an unrecognized tax benefit to be presented as a decrease in a deferred tax asset where a net operating loss, a similar tax loss, or a tax credit carryforward exists and certain criteria are met. The Company adopted this guidance beginning in the first quarter of fiscal 2014. As the accounting standard only impacted presentation, the new standard did not have an impact on the Company’s financial position, results of operations, or cash flows.
In April 2014, the FASB issued authoritative guidance which specifies that only disposals, such as a disposal of a major line of business, representing a strategic shift in operations should be presented as discontinued operations. In addition, the new guidance requires expanded disclosures about discontinued operations that will provide financial statement users with more information about the assets, liabilities, income, and expenses of discontinued operations. The Company adopted this guidance in the fourth quarter of fiscal 2014. An entity should not apply the amendments in this new guidance to a component of an entity that is classified as held for sale before the effective date even if the component of an entity is disposed of after the effective date. As the accounting standard only impacted presentation, the new standard did not have an impact on the Company’s financial position, results of operations, or cash flows.
In May 2015, the FASB issued amended guidance on disclosures for investments in certain entities that calculate net asset value per share (“NAV”) or its equivalent. The new guidance requires the investments for which fair value is measured at NAV (or its equivalent) to be removed from fair value hierarchy.  The Company adopted this guidance as of November 30, 2015.  The new guidance was applied retrospectively to all periods presented.  As the accounting standard only impacted presentation, the new standard did not have an impact on the Company’s financial position, results of operations, or cash flows.
Recently Issued Accounting Pronouncements
In May 2014, the FASB amended the existing accounting standards for revenue recognition. The amendments are based on the principle that revenue should be recognized to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The FASB deferred the effective date for this guidance by one year to December 15, 2017 for annual reporting periods beginning after that. Earlier application of this guidance is permitted but not before the original date of December 15, 2016. The amendments may be applied retrospectively to each prior period presented or retrospectively with the cumulative effect recognized as of the date of initial application. The Company is currently evaluating the impact of these amendments and the transition alternatives on its consolidated financial statements.
In August 2014, the FASB issued an amendment to the accounting guidance related to the evaluation of an entity to continue as a going concern. The amendment establishes management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern in connection with preparing financial statements for each annual and interim reporting period. The update also gives guidance to determine whether to disclose information about relevant conditions and events when there is substantial doubt about an entity’s ability to continue as a going concern. The guidance is effective for annual periods ending after December 15, 2016, and for annual periods and interim periods thereafter. The new guidance is not expected to have an impact on the Company’s financial position, results of operations, or cash flows.
In April 2015, the FASB issued an amendment to the accounting guidance related to the presentation of debt issuance costs. The amendment requires that debt issuance costs related to a debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts or premiums. The guidance is effective for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact of this amendment on its consolidated financial statements.
In July 2015, the FASB issued guidance to change the subsequent measurement of inventory from lower of cost or market to lower of cost and net realizable value. The guidance is effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. Earlier application is permitted as of the beginning of an interim or annual reporting period. The Company is evaluating the impact of adopting this new accounting guidance on its consolidated financial statements.
In November 2015, FASB issued guidance that requires deferred tax liabilities and assets to be classified as noncurrent in the consolidated balance sheet. The standard will be effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early adoption is permitted for financial statements that have not been previously issued. The standard may be applied either prospectively to all deferred tax liabilities and assets or retrospectively to all periods presented. The Company is evaluating the impact of adopting this new accounting guidance on its consolidated financial statements.

19



Note 2. Restatement
The Company corrected errors in prior periods primarily related to the following matters: (i) purchase accounting associated with contracts acquired as part of the acquisition of the Rocketdyne Business; (ii) contract accounting related to subsequent modifications to one significant acquired contract; (iii) contract accounting related to the improper recognition of sales associated with incentives; and (iv) other individually immaterial items. A summary of the impact to pretax income (loss) from continuing operations by reporting period is presented below (in millions):
 
 
Income (loss) before income taxes
Reporting Period
 
First nine months of fiscal 2015
 
Fiscal 2014
 
Fiscal 2013
Purchase accounting for contracts acquired as part of the acquisition of the Rocketdyne Business (1)
 
$
(0.5
)
 
$
3.1

 
$
(7.8
)
Contract accounting related to subsequent modifications to one significant acquired Rocketdyne Business contract (2)
 
1.3

 
2.9

 

Contract accounting related to improper recognition of sales incentives (3)
 

 
1.9

 
(2.0
)
Other individually immaterial items
 
(1.2
)
 
(1.5
)
 
0.3

___________
(1) The Company's errors associated with purchase accounting primarily related to the following: (i) fair value assessment of Rocketdyne Business acquired customer contracts at the acquisition date following the close of the transaction. The Company failed to fair value three acquired contracts in purchase accounting; and (ii) the estimates of the Rocketdyne Business contracts' percentage of completion used to recognize net sales should have been based on its estimate of remaining effort on such contracts at the acquisition date instead of the inception date of the contract.
(2) The Company did not appropriately account for one significant acquired Rocketdyne Business contract amendment. Instead of being accounted for as a modification, the amendment was accounted for as a new contract.
(3) The Company immediately recognized incentives as sales based on the full amount received rather than on the percentage of completion of the related contract.
The Company also corrected previously disclosed immaterial out of period adjustments as part of this restatement and other balance sheet misclassifications.
The correction of the matters described above resulted in the following adjustments to the previously issued consolidated financial statements: (i) an increase of $0.3 million, or $0.00 loss per share, to net loss for the first nine months of fiscal 2015; (ii) a decrease of $3.0 million, or $0.06 loss per share, to net loss for fiscal 2014; and (iii) a decrease of $5.0 million, or $0.06 diluted income per share, to net income for fiscal 2013. A summary of the impact to the consolidated statements of operations by reporting period is presented below (in millions):
Reporting Period
 
Net (Loss) Income
First nine months of fiscal 2015
 
$
(0.3
)
Fiscal 2014
 
3.0

Fiscal 2013
 
(5.0
)
The Company concluded these errors were material in the aggregate to the prior reporting periods, and therefore, restatement of previously filed financial statements was necessary to the Company's previously issued fiscal 2014 and 2013 consolidated financial statements and each of the quarterly 2015 and 2014 unaudited condensed consolidated financial statements.
The account balances labeled “As Reported” in the following tables for the years ended November 30, 2014 and 2013 represent the previously reported financial statements as presented in the Company's Annual Report on Form 10-K for the year ended November 30, 2014. The effects of these prior period errors on the consolidated financial statements are as follows:





20



Consolidated Balance Sheet
 
November 30, 2014
 
As Reported
 
Adjustments
 
As Restated
 
(In millions)
ASSETS
 
 
 
 
Current Assets
 
 
 
 
 
Cash and cash equivalents
$
265.9

 
$

 
$
265.9

Accounts receivable
172.9

 
(2.4
)
 
170.5

Inventories
139.0

 
(1.0
)
 
138.0

Recoverable from the U.S. government and other third parties for environmental remediation costs
19.4

 

 
19.4

Receivable from Northrop
6.0

 

 
6.0

Other current assets, net
35.9

 
2.7

 
38.6

Income taxes
2.1

 

 
2.1

Deferred income taxes
25.3

 
(5.4
)
 
19.9

Total Current Assets
666.5

 
(6.1
)
 
660.4

Noncurrent Assets
 
 
 
 
 
Property, plant and equipment, net
367.5

 
(1.0
)
 
366.5

Real estate held for entitlement and leasing
94.4

 

 
94.4

Recoverable from the U.S. government and other third parties for environmental remediation costs
81.2

 
6.0

 
87.2

Receivable from Northrop
74.8

 
(6.0
)
 
68.8

Deferred income taxes
259.0

 
2.4

 
261.4

Goodwill
164.4

 
(6.3
)
 
158.1

Intangible assets
122.2

 

 
122.2

Income taxes

 
6.6

 
6.6

Other noncurrent assets, net
91.6

 
1.4

 
93.0

Total Noncurrent Assets
1,255.1

 
3.1

 
1,258.2

Total Assets
$
1,921.6

 
$
(3.0
)
 
$
1,918.6

LIABILITIES, REDEEMABLE COMMON STOCK, AND STOCKHOLDERS’ DEFICIT
 
 
 
 
Current Liabilities
 
 
 
 
 
Short-term borrowings and current portion of long-term debt
$
5.3

 
$

 
$
5.3

Accounts payable
103.5

 
0.5

 
104.0

Reserves for environmental remediation costs
31.9

 

 
31.9

Postretirement medical and life insurance benefits
6.4

 

 
6.4

Advance payments on contracts
198.5

 
(1.1
)
 
197.4

Other current liabilities
221.7

 
(0.3
)
 
221.4

Total Current Liabilities
567.3

 
(0.9
)
 
566.4

Noncurrent Liabilities
 
 
 
 
 
Senior debt
93.8

 

 
93.8

Second-priority senior notes
460.0

 

 
460.0

Convertible subordinated notes
133.8

 

 
133.8

Other debt
89.3

 

 
89.3

Reserves for environmental remediation costs
134.1

 

 
134.1

Pension benefits
482.8

 

 
482.8

Postretirement medical and life insurance benefits
51.7

 

 
51.7

Other noncurrent liabilities
79.7

 
0.9

 
80.6

Total Noncurrent Liabilities
1,525.2

 
0.9

 
1,526.1

Total Liabilities
2,092.5

 

 
2,092.5

Commitments and contingencies (Note 9)

 

 

Redeemable common stock
1.6

 

 
1.6

Stockholders’ Deficit
 
 

 
 
Preference stock

 

 

Common stock
5.9

 

 
5.9

Other capital
287.3

 
0.1

 
287.4

Treasury stock
(64.5
)
 

 
(64.5
)
Accumulated deficit
(67.0
)
 
(3.6
)
 
(70.6
)
Accumulated other comprehensive loss, net of income taxes
(334.2
)
 
0.5

 
(333.7
)
Total Stockholders’ Deficit
(172.5
)
 
(3.0
)
 
(175.5
)
Total Liabilities, Redeemable Common Stock and Stockholders’ Deficit
$
1,921.6

 
$
(3.0
)
 
$
1,918.6


21




Consolidated Statements of Operations and Comprehensive (Loss) Income
 
Year Ended 2014
 
As Reported
 
Adjustments
 
As Restated
 
(In millions, except per share amounts)
Net sales
$
1,597.4

 
$
4.8

 
$
1,602.2

Operating costs and expenses:
 
 
 
 
 
Cost of sales (exclusive of items shown separately below)
1,408.1

 
(1.9
)
 
1,406.2

Selling, general and administrative
37.9

 
0.3

 
38.2

Depreciation and amortization
63.7

 

 
63.7

Other expense, net:
 
 

 
 
Loss on debt repurchased
60.6

 

 
60.6

Other
13.9

 

 
13.9

Total operating costs and expenses
1,584.2

 
(1.6
)
 
1,582.6

Operating income
13.2

 
6.4

 
19.6

Non-operating (income) expense:
 
 
 
 
 
Interest income
(0.1
)
 

 
(0.1
)
Interest expense
52.7

 

 
52.7

Total non-operating expense, net
52.6

 

 
52.6

Loss from continuing operations before income taxes
(39.4
)
 
6.4

 
(33.0
)
Income tax provision
12.9

 
3.4

 
16.3

Loss from continuing operations
(52.3
)
 
3.0

 
(49.3
)
Loss from discontinued operations, net of income taxes
(0.7
)
 

 
(0.7
)
Net loss
$
(53.0
)
 
$
3.0

 
$
(50.0
)
Loss per share of common stock
 
 
 
 
 
Basic and Diluted:
 
 
 
 
 
Loss per share from continuing operations
$
(0.91
)
 
$
0.06

 
$
(0.85
)
Loss per share from discontinued operations, net of income taxes
(0.01
)
 

 
(0.01
)
Net loss per share
$
(0.92
)
 
$
0.06

 
$
(0.86
)
Weighted average shares of common stock outstanding, basic and diluted
57.9

 

 
57.9

 
Year Ended 2014
 
As Reported
 
Adjustments
 
As Restated
 
(In millions)
Net loss
$
(53.0
)
 
$
3.0

 
$
(50.0
)
Other comprehensive loss:
 
 
 
 
 
Amortization of net actuarial losses, net of income taxes
30.7

 
0.4

 
31.1

Actuarial losses, net of income taxes
(142.0
)
 
6.0

 
(136.0
)
Amortization of prior service credits, net of income taxes
(0.5
)
 

 
(0.5
)
Comprehensive loss
$
(164.8
)
 
$
9.4

 
$
(155.4
)


22



 
Year Ended 2013
 
As Reported
 
Adjustments
 
As Restated
 
(In millions, except per share amounts)
Net sales
$
1,383.1

 
$
(5.0
)
 
$
1,378.1

Operating costs and expenses:
 
 
 
 
 
Cost of sales (exclusive of items shown separately below)
1,229.6

 
4.7

 
1,234.3

Selling, general and administrative
53.6

 

 
53.6

Depreciation and amortization
43.8

 
(0.3
)
 
43.5

Other expense, net:
 
 

 
 
Loss on debt repurchased
5.0

 

 
5.0

Other
28.8

 
0.1

 
28.9

Total operating costs and expenses
1,360.8

 
4.5

 
1,365.3

Operating income
22.3

 
(9.5
)
 
12.8

Non-operating (income) expense:
 
 
 
 
 
Interest income
(0.2
)
 

 
(0.2
)
Interest expense
48.7

 

 
48.7

Total non-operating expense, net
48.5

 

 
48.5

Loss from continuing operations before income taxes
(26.2
)
 
(9.5
)
 
(35.7
)
Income tax benefit
(193.9
)
 
(4.5
)
 
(198.4
)
Income from continuing operations
167.7

 
(5.0
)
 
162.7

Income from discontinued operations, net of income taxes
0.2

 

 
0.2

Net income
$
167.9

 
$
(5.0
)
 
$
162.9

Income per share of common stock
 
 
 
 
 
Basic:
 
 
 
 
 
Income per share from continuing operations
$
2.76

 
$
(0.08
)
 
$
2.68

Income per share from discontinued operations, net of income taxes

 

 

Net income per share
$
2.76

 
$
(0.08
)
 
$
2.68

Diluted:
 
 
 
 
 
Income per share from continuing operations
$
2.11

 
$
(0.06
)
 
$
2.05

Income per share from discontinued operations, net of income taxes

 

 

Net income per share
$
2.11

 
$
(0.06
)
 
$
2.05

Weighted average shares of common stock outstanding, basic
59.6

 

 
59.6

Weighted average shares of common stock outstanding, diluted
81.9

 

 
81.9

 
Year Ended 2013
 
As Reported
 
Adjustments
 
As Restated
 
(In millions)
Net income
$
167.9

 
$
(5.0
)
 
$
162.9

Other comprehensive income:
 
 

 
 
Amortization of actuarial losses, net of income taxes
91.3

 

 
91.3

Actuarial gains, net of income taxes
173.5

 
(5.9
)
 
167.6

Amortization of prior service credits, net of income taxes
(0.9
)
 

 
(0.9
)
Comprehensive income
$
431.8

 
$
(10.9
)
 
$
420.9



23



Consolidated Statements of Cash Flows
 
Year Ended 2014
 
As Reported
 
Adjustments
 
As Restated
 
(In millions)
Operating Activities
 
 
 
 
 
Net loss
$
(53.0
)
 
$
3.0

 
$
(50.0
)
Adjustments to reconcile net loss to net cash provided by operating activities:
 
 
 
 
 
Loss from discontinued operations, net of income taxes
0.7

 

 
0.7

Depreciation and amortization
63.7

 

 
63.7

Amortization of financing costs
3.6

 

 
3.6

Stock-based compensation
5.7

 

 
5.7

Retirement benefit expense
35.6

 
0.9

 
36.5

Loss on debt repurchased
60.6

 

 
60.6

Loss on bank amendment
0.2

 

 
0.2

Loss on disposal of long-lived assets
2.8

 

 
2.8

Gain on sale of technology
(6.8
)
 

 
(6.8
)
Tax benefit on stock-based awards
(1.5
)
 
0.2

 
(1.3
)
Changes in assets and liabilities, net of effects from acquisition:
 
 
 
 
 
Accounts receivable
41.0

 
(12.1
)
 
28.9

Inventories
(33.9
)
 
1.9

 
(32.0
)
Other current assets, net
(12.8
)
 
2.0

 
(10.8
)
Income tax receivable
11.1

 
(7.4
)
 
3.7

Real estate held for entitlement and leasing
(15.0
)
 

 
(15.0
)
Receivable from Northrop
(2.8
)
 

 
(2.8
)
Recoverable from the U.S. government and other third parties for environmental remediation costs
8.5

 

 
8.5

Other noncurrent assets
(24.3
)
 
0.2

 
(24.1
)
Accounts payable
(19.0
)
 
0.8

 
(18.2
)
Retirement benefits
(5.3
)
 

 
(5.3
)
Advance payments on contracts
94.1

 
2.8

 
96.9

Other current liabilities
22.0

 
(2.2
)
 
19.8

Deferred income taxes
(18.1
)
 
11.0

 
(7.1
)
Reserves for environmental remediation costs
(5.3
)
 

 
(5.3
)
Other noncurrent liabilities and other
0.7

 
(0.9
)
 
(0.2
)
Net cash provided by continuing operations
152.5

 
0.2

 
152.7

Net cash used in discontinued operations
(2.1
)
 

 
(2.1
)
Net Cash Provided by Operating Activities
150.4

 
0.2

 
150.6

Investing Activities
 
 
 
 
 
Purchase of Rocketdyne Business
0.2

 

 
0.2

Proceeds from sale of technology
7.5

 

 
7.5

Capital expenditures
(43.4
)
 

 
(43.4
)
Net Cash Used in Investing Activities
(35.7
)
 

 
(35.7
)
Financing Activities
 
 
 
 
 
Proceeds from issuance of debt
189.0

 

 
189.0

Debt issuance costs
(4.2
)
 

 
(4.2
)
Debt repayments/repurchases
(166.3
)
 

 
(166.3
)
Proceeds from shares issued under equity plans, net
0.2

 

 
0.2

Repurchase of shares to satisfy tax withholding obligations
(2.1
)
 

 
(2.1
)
Purchase of treasury stock
(64.5
)
 

 
(64.5
)
Tax benefit on stock-based awards
1.5

 
(0.2
)
 
1.3

Net Cash Used in Financing Activities
(46.4
)
 
(0.2
)
 
(46.6
)
Net Increase in Cash and Cash Equivalents
68.3

 

 
68.3

Cash and Cash Equivalents at Beginning of Period
197.6

 

 
197.6

Cash and Cash Equivalents at End of Period
$
265.9

 
$

 
$
265.9


24



 
Year Ended 2013
 
As Reported
 
Adjustments
 
As Restated
 
(In millions)
Operating Activities
 
 
 
 
 
Net income
$
167.9

 
$
(5.0
)
 
$
162.9

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
 
 
Income from discontinued operations, net of income taxes
(0.2
)
 

 
(0.2
)
Depreciation and amortization
43.8

 
(0.3
)
 
43.5

Amortization of financing costs
4.5

 

 
4.5

Stock-based compensation
14.1

 

 
14.1

Retirement benefit expense
65.0

 

 
65.0

Loss on debt repurchased
5.0

 

 
5.0

Tax benefit on stock-based awards

 
(0.2
)
 
(0.2
)
Changes in assets and liabilities, net of effects from acquisition:
 
 
 
 
 
Accounts receivable
(37.6
)
 
13.6

 
(24.0
)
Inventories
(25.5
)
 
(0.9
)
 
(26.4
)
Other current assets, net
0.1

 
(4.5
)
 
(4.4
)
Income tax receivable
(12.6
)
 
0.8

 
(11.8
)
Real estate held for entitlement and leasing
(4.4
)
 

 
(4.4
)
Receivable from Northrop
(2.7
)
 
6.0

 
3.3

Recoverable from the U.S. government and other third parties for environmental remediation costs
21.1

 
(6.0
)
 
15.1

Other noncurrent assets
(7.8
)
 
5.8

 
(2.0
)
Accounts payable
50.1

 
(0.4
)
 
49.7

Retirement benefits
(5.4
)
 

 
(5.4
)
Advance payments on contracts
(43.9
)
 
(3.9
)
 
(47.8
)
Other current liabilities
56.8

 
1.0

 
57.8

Deferred income taxes
(191.3
)
 
(8.2
)
 
(199.5
)
Reserves for environmental remediation costs
(18.2
)
 

 
(18.2
)
Other noncurrent liabilities and other
(1.1
)
 
2.0

 
0.9

Net cash provided by continuing operations
77.7

 
(0.2
)
 
77.5

Net cash used in discontinued operations
(0.1
)
 

 
(0.1
)
Net Cash Provided by Operating Activities
77.6

 
(0.2
)
 
77.4

Investing Activities
 
 
 
 
 
Purchases of restricted cash investments
(470.0
)
 

 
(470.0
)
Sale of restricted cash investments
470.0

 

 
470.0

Purchase of Rocketdyne Business
(411.2
)
 

 
(411.2
)
Purchases of investments
(0.5
)
 

 
(0.5
)
Capital expenditures
(63.2
)
 

 
(63.2
)
Net Cash Used in Investing Activities
(474.9
)
 

 
(474.9
)
Financing Activities
 
 
 
 
 
Proceeds from issuance of debt
460.0

 

 
460.0

Debt issuance costs
(14.9
)
 

 
(14.9
)
Debt repayments/repurchases
(12.8
)
 

 
(12.8
)
Proceeds from shares issued under equity plans, net
0.7

 

 
0.7

Repurchase of shares to satisfy tax withholding obligations
(0.2
)
 

 
(0.2
)
Tax benefit on stock-based awards

 
0.2

 
0.2

Net Cash Provided by Financing Activities
432.8

 
0.2

 
433.0

Net Increase in Cash and Cash Equivalents
35.5

 

 
35.5

Cash and Cash Equivalents at Beginning of Period
162.1

 

 
162.1

Cash and Cash Equivalents at End of Period
$
197.6

 
$

 
$
197.6


The following tables present the unaudited condensed consolidated quarterly financial data for the first three quarters in the years ended November 30, 2015 and 2014:

25



Unaudited Condensed Consolidated Balance Sheets
 
August 31, 2015
 
May 31, 2015
 
As Reported
 
Adjustments
 
As Restated
 
As Reported
 
Adjustments
 
As Restated
 
(In millions)
 
(In millions)
ASSETS
 
 
 
 
 
 
 
 
 
 
Current Assets
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
243.3

 
$

 
$
243.3

 
$
253.5

 
$

 
$
253.5

Accounts receivable
186.7

 
2.6

 
189.3

 
173.7

 
1.9

 
175.6

Inventories
148.7

 
(0.8
)
 
147.9

 
150.3

 
(0.2
)
 
150.1

Recoverable from the U.S. government and other third parties for environmental remediation costs
23.2

 

 
23.2

 
23.7

 

 
23.7

Receivable from Northrop
6.0

 

 
6.0

 
6.0

 

 
6.0

Other current assets, net
60.0

 
3.3

 
63.3

 
45.4

 
3.6

 
49.0

Deferred income taxes
19.4

 
(5.4
)
 
14.0

 
24.8

 
(5.5
)
 
19.3

Total Current Assets
687.3

 
(0.3
)
 
687.0

 
677.4

 
(0.2
)
 
677.2

Noncurrent Assets
 
 
 
 
 
 
 
 
 
 
 
Property, plant and equipment, net
351.8

 

 
351.8

 
356.3

 

 
356.3

Real estate held for entitlement and leasing
84.2

 

 
84.2

 
82.9

 

 
82.9

Recoverable from the U.S. government and other third parties for environmental remediation costs
123.2

 

 
123.2

 
76.8

 

 
76.8

Receivable from Northrop
70.0

 

 
70.0

 
69.7

 

 
69.7

Deferred income taxes
253.6

 
1.0

 
254.6

 
245.3

 
2.0

 
247.3

Goodwill
164.4

 
(6.3
)
 
158.1

 
164.4

 
(6.3
)
 
158.1

Intangible assets
112.1

 

 
112.1

 
115.5

 

 
115.5

Other noncurrent assets, net
110.8

 
5.8

 
116.6

 
109.8

 
5.7

 
115.5

Total Noncurrent Assets
1,270.1

 
0.5

 
1,270.6

 
1,220.7

 
1.4

 
1,222.1

Total Assets
$
1,957.4

 
$
0.2

 
$
1,957.6

 
$
1,898.1

 
$
1.2

 
$
1,899.3

LIABILITIES, REDEEMABLE COMMON STOCK, AND STOCKHOLDERS’ DEFICIT
Current Liabilities
 
 
 
 
 
 
 
 
 
 
 
Short-term borrowings and current portion of long-term debt
$
5.3

 
$

 
$
5.3

 
$
5.3

 
$

 
$
5.3

Accounts payable
88.7

 

 
88.7

 
87.6

 
0.5

 
88.1

Reserves for environmental remediation costs
37.6

 

 
37.6

 
38.7

 

 
38.7

Postretirement medical and life insurance benefits
6.4

 

 
6.4

 
6.4

 

 
6.4

Advance payments on contracts
211.7

 

 
211.7

 
197.3

 

 
197.3

Other current liabilities
241.3

 
2.4

 
243.7

 
198.5

 
2.4

 
200.9

Total Current Liabilities
591.0

 
2.4

 
593.4

 
533.8

 
2.9

 
536.7

Noncurrent Liabilities
 
 
 
 
 
 
 
 
 
 
 
Senior debt
90.0

 

 
90.0

 
91.3

 

 
91.3

Second-priority senior notes
460.0

 

 
460.0

 
460.0

 

 
460.0

Convertible subordinated notes
84.8

 

 
84.8

 
98.0

 

 
98.0

Other debt
21.1

 

 
21.1

 
63.3

 

 
63.3

Reserves for environmental remediation costs
198.5

 

 
198.5

 
122.8

 

 
122.8

Pension benefits
471.7

 
0.2

 
471.9

 
475.4

 
0.1

 
475.5

Postretirement medical and life insurance benefits
49.4

 

 
49.4

 
50.1

 

 
50.1

Other noncurrent liabilities
98.1

 
(0.3
)
 
97.8

 
99.0

 
0.7

 
99.7

Total Noncurrent Liabilities
1,473.6

 
(0.1
)
 
1,473.5

 
1,459.9

 
0.8

 
1,460.7

Total Liabilities
2,064.6

 
2.3

 
2,066.9

 
1,993.7

 
3.7

 
1,997.4

Redeemable common stock
0.1

 

 
0.1

 
0.1

 

 
0.1

Stockholders’ Deficit
 
 

 
 
 
 
 
 
 
 
Common stock
6.4

 

 
6.4

 
6.3

 

 
6.3

Other capital
339.6

 
0.9

 
340.5

 
324.8

 
1.0

 
325.8

Treasury stock
(64.5
)
 

 
(64.5
)
 
(64.5
)
 

 
(64.5
)
Accumulated deficit
(90.6
)
 
(3.9
)
 
(94.5
)
 
(52.5
)
 
(4.1
)
 
(56.6
)
Accumulated other comprehensive loss, net of income taxes
(298.2
)
 
0.9

 
(297.3
)
 
(309.8
)
 
0.6

 
(309.2
)
Total Stockholders’ Deficit
(107.3
)
 
(2.1
)
 
(109.4
)
 
(95.7
)
 
(2.5
)
 
(98.2
)
Total Liabilities, Redeemable Common Stock and Stockholders’ Deficit
$
1,957.4

 
$
0.2

 
$
1,957.6

 
$
1,898.1

 
$
1.2

 
$
1,899.3


26



 
February 28, 2015
 
August 31, 2014
Unaudited
As Reported
 
Adjustments
 
As Restated
 
As Reported
 
Adjustments (1)
 
As Restated
 
(In millions)
 
(In millions)
ASSETS
 
 
 
 
 
 
 
 
 
 
Current Assets
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
215.7

 
$

 
$
215.7

 
$
154.9

 
$

 
$
154.9

Accounts receivable
206.1

 
(16.1
)
 
190.0

 
214.7

 
(14.2
)
 
200.5

Inventories
161.4

 
0.1

 
161.5

 
132.3

 
(0.5
)
 
131.8

Recoverable from the U.S. government and other third parties for environmental remediation costs
23.5

 

 
23.5

 
20.1

 

 
20.1

Receivable from Northrop
6.0

 

 
6.0

 
6.0

 

 
6.0

Other current assets, net
42.5

 
1.2

 
43.7

 
26.7

 
3.4

 
30.1

Income taxes
1.9

 
0.4

 
2.3

 
13.4

 
0.3

 
13.7

Deferred income taxes
22.5

 
(3.8
)
 
18.7

 
4.0

 
6.7

 
10.7

Total Current Assets
679.6

 
(18.2
)
 
661.4

 
572.1

 
(4.3
)
 
567.8

Noncurrent Assets
 
 
 
 
 
 
 
 
 
 
 
Property, plant and equipment, net
358.8

 
(1.6
)
 
357.2

 
370.6

 
(1.3
)
 
369.3

Real estate held for entitlement and leasing
81.5

 

 
81.5

 
87.3

 

 
87.3

Recoverable from the U.S. government and other third parties for environmental remediation costs
79.3

 

 
79.3

 
83.6

 
6.0

 
89.6

Receivable from Northrop
69.4

 

 
69.4

 
74.0

 
(6.0
)
 
68.0

Deferred income taxes
254.5

 
1.5

 
256.0

 
180.0

 
2.5

 
182.5

Goodwill
164.4

 
(6.3
)
 
158.1

 
164.4

 
(6.3
)
 
158.1

Intangible assets
118.8

 

 
118.8

 
125.6

 

 
125.6

Assets held for sale
14.2

 

 
14.2

 

 

 

Other noncurrent assets, net
91.2

 
8.6

 
99.8

 
92.1

 
2.0

 
94.1

Total Noncurrent Assets
1,232.1

 
2.2

 
1,234.3

 
1,177.6

 
(3.1
)
 
1,174.5

Total Assets
$
1,911.7

 
$
(16.0
)
 
$
1,895.7

 
$
1,749.7

 
$
(7.4
)
 
$
1,742.3

LIABILITIES, REDEEMABLE COMMON STOCK, AND STOCKHOLDERS’ DEFICIT
Current Liabilities
 
 
 
 
 
 
 
 
 
 
 
Short-term borrowings and current portion of long-term debt
$
5.3

 
$

 
$
5.3

 
$
5.5

 
$

 
$
5.5

Accounts payable
84.5

 
0.5

 
85.0

 
115.4

 

 
115.4

Reserves for environmental remediation costs
38.3

 

 
38.3

 
35.0

 

 
35.0

Postretirement medical and life insurance benefits
6.4

 

 
6.4

 
7.2

 

 
7.2

Advance payments on contracts
224.0

 
(17.0
)
 
207.0

 
122.4

 
(6.4
)
 
116.0

Other current liabilities
211.3

 
2.2

 
213.5

 
216.4

 
1.7

 
218.1

Total Current Liabilities
569.8

 
(14.3
)
 
555.5

 
501.9

 
(4.7
)
 
497.2

Noncurrent Liabilities
 
 
 
 
 
 
 
 
 
 
 
Senior debt
92.5

 

 
92.5

 
95.0

 

 
95.0

Second-priority senior notes
460.0

 

 
460.0

 
460.0

 

 
460.0

Convertible subordinated notes
99.4

 

 
99.4

 
133.6

 

 
133.6

Other debt
81.3

 

 
81.3

 
89.4

 

 
89.4

Reserves for environmental remediation costs
124.3

 

 
124.3

 
133.6

 

 
133.6

Pension benefits
479.1

 

 
479.1

 
248.3

 
9.4

 
257.7

Postretirement medical and life insurance benefits
50.6

 

 
50.6

 
57.1

 

 
57.1

Other noncurrent liabilities
81.1

 
0.7

 
81.8

 
79.3

 

 
79.3

Total Noncurrent Liabilities
1,468.3

 
0.7

 
1,469.0

 
1,296.3

 
9.4

 
1,305.7

Total Liabilities
2,038.1

 
(13.6
)
 
2,024.5

 
1,798.2

 
4.7

 
1,802.9

Redeemable common stock
0.1

 

 
0.1

 
0.2

 

 
0.2

Stockholders’ Deficit
 
 

 
 
 
 
 
 
 
 
Common stock
6.3

 

 
6.3

 
5.9

 

 
5.9

Other capital
324.6

 

 
324.6

 
285.4

 

 
285.4

Treasury stock
(64.5
)
 

 
(64.5
)
 
(64.5
)
 

 
(64.5
)
Accumulated deficit
(70.9
)
 
(3.0
)
 
(73.9
)
 
(75.8
)
 
(6.7
)
 
(82.5
)
Accumulated other comprehensive loss, net of income taxes
(322.0
)
 
0.6

 
(321.4
)
 
(199.7
)
 
(5.4
)
 
(205.1
)
Total Stockholders’ Deficit
(126.5
)
 
(2.4
)
 
(128.9
)
 
(48.7
)
 
(12.1
)
 
(60.8
)
Total Liabilities, Redeemable Common Stock and Stockholders’ Deficit
$
1,911.7

 
$
(16.0
)
 
$
1,895.7

 
$
1,749.7

 
$
(7.4
)
 
$
1,742.3

_______
(1) Includes adjustments related to the previously reported errors that were revised in the Company's fiscal 2014 Form 10-K and the additional adjustments related to the restatement.

27



 
May 31, 2014
 
February 28, 2014
Unaudited
As Reported
 
Adjustments (1)
 
As Restated
 
As Reported
 
Adjustments (1)
 
As Restated
 
(In millions)
 
(In millions)
ASSETS
 
 
 
 
 
 
 
 
 
 
Current Assets
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
120.7

 
$

 
$
120.7

 
$
144.1

 
$

 
$
144.1

Accounts receivable
191.7

 
(14.4
)
 
177.3

 
199.2

 
(13.1
)
 
186.1

Inventories
131.9

 
(0.2
)
 
131.7

 
139.2

 
(3.0
)
 
136.2

Recoverable from the U.S. government and other third parties for environmental remediation costs
21.0

 

 
21.0

 
22.4

 

 
22.4

Receivable from Northrop
6.0

 

 
6.0

 
6.0

 

 
6.0

Other current assets, net
19.6

 
4.9

 
24.5

 
22.5

 
6.1

 
28.6

Income taxes
10.7

 
1.1

 
11.8

 
5.8

 
6.0

 
11.8

Deferred income taxes
16.2

 
2.4

 
18.6

 
18.6

 
0.6

 
19.2

Total Current Assets
517.8

 
(6.2
)
 
511.6

 
557.8

 
(3.4
)
 
554.4

Noncurrent Assets
 
 
 
 
 
 
 
 
 
 
 
Property, plant and equipment, net
370.6

 
(1.0
)
 
369.6

 
372.7

 
(0.3
)
 
372.4

Real estate held for entitlement and leasing
83.2

 

 
83.2

 
81.2

 

 
81.2

Recoverable from the U.S. government and other third parties for environmental remediation costs
81.5

 
6.0

 
87.5

 
86.5

 
6.0

 
92.5

Receivable from Northrop
73.2

 
(6.0
)
 
67.2

 
72.3

 
(6.0
)
 
66.3

Deferred income taxes
170.2

 
10.0

 
180.2

 
175.9

 
9.7

 
185.6

Goodwill
164.4

 
(6.3
)
 
158.1

 
159.4

 
(6.3
)
 
153.1

Intangible assets
128.9

 

 
128.9

 
132.3

 

 
132.3

Other noncurrent assets, net
85.8

 
1.1

 
86.9

 
76.5

 
3.5

 
80.0

Total Noncurrent Assets
1,157.8

 
3.8

 
1,161.6

 
1,156.8

 
6.6

 
1,163.4

Total Assets
$
1,675.6

 
$
(2.4
)
 
$
1,673.2

 
$
1,714.6

 
$
3.2

 
$
1,717.8

LIABILITIES, REDEEMABLE COMMON STOCK, AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current Liabilities
 
 
 
 
 
 
 
 
 
 
 
Short-term borrowings and current portion of long-term debt
$
4.2

 
$

 
$
4.2

 
$
3.0

 
$

 
$
3.0

Accounts payable
94.5

 
(0.1
)
 
94.4

 
98.0

 
(0.9
)
 
97.1

Reserves for environmental remediation costs
36.0

 

 
36.0

 
38.0

 

 
38.0

Postretirement medical and life insurance benefits
7.2

 

 
7.2

 
7.2

 

 
7.2

Advance payments on contracts
110.5

 
(7.1
)
 
103.4

 
95.2

 
(1.0
)
 
94.2

Other current liabilities
178.7

 
5.0

 
183.7

 
212.1

 
5.6

 
217.7

Total Current Liabilities
431.1

 
(2.2
)
 
428.9

 
453.5

 
3.7

 
457.2

Noncurrent Liabilities
 
 
 
 
 
 
 
 
 
 
 
Senior debt
96.3

 

 
96.3

 
41.9

 

 
41.9

Second-priority senior notes
460.0

 

 
460.0

 
460.0

 

 
460.0

Convertible subordinated notes
143.0

 

 
143.0

 
188.7

 

 
188.7

Other debt
79.5

 

 
79.5

 
0.5

 

 
0.5

Reserves for environmental remediation costs
127.7

 

 
127.7

 
132.4

 

 
132.4

Pension benefits
252.7

 
9.4

 
262.1

 
257.2

 
9.3

 
266.5

Postretirement medical and life insurance benefits
57.5

 

 
57.5

 
58.5

 

 
58.5

Other noncurrent liabilities
76.8

 
1.5

 
78.3

 
74.1

 
2.4

 
76.5

Total Noncurrent Liabilities
1,293.5

 
10.9

 
1,304.4

 
1,213.3

 
11.7

 
1,225.0

Total Liabilities
1,724.6

 
8.7

 
1,733.3

 
1,666.8

 
15.4

 
1,682.2

Redeemable common stock
0.1

 

 
0.1

 
0.1

 

 
0.1

Stockholders’ (Deficit) Equity
 
 

 
 
 
 
 
 
 
 
Common stock
5.9

 

 
5.9

 
5.9

 

 
5.9

Other capital
283.0

 
0.2

 
283.2

 
281.4

 
0.2

 
281.6

Treasury stock
(64.5
)
 

 
(64.5
)
 
(8.6
)
 

 
(8.6
)
Accumulated deficit
(66.3
)
 
(5.7
)
 
(72.0
)
 
(16.1
)
 
(6.7
)
 
(22.8
)
Accumulated other comprehensive loss
(207.2
)
 
(5.6
)
 
(212.8
)
 
(214.9
)
 
(5.7
)
 
(220.6
)
Total Stockholders’ (Deficit) Equity
(49.1
)
 
(11.1
)
 
(60.2
)
 
47.7

 
(12.2
)
 
35.5

Total Liabilities, Redeemable Common Stock and Stockholders’ (Deficit) Equity
$
1,675.6

 
$
(2.4
)
 
$
1,673.2

 
$
1,714.6

 
$
3.2

 
$
1,717.8

_______
(1) Includes adjustments related to the previously reported errors that were revised in the Company's fiscal 2014 Form 10-K and the additional adjustments related to the restatement.

28



Unaudited Condensed Consolidated Statements of Operations
and Comprehensive (Loss) Income
 
Three Months Ended August 31, 2015
 
Nine Months Ended August 31, 2015
 
As Reported
 
Adjustments
 
As Restated
 
As Reported
 
Adjustments
 
As Restated
 
(In millions, except per share amounts)
 
(In millions, except per share amounts)
Net sales
$
440.5

 
$
0.5

 
$
441.0

 
$
1,216.0

 
$
5.8

 
$
1,221.8

Operating costs and expenses:
 
 
 
 
 
 
 
 
 
 
 
Cost of sales (exclusive of items shown separately below)
373.3

 
(0.2
)
 
373.1

 
1,026.4

 
4.8

 
1,031.2

AR1 research and development (see Note 1)
8.3

 

 
8.3

 
10.5

 

 
10.5

Selling, general and administrative
11.5

 

 
11.5

 
39.6

 
1.1

 
40.7

Depreciation and amortization
16.1

 

 
16.1

 
48.2

 
0.3

 
48.5

Other expense, net:
 
 

 
 
 
 
 

 
 
Loss on debt repurchased
1.1

 

 
1.1

 
1.8

 

 
1.8

Legal settlement
50.0

 

 
50.0

 
50.0

 

 
50.0

Other
29.3

 

 
29.3

 
33.1

 

 
33.1

Total operating costs and expenses
489.6

 
(0.2
)
 
489.4

 
1,209.6

 
6.2

 
1,215.8

Operating (loss) income
(49.1
)
 
0.7

 
(48.4
)
 
6.4

 
(0.4
)
 
6.0

Non-operating (income) expense:
 
 
 
 
 
 
 
 
 
 
 
Interest income
(0.1
)
 

 
(0.1
)
 
(0.2
)
 

 
(0.2
)
Interest expense
11.9

 

 
11.9

 
38.5

 

 
38.5

Total non-operating expense, net
11.8

 

 
11.8

 
38.3

 

 
38.3

Loss from continuing operations before income taxes
(60.9
)
 
0.7

 
(60.2
)
 
(31.9
)
 
(0.4
)
 
(32.3
)
Income tax benefit
(22.2
)
 
0.5

 
(21.7
)
 
(7.5
)
 
(0.1
)
 
(7.6
)
Loss from continuing operations
(38.7
)
 
0.2

 
(38.5
)
 
(24.4
)
 
(0.3
)
 
(24.7
)
Income from discontinued operations, net of income taxes
0.6

 

 
0.6

 
0.8

 

 
0.8

Net loss
$
(38.1
)
 
$
0.2

 
$
(37.9
)
 
$
(23.6
)
 
$
(0.3
)
 
$
(23.9
)
Loss per share of common stock
 
 
 
 
 
 
 
 
 
 
 
Basic and diluted:
 
 
 
 
 
 
 
 
 
 
 
Loss per share from continuing operations
$
(0.63
)
 
$
0.01

 
$
(0.62
)
 
$
(0.40
)
 
$

 
$
(0.40
)
Income per share from discontinued operations, net of income taxes
0.01

 

 
0.01

 
0.01

 

 
0.01

Net loss per share
$
(0.62
)
 
$
0.01

 
$
(0.61
)
 
$
(0.39
)
 
$

 
$
(0.39
)
Weighted average shares of common stock outstanding, basic and diluted
61.8

 

 
61.8

 
60.5

 

 
60.5

 
Three Months Ended August 31, 2015
 
Nine Months Ended August 31, 2015
 
As Reported
 
Adjustments
 
As Restated
 
As Reported
 
Adjustments
 
As Restated
 
(In millions)
 
(In millions)
Net loss
$
(38.1
)
 
$
0.2

 
$
(37.9
)
 
$
(23.6
)
 
$
(0.3
)
 
$
(23.9
)
Other comprehensive income:
 
 
 
 
 
 
 
 
 
 
 
Amortization of actuarial losses and prior service credits, net of income taxes
11.6

 
0.2

 
11.8

 
36.0

 
0.2

 
36.2

Comprehensive (loss) income
$
(26.5
)
 
$
0.4

 
$
(26.1
)
 
$
12.4

 
$
(0.1
)
 
$
12.3



29



 
Three Months Ended May 31, 2015
 
Six Months Ended May 31, 2015
Unaudited
As Reported
 
Adjustments
 
As Restated
 
As Reported
 
Adjustments
 
As Restated
 
(In millions, except per share amounts)
 
(In millions, except per share amounts)
Net sales
$
456.9

 
$
0.9

 
$
457.8

 
$
775.5

 
$
5.3

 
$
780.8

Operating costs and expenses:
 
 
 
 
 
 
 
 
 
 
 
Cost of sales (exclusive of items shown separately below)
370.3

 
2.4

 
372.7

 
653.1

 
5.0

 
658.1

AR1 research and development (see Note 1)
2.2

 

 
2.2

 
2.2

 

 
2.2

Selling, general and administrative
12.6

 
1.0

 
13.6

 
28.1

 
1.1

 
29.2

Depreciation and amortization
16.1

 

 
16.1

 
32.1

 
0.3

 
32.4

Other expense, net:
 
 

 
 
 
 
 

 
 
Loss on debt repurchased
0.5

 

 
0.5

 
0.7

 

 
0.7

Other
2.3

 

 
2.3

 
3.8

 

 
3.8

Total operating costs and expenses
404.0

 
3.4

 
407.4

 
720.0

 
6.4

 
726.4

Operating income
52.9

 
(2.5
)
 
50.4

 
55.5

 
(1.1
)
 
54.4

Non-operating (income) expense:
 
 
 
 
 
 
 
 
 
 
 
Interest income

 

 

 
(0.1
)
 

 
(0.1
)
Interest expense
13.2

 

 
13.2

 
26.6

 

 
26.6

Total non-operating expense, net
13.2

 

 
13.2

 
26.5

 

 
26.5

Income from continuing operations before income taxes
39.7

 
(2.5
)
 
37.2

 
29.0

 
(1.1
)
 
27.9

Income tax provision
21.3

 
(1.4
)
 
19.9

 
14.7

 
(0.6
)
 
14.1

Income from continuing operations
18.4

 
(1.1
)
 
17.3

 
14.3

 
(0.5
)
 
13.8

Income from discontinued operations, net of income taxes

 

 

 
0.2

 

 
0.2

Net income
$
18.4

 
$
(1.1
)
 
$
17.3

 
$
14.5

 
$
(0.5
)
 
$
14.0

Income per share of common stock
 
 
 
 
 
 
 
 
 
 
 
Basic:
 
 
 
 
 
 
 
 
 
 
 
Income per share from continuing operations
$
0.29

 
$
(0.01
)
 
$
0.28

 
$
0.23

 
$

 
$
0.23

Income per share from discontinued operations, net of income taxes

 

 

 

 

 

Net income per share
$
0.29

 
$
(0.01
)
 
$
0.28

 
$
0.23

 
$

 
$
0.23

Diluted:
 
 
 
 
 
 
 
 
 
 
 
Income per share from continuing operations
$
0.26

 
$
(0.01
)
 
$
0.25

 
$
0.22

 
$

 
$
0.22

Income per share from discontinued operations, net of income taxes

 

 

 

 

 

Net income per share
$
0.26

 
$
(0.01
)
 
$
0.25

 
$
0.22

 
$

 
$
0.22

Weighted average shares of common stock outstanding, basic
61.2

 

 
61.2

 
59.9

 

 
59.9

Weighted average shares of common stock outstanding, diluted
72.3

 

 
72.3

 
72.2

 

 
72.2

 
Three Months Ended May 31, 2015
 
Six Months Ended May 31, 2015
Unaudited
As Reported
 
Adjustments
 
As Restated
 
As Reported
 
Adjustments
 
As Restated
 
(In millions)
 
(In millions)
Net income
$
18.4

 
$
(1.1
)
 
$
17.3

 
$
14.5

 
$
(0.5
)
 
$
14.0

Other comprehensive income:
 
 
 
 
 
 
 
 
 
 
 
Amortization of actuarial losses and prior service credits, net of income taxes
12.2

 
0.1

 
12.3

 
24.4

 

 
24.4

Comprehensive income
$
30.6

 
$
(1.0
)
 
$
29.6

 
$
38.9

 
$
(0.5
)
 
$
38.4



30



 
Three Months Ended February 28, 2015
 
Three Months Ended November 30, 2014
Unaudited
As Reported
 
Adjustments
 
As Restated
 
As Reported
 
Adjustments
 
As Restated
 
(In millions, except per share amounts)
 
(In millions, except per share amounts)
Net sales
$
318.6

 
$
4.4

 
$
323.0

 
$
439.6

 
$
4.0

 
$
443.6

Operating costs and expenses:
 
 
 
 
 
 
 
 
 
 
 
Cost of sales (exclusive of items shown separately below)
282.8

 
2.6

 
285.4

 
373.7

 
0.2

 
373.9

Selling, general and administrative
15.5

 
0.1

 
15.6

 
9.8

 
0.1

 
9.9

Depreciation and amortization
16.0

 
0.3

 
16.3

 
17.3

 

 
17.3

Other expense, net:
 
 

 
 
 
 
 
 
 

Loss on debt repurchased
0.2

 

 
0.2

 

 

 

Other
1.5

 

 
1.5

 
2.3

 

 
2.3

Total operating costs and expenses
316.0

 
3.0

 
319.0

 
403.1

 
0.3

 
403.4

Operating income
2.6

 
1.4

 
4.0

 
36.5

 
3.7

 
40.2

Interest income
(0.1
)
 

 
(0.1
)
 
(0.1
)
 

 
(0.1
)
Interest expense
13.4

 

 
13.4

 
13.7

 

 
13.7

Total non-operating expense, net
13.3

 

 
13.3

 
13.6

 

 
13.6

(Loss) income from continuing operations before income taxes
(10.7
)
 
1.4

 
(9.3
)
 
22.9

 
3.7

 
26.6

Income tax (benefit) provision
(6.6
)
 
0.8

 
(5.8
)
 
12.7

 
1.9

 
14.6

(Loss) income from continuing operations
(4.1
)
 
0.6

 
(3.5
)
 
10.2

 
1.8

 
12.0

Income (loss) from discontinued operations, net of income taxes
0.2

 

 
0.2

 
(0.1
)
 

 
(0.1
)
Net (loss) income
$
(3.9
)
 
$
0.6

 
$
(3.3
)
 
$
10.1

 
1.8

 
$
11.9

(Loss) Income per share of common stock
 
 
 
 
 
 
 
 
 
 
 
Basic:
 
 
 
 
 
 
 
 
 
 
 
(Loss) income per share from continuing operations
$
(0.07
)
 
$
0.01

 
$
(0.06
)
 
$
0.17

 
$
0.03

 
$
0.20

Income (loss) per share from discontinued operations, net of income taxes

 

 

 

 

 

Net (loss) income per share
$
(0.07
)
 
$
0.01

 
$
(0.06
)
 
$
0.17

 
$
0.03

 
$
0.20

Diluted:
 
 
 
 
 
 
 
 
 
 
 
(Loss) income per share from continuing operations
$
(0.07
)
 
$
0.01

 
$
(0.06
)
 
0.15

 
0.03

 
0.18

Income (loss) per share from discontinued operations, net of income taxes

 

 

 

 

 

Net (loss) income per share
$
(0.07
)
 
$
0.01

 
$
(0.06
)
 
0.15

 
0.03

 
0.18

Weighted average shares of common stock outstanding, basic
58.9

 

 
58.9

 
56.9

 

 
56.9

Weighted average shares of common stock outstanding, diluted
58.9

 

 
58.9

 
72.0

 

 
72.0

 
Three Months Ended February 28, 2015
 
Three Months Ended November 30, 2014
Unaudited
As Reported
 
Adjustments
 
As Restated
 
As Reported
 
Adjustments
 
As Restated
 
(In millions)
 
(In millions)
Net (loss) income
$
(3.9
)
 
$
0.6

 
$
(3.3
)
 
$
10.1

 
1.8

 
$
11.9

Other comprehensive income:
 
 
 
 
 
 
 
 
 
 
 
Actuarial losses arising during the period, net of income taxes

 

 

 
(142.0
)
 
6.0

 
(136.0
)
Amortization of actuarial losses and prior service credits, net of income taxes
12.2

 
(0.1
)
 
12.1

 
7.5

 
(0.1
)
 
7.4

Comprehensive income
$
8.3

 
$
0.5

 
$
8.8

 
$
(124.4
)
 
$
7.7

 
$
(116.7
)


31



 
Three Months Ended August 31, 2014
 
Nine Months Ended August 31, 2014
Unaudited
As Reported
 
Adjustments
 
As Restated
 
As Reported
 
Adjustments
 
As Restated
 
(In millions, except per share amounts)
 
(In millions, except per share amounts)
Net sales
$
421.2

 
$
(0.8
)
 
$
420.4

 
$
1,157.8

 
$
0.8

 
$
1,158.6

Operating costs and expenses:
 
 
 
 
 
 
 
 
 
 
 
Cost of sales (exclusive of items shown separately below)
376.5

 
(0.7
)
 
375.8

 
1,034.4

 
(2.1
)
 
1,032.3

Selling, general and administrative
9.7

 
0.1

 
9.8

 
28.1

 
0.2

 
28.3

Depreciation and amortization
15.8

 
(0.1
)
 
15.7

 
46.4

 

 
46.4

Other expense, net:
 
 

 
 
 
 
 

 
 
Loss on debt repurchased
9.8

 

 
9.8

 
60.6

 

 
60.6

Other
6.5

 

 
6.5

 
11.6

 

 
11.6

Total operating costs and expenses
418.3

 
(0.7
)
 
417.6

 
1,181.1

 
(1.9
)
 
1,179.2

Operating income (loss)
2.9

 
(0.1
)
 
2.8

 
(23.3
)
 
2.7

 
(20.6
)
Non-operating (income) expense:
 
 
 
 
 
 
 
 
 
 
 
Interest income

 

 

 

 

 

Interest expense
14.0

 

 
14.0

 
39.0

 

 
39.0

Total non-operating expense, net
14.0

 

 
14.0

 
39.0

 

 
39.0

Loss from continuing operations before income taxes
(11.1
)
 
(0.1
)
 
(11.2
)
 
(62.3
)
 
2.7

 
(59.6
)
Income tax (benefit) provision
(1.0
)
 
0.5

 
(0.5
)
 
0.2

 
1.5

 
1.7

Loss from continuing operations
(10.1
)
 
(0.6
)
 
(10.7
)
 
(62.5
)
 
1.2

 
(61.3
)
Income (loss) from discontinued operations, net of income taxes
0.2

 

 
0.2

 
(0.6
)
 

 
(0.6
)
Net loss
$
(9.9
)
 
$
(0.6
)
 
$
(10.5
)
 
$
(63.1
)
 
$
1.2

 
$
(61.9
)
Loss per share of common stock
 
 
 
 
 
 
 
 
 
 
 
Basic and diluted:
 
 
 
 
 
 
 
 
 
 
 
Loss per share from continuing operations
$
(0.18
)
 
$
(0.01
)
 
$
(0.19
)
 
$
(1.07
)
 
$
0.02

 
$
(1.05
)
Loss per share from discontinued operations, net of income taxes

 

 

 
(0.01
)
 

 
(0.01
)
Net loss per share
$
(0.18
)
 
$
(0.01
)
 
$
(0.19
)
 
$
(1.08
)
 
$
0.02

 
$
(1.06
)
Weighted average shares of common stock outstanding, basic and diluted
56.9

 

 
56.9

 
58.2

 

 
58.2

 
Three Months Ended August 31, 2014
 
Nine Months Ended August 31, 2014
Unaudited
As Reported
 
Adjustments
 
As Restated
 
As Reported
 
Adjustments
 
As Restated
 
(In millions)
 
(In millions)
Net loss
$
(9.9
)
 
$
(0.6
)
 
$
(10.5
)
 
$
(63.1
)
 
$
1.2

 
$
(61.9
)
Other comprehensive income:
 
 
 
 
 
 
 
 
 
 
 
Amortization of actuarial losses and prior service credits, net of income taxes
7.5

 
0.2

 
7.7

 
22.7

 
0.5

 
23.2

Comprehensive loss
$
(2.4
)
 
$
(0.4
)
 
$
(2.8
)
 
$
(40.4
)
 
$
1.7

 
$
(38.7
)


32



 
Three Months Ended May 31, 2014
 
Six Months Ended May 31, 2014
Unaudited
As Reported
 
Adjustments
 
As Restated
 
As Reported
 
Adjustments
 
As Restated
 
(In millions, except per share amounts)
 
(In millions, except per share amounts)
Net sales
$
404.5

 
$
2.1

 
$
406.6

 
$
736.6

 
$
1.6

 
$
738.2

Operating costs and expenses:
 
 
 
 
 
 
 
 
 
 
 
Cost of sales (exclusive of items shown separately below)
369.4

 
(0.4
)
 
369.0

 
657.9

 
(1.4
)
 
656.5

Selling, general and administrative
9.2

 
(0.3
)
 
8.9

 
18.4

 
0.1

 
18.5

Depreciation and amortization
15.7

 
0.1

 
15.8

 
30.6

 
0.1

 
30.7

Other expense, net:
 
 

 
 
 
 
 

 
 
Loss on debt repurchased
45.9

 

 
45.9

 
50.8

 

 
50.8

Other
2.4

 
0.2

 
2.6

 
5.1

 

 
5.1

Total operating costs and expenses
442.6

 
(0.4
)
 
442.2

 
762.8

 
(1.2
)
 
761.6

Operating loss
(38.1
)
 
2.5

 
(35.6
)
 
(26.2
)
 
2.8

 
(23.4
)
Non-operating (income) expense:
 
 
 
 
 
 
 
 
 
 
 
Interest income

 

 

 

 

 

Interest expense
12.6

 

 
12.6

 
25.0

 

 
25.0

Total non-operating expense, net
12.6

 

 
12.6

 
25.0

 

 
25.0

Loss from continuing operations before income taxes
(50.7
)
 
2.5

 
(48.2
)
 
(51.2
)
 
2.8

 
(48.4
)
Income tax (benefit) provision
(0.6
)
 
0.8

 
0.2

 
1.2

 
1.0

 
2.2

Loss from continuing operations
(50.1
)
 
1.7

 
(48.4
)
 
(52.4
)
 
1.8

 
(50.6
)
Loss from discontinued operations, net of income taxes
(0.8
)
 

 
(0.8
)
 
(0.8
)
 

 
(0.8
)
Net loss
$
(50.9
)
 
$
1.7

 
$
(49.2
)
 
$
(53.2
)
 
$
1.8

 
$
(51.4
)
Loss per share of common stock
 
 
 
 
 
 
 
 
 
 
 
Basic and diluted:
 
 
 
 
 
 
 
 
 
 
 
Loss per share from continuing operations
$
(0.87
)
 
$
0.03

 
$
(0.84
)
 
$
(0.90
)
 
$
0.04

 
$
(0.86
)
Loss per share from discontinued operations, net of income taxes
(0.01
)
 

 
(0.01
)
 
(0.01
)
 

 
(0.01
)
Net loss per share
$
(0.88
)
 
$
0.03

 
$
(0.85
)
 
$
(0.91
)
 
$
0.04

 
$
(0.87
)
Weighted average shares of common stock outstanding, basic and diluted
57.9

 

 
57.9

 
58.7

 

 
58.7

 
Three Months Ended May 31, 2014
 
Six Months Ended May 31, 2014
Unaudited
As Reported
 
Adjustments
 
As Restated
 
As Reported
 
Adjustments
 
As Restated
 
(In millions)
 
(In millions)
Net loss
$
(50.9
)
 
$
1.7

 
$
(49.2
)
 
$
(53.2
)
 
$
1.8

 
$
(51.4
)
Other comprehensive income:
 
 
 
 
 
 
 
 
 
 
 
Amortization of actuarial losses and prior service credits, net of income taxes
7.7

 
0.1

 
7.8

 
15.2

 
0.3

 
15.5

Comprehensive loss
$
(43.2
)
 
$
1.8

 
$
(41.4
)
 
$
(38.0
)
 
$
2.1

 
$
(35.9
)


33



 
Three Months Ended February 28, 2014
Unaudited
As Reported
 
Adjustments
 
As Restated
 
(In millions, except per share amounts)
Net sales
$
332.1

 
$
(0.5
)
 
$
331.6

Operating costs and expenses:
 
 
 
 
 
Cost of sales (exclusive of items shown separately below)
288.5

 
(1.0
)
 
287.5

Selling, general and administrative
9.2

 
0.4

 
9.6

Depreciation and amortization
14.9

 

 
14.9

Other expense, net:
 
 

 
 
Loss on debt repurchased
4.9

 

 
4.9

Other
2.7

 
(0.2
)
 
2.5

Total operating costs and expenses
320.2

 
(0.8
)
 
319.4

Operating income
11.9

 
0.3

 
12.2

Non-operating (income) expense:
 
 
 
 
 
Interest income

 

 

Interest expense
12.4

 

 
12.4

Total non-operating expense, net
12.4

 

 
12.4

Loss from continuing operations before income taxes
(0.5
)
 
0.3

 
(0.2
)
Income tax provision
1.8

 
0.2

 
2.0

Loss from continuing operations
(2.3
)
 
0.1

 
(2.2
)
Income from discontinued operations, net of income taxes

 

 

Net loss
$
(2.3
)
 
$
0.1

 
$
(2.2
)
Loss per share of common stock
 
 
 
 
 
Basic and diluted:
 
 
 
 
 
Loss per share from continuing operations
$
(0.04
)
 
$

 
$
(0.04
)
Loss per share from discontinued operations, net of income taxes

 

 

Net loss per share
$
(0.04
)
 
$

 
$
(0.04
)
Weighted average shares of common stock outstanding, basic and diluted
59.9

 

 
59.9

 
Three Months Ended February 28, 2014
Unaudited
As Reported
 
Adjustments
 
As Restated
 
(In millions)
Net loss
$
(2.3
)
 
$
0.1

 
$
(2.2
)
Other comprehensive income:
 
 
 
 
 
Amortization of actuarial losses and prior service credits, net of income taxes
7.5

 
0.2

 
7.7

Comprehensive income
$
5.2

 
$
0.3

 
$
5.5






34



Unaudited Condensed Consolidated Statements of Cash Flows
 
Nine Months Ended August 31, 2015
 
Six Months Ended May 31, 2015
 
As Reported
 
Adjustments
 
As Restated
 
As Reported
 
Adjustments
 
As Restated
 
(In millions)
 
(In millions)
Operating Activities
 
 
 
 
 
 
 
 
 
 
 
Net (loss) income
$
(23.6
)
 
$
(0.3
)
 
$
(23.9
)
 
$
14.5

 
$
(0.5
)
 
$
14.0

Adjustments to reconcile net (loss) income to net cash provided by operating activities:
 
 
 
 
 
 
 
 
 
 
 
Income from discontinued operations, net of income taxes
(0.8
)
 

 
(0.8
)
 
(0.2
)
 

 
(0.2
)
Depreciation and amortization
48.2

 
0.3

 
48.5

 
32.1

 
0.3

 
32.4

Amortization of financing costs
2.0

 

 
2.0

 
1.4

 

 
1.4

Stock-based compensation
9.6

 
0.8

 
10.4

 
7.3

 
1.0

 
8.3

Retirement benefit expense
50.0

 
0.6

 
50.6

 
33.4

 
0.4

 
33.8

Loss on debt repurchased
1.8

 

 
1.8

 
0.7

 

 
0.7

Loss on disposal of long-lived assets
0.2

 

 
0.2

 
0.2

 

 
0.2

Tax benefit on stock-based awards
(2.0
)
 

 
(2.0
)
 
(1.5
)
 

 
(1.5
)
Changes in assets and liabilities, net of effects from acquisition:
 
 
 
 
 
 
 
 
 
 
 
Accounts receivable
(13.8
)
 
(5.0
)
 
(18.8
)
 
(0.8
)
 
(4.3
)
 
(5.1
)
Inventories
(9.7
)
 
(0.2
)
 
(9.9
)
 
(11.3
)
 
(0.8
)
 
(12.1
)
Other current assets, net
(19.4
)
 
(0.7
)
 
(20.1
)
 
(7.5
)
 
(0.9
)
 
(8.4
)
Real estate held for entitlement and leasing
(5.1
)
 

 
(5.1
)
 
(4.0
)
 

 
(4.0
)
Receivable from Northrop
4.8

 
(6.0
)
 
(1.2
)
 
5.1

 
(6.0
)
 
(0.9
)
Recoverable from the U.S. government and other third parties for environmental remediation costs
(45.8
)
 
6.0

 
(39.8
)
 
0.1

 
6.0

 
6.1

Other noncurrent assets
(11.2
)
 
0.4

 
(10.8
)
 
(9.0
)
 
0.3

 
(8.7
)
Accounts payable
(14.8
)
 
(0.5
)
 
(15.3
)
 
(15.9
)
 

 
(15.9
)
Retirement benefits
(3.7
)
 

 
(3.7
)
 
(2.6
)
 

 
(2.6
)
Advance payments on contracts
13.2

 
1.1

 
14.3

 
(1.2
)
 
1.1

 
(0.1
)
Other current liabilities
15.7

 
3.8

 
19.5

 
(25.6
)
 
3.6

 
(22.0
)
Deferred income taxes
(11.8
)
 
1.1

 
(10.7
)
 
(0.9
)
 
0.3

 
(0.6
)
Reserves for environmental remediation costs
70.1

 

 
70.1

 
(4.5
)
 

 
(4.5
)
Other noncurrent liabilities and other
16.6

 
(1.4
)
 
15.2

 
18.6

 
(0.5
)
 
18.1

Net Cash Provided by Operating Activities
70.5

 

 
70.5

 
28.4

 

 
28.4

Investing Activities
 
 
 
 
 
 
 
 
 
 
 
Capital expenditures
(17.9
)
 

 
(17.9
)
 
(9.4
)
 

 
(9.4
)
Net Cash Used in Investing Activities
(17.9
)
 

 
(17.9
)
 
(9.4
)
 

 
(9.4
)
Financing Activities
 
 
 
 
 
 
 
 
 
 
 
Debt repayments/repurchases
(72.0
)
 

 
(72.0
)
 
(28.5
)
 

 
(28.5
)
Proceeds from shares issued under equity plans, net
1.3

 

 
1.3

 

 

 

Repurchase of shares to satisfy tax withholding obligations
(6.5
)
 

 
(6.5
)
 
(4.4
)
 

 
(4.4
)
Tax benefit on stock-based awards
2.0

 

 
2.0

 
1.5

 

 
1.5

Net Cash Used in Financing Activities
(75.2
)
 

 
(75.2
)
 
(31.4
)
 

 
(31.4
)
Net Decrease in Cash and Cash Equivalents
(22.6
)
 

 
(22.6
)
 
(12.4
)
 

 
(12.4
)
Cash and Cash Equivalents at Beginning of Period
265.9

 

 
265.9

 
265.9

 

 
265.9

Cash and Cash Equivalents at End of Period
$
243.3

 
$

 
$
243.3

 
$
253.5

 
$

 
$
253.5


35



 
Three Months Ended February 28, 2015
 
Nine Months Ended August 31, 2014
Unaudited
As Reported
 
Adjustments
 
As Restated
 
As Reported
 
Adjustments
 
As Restated
 
(In millions)
 
(In millions)
Operating Activities
 
 
 
 
 
 
 
 
 
 
 
Net loss
$
(3.9
)
 
$
0.6

 
$
(3.3
)
 
$
(63.1
)
 
$
1.2

 
$
(61.9
)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
 
 
 
 
 
 
 
 
 
 
 
(Income) loss from discontinued operations, net of income taxes
(0.2
)
 

 
(0.2
)
 
0.6

 

 
0.6

Depreciation and amortization
16.0

 
0.3

 
16.3

 
46.4

 

 
46.4

Amortization of financing costs
0.7

 

 
0.7

 
2.7

 

 
2.7

Stock-based compensation
5.3

 

 
5.3

 
4.5

 

 
4.5

Retirement benefit expense
16.6

 
0.2

 
16.8

 
26.7

 
0.8

 
27.5

Loss on debt repurchased
0.2

 

 
0.2

 
60.6

 

 
60.6

Loss on bank amendment

 

 

 
0.2

 

 
0.2

Loss on disposal of long-lived assets
0.2

 

 
0.2

 
2.5

 

 
2.5

Tax benefit on stock-based awards
(1.4
)
 

 
(1.4
)
 
(1.5
)
 
0.2

 
(1.3
)
Changes in assets and liabilities, net of effects from acquisition:
 
 
 
 
 
 
 
 
 
 
 
Accounts receivable
(33.2
)
 
13.7

 
(19.5
)
 
(0.8
)
 
(0.3
)
 
(1.1
)
Inventories
(22.4
)
 
(1.1
)
 
(23.5
)
 
(25.5
)
 
(0.3
)
 
(25.8
)
Other current assets, net
(6.2
)
 
0.9

 
(5.3
)
 
(3.0
)
 
0.8

 
(2.2
)
Real estate held for entitlement and leasing
(1.5
)
 

 
(1.5
)
 
(7.7
)
 

 
(7.7
)
Receivable from Northrop
5.4

 
(6.0
)
 
(0.6
)
 
(2.0
)
 

 
(2.0
)
Recoverable from the U.S. government and other third parties for environmental remediation costs
(2.2
)
 
6.0

 
3.8

 
5.4

 

 
5.4

Other noncurrent assets
14.3

 
(0.9
)
 
13.4

 
(24.0
)
 
(0.4
)
 
(24.4
)
Assets held for sale
(14.2
)
 

 
(14.2
)
 

 

 

Accounts payable
(19.0
)
 

 
(19.0
)
 
(7.1
)
 
0.4

 
(6.7
)
Retirement benefits
(1.6
)
 

 
(1.6
)
 
(4.2
)
 

 
(4.2
)
Advance payments on contracts
25.5

 
(15.9
)
 
9.6

 
18.0

 
(2.5
)
 
15.5

Other current liabilities
(11.3
)
 
3.4

 
(7.9
)
 
10.9

 
(0.3
)
 
10.6

Deferred income taxes
(0.3
)
 
(0.8
)
 
(1.1
)
 
(6.1
)
 
2.7

 
(3.4
)
Reserves for environmental remediation costs
(3.4
)
 

 
(3.4
)
 
(2.7
)
 

 
(2.7
)
Other noncurrent liabilities and other
1.0

 
(0.4
)
 
0.6

 
3.4

 
(2.1
)
 
1.3

Net cash (used in) provided by continuing operations
(35.6
)
 

 
(35.6
)
 
34.2

 
0.2

 
34.4

Net cash used in discontinued operations

 

 

 
(0.1
)
 

 
(0.1
)
Net Cash (Used in) Provided by Operating Activities
(35.6
)
 

 
(35.6
)
 
34.1

 
0.2

 
34.3

Investing Activities
 
 
 
 
 
 
 
 
 
 
 
Purchase of Rocketdyne Business

 

 

 
0.2

 

 
0.2

Capital expenditures
(4.3
)
 

 
(4.3
)
 
(31.9
)
 

 
(31.9
)
Net Cash Used in Investing Activities
(4.3
)
 

 
(4.3
)
 
(31.7
)
 

 
(31.7
)
Financing Activities
 
 
 
 
 
 
 
 
 
 
 
Proceeds from issuance of debt

 

 

 
189.0

 

 
189.0

Debt issuance costs

 

 

 
(4.2
)
 

 
(4.2
)
Debt repayments/repurchases
(9.3
)
 

 
(9.3
)
 
(165.0
)
 

 
(165.0
)
Repurchase of shares to satisfy tax withholding obligations
(2.4
)
 

 
(2.4
)
 
(1.9
)
 

 
(1.9
)
Purchase of treasury stock

 

 

 
(64.5
)
 

 
(64.5
)
Tax benefit on stock-based awards
1.4

 

 
1.4

 
1.5

 
(0.2
)
 
1.3

Net Cash Used in Financing Activities
(10.3
)
 

 
(10.3
)
 
(45.1
)
 
(0.2
)
 
(45.3
)
Net Decrease in Cash and Cash Equivalents
(50.2
)
 

 
(50.2
)
 
(42.7
)
 

 
(42.7
)
Cash and Cash Equivalents at Beginning of Period
265.9

 

 
265.9

 
197.6

 

 
197.6

Cash and Cash Equivalents at End of Period
$
215.7

 
$

 
$
215.7

 
$
154.9

 
$

 
$
154.9


36



 
Six Months Ended May 31, 2014
 
Three Months Ended February 28, 2014
Unaudited
As Reported
 
Adjustments
 
As Restated
 
As Reported
 
Adjustments
 
As Restated
 
(In millions)
 
(In millions)
Operating Activities
 
 
 
 
 
 
 
 
 
 
 
Net loss
$
(53.2
)
 
$
1.8

 
$
(51.4
)
 
$
(2.3
)
 
$
0.1

 
$
(2.2
)
Adjustments to reconcile net loss to net cash used in operating activities:
 
 
 
 
 
 
 
 
 
 
 
Loss from discontinued operations, net of income taxes
0.8

 

 
0.8

 

 

 

Depreciation and amortization
30.6

 
0.1

 
30.7

 
14.9

 

 
14.9

Amortization of financing costs
1.8

 

 
1.8

 
0.9

 

 
0.9

Stock-based compensation
3.0

 

 
3.0

 
1.4

 

 
1.4

Retirement benefit expense
17.8

 
0.5

 
18.3

 
8.9

 
0.2

 
9.1

Loss on debt repurchased
50.8

 

 
50.8

 
4.9

 

 
4.9

Loss on bank amendment
0.2

 

 
0.2

 

 

 

Tax benefit on stock-based awards
(1.3
)
 

 
(1.3
)
 
(1.1
)
 

 
(1.1
)
Changes in assets and liabilities, net of effects from acquisition:
 
 
 
 
 
 
 
 
 
 
 
Accounts receivable
21.5

 
0.6

 
22.1

 
14.3

 
(0.7
)
 
13.6

Inventories
(25.1
)
 
(0.6
)
 
(25.7
)
 
(31.6
)
 
2.2

 
(29.4
)
Other current assets, net
3.7

 
(0.2
)
 
3.5

 

 
(1.5
)
 
(1.5
)
Income tax receivable
3.2

 
(1.3
)
 
1.9

 
6.6

 
(6.6
)
 

Real estate held for entitlement and leasing
(3.6
)
 

 
(3.6
)
 
(1.1
)
 

 
(1.1
)
Receivable from Northrop
(1.2
)
 

 
(1.2
)
 
(0.3
)
 

 
(0.3
)
Recoverable from the U.S. government and other third parties for environmental remediation costs
6.6

 

 
6.6

 
0.2

 

 
0.2

Other noncurrent assets
(15.6
)
 
0.1

 
(15.5
)
 
(4.2
)
 
(2.6
)
 
(6.8
)
Accounts payable
(28.0
)
 
0.4

 
(27.6
)
 
(24.5
)
 
(0.6
)
 
(25.1
)
Retirement benefits
(3.2
)
 

 
(3.2
)
 
(1.5
)
 

 
(1.5
)
Advance payments on contracts
6.1

 
(3.2
)
 
2.9

 
(9.2
)
 
2.9

 
(6.3
)
Other current liabilities
(27.7
)
 
2.7

 
(25.0
)
 
6.4

 
4.5

 
10.9

Deferred income taxes
(3.6
)
 
(0.3
)
 
(3.9
)
 
(6.8
)
 
1.8

 
(5.0
)
Reserves for environmental remediation costs
(7.6
)
 

 
(7.6
)
 
(0.9
)
 

 
(0.9
)
Other noncurrent liabilities and other
1.8

 
(0.6
)
 
1.2

 
(0.3
)
 
0.3

 

Net cash used in continuing operations
(22.2
)
 

 
(22.2
)
 
(25.3
)
 

 
(25.3
)
Net cash used in discontinued operations
(0.1
)
 

 
(0.1
)
 

 

 

Net Cash Used in Operating Activities
(22.3
)
 

 
(22.3
)
 
(25.3
)
 

 
(25.3
)
Investing Activities
 
 
 
 
 
 
 
 
 
 
 
Capital expenditures
(18.5
)
 

 
(18.5
)
 
(9.3
)
 

 
(9.3
)
Net Cash Used in Investing Activities
(18.5
)
 

 
(18.5
)
 
(9.3
)
 

 
(9.3
)
Financing Activities
 
 
 
 
 
 
 
 
 
 
 
Proceeds from issuance of debt
179.0

 

 
179.0

 

 

 

Debt issuance costs
(4.1
)
 

 
(4.1
)
 

 

 

Debt repayments/repurchases
(145.8
)
 

 
(145.8
)
 
(10.0
)
 

 
(10.0
)
Repurchase of shares to satisfy tax withholding obligations
(2.0
)
 

 
(2.0
)
 
(1.4
)
 

 
(1.4
)
Purchase of treasury stock
(64.5
)
 

 
(64.5
)
 
(8.6
)
 

 
(8.6
)
Tax benefit on stock-based awards
1.3

 

 
1.3

 
1.1

 

 
1.1

Net Cash Used in Financing Activities
(36.1
)
 

 
(36.1
)
 
(18.9
)
 

 
(18.9
)
Net Decrease in Cash and Cash Equivalents
(76.9
)
 

 
(76.9
)
 
(53.5
)
 

 
(53.5
)
Cash and Cash Equivalents at Beginning of Period
197.6

 

 
197.6

 
197.6

 

 
197.6

Cash and Cash Equivalents at End of Period
$
120.7

 
$

 
$
120.7

 
$
144.1

 
$

 
$
144.1


37



Note 3. (Loss) Income Per Share of Common Stock, (As Restated for fiscal 2014 and 2013)
A reconciliation of the numerator and denominator used to calculate basic and diluted (loss) income per share of common stock (“EPS”) is presented in the following table:
 
Year Ended
 
2015
 
2014
 
2013
 
(In millions, except per share amounts)
Numerator:
 
 
 
 
 
(Loss) income from continuing operations
$
(17.1
)
 
$
(49.3
)
 
$
162.7

Income (loss) from discontinued operations, net of income taxes
0.9

 
(0.7
)
 
0.2

Net (loss) income
(16.2
)
 
(50.0
)
 
162.9

Income allocated to participating securities

 

 
(3.1
)
Net (loss) income for basic earnings per share
(16.2
)
 
(50.0
)
 
159.8

Interest on convertible subordinated debentures

 

 
8.1

Net (loss) income for diluted earnings per share
$
(16.2
)
 
$
(50.0
)
 
$
167.9

Denominator:
 
 
 
 
 
Basic weighted average shares
61.1

 
57.9

 
59.6

Effect of:
 
 
 
 
 
  Convertible subordinated notes

 

 
22.1

  Employee stock options

 

 
0.2

Diluted weighted average shares
61.1

 
57.9

 
81.9

Basic:
 
 
 
 
 
(Loss) income per share from continuing operations
$
(0.28
)
 
$
(0.85
)
 
$
2.68

Income (loss) per share from discontinued operations, net of income taxes
0.01

 
(0.01
)
 

Net (loss) income per share
$
(0.27
)
 
$
(0.86
)
 
$
2.68

Diluted:
 
 
 
 
 
(Loss) income per share from continuing operations
$
(0.28
)
 
$
(0.85
)
 
$
2.05

Income (loss) per share from discontinued operations, net of income taxes
0.01

 
(0.01
)
 

Net (loss) income per share
$
(0.27
)
 
$
(0.86
)
 
$
2.05

The following table sets forth the potentially dilutive securities excluded from the computation because their effect would have been anti-dilutive: 
 
Year Ended
 
2015
 
2014
 
2013
 
(In millions)
4 1/16% Debentures
11.0

 
17.9

 

Employee stock options and stock purchase plan
0.2

 
0.2

 

Unvested restricted shares
1.6

 
1.7

 
1.1

Total potentially dilutive securities
12.8

 
19.8

 
1.1


38



Note 4.
Balance Sheet Accounts and Supplemental Disclosures, (As Restated for fiscal 2014 and 2013)
a.  Accounts Receivable
 
As of November 30,

2015
 
2014
 
(In millions)
Billed
$
90.4


$
68.1

Unbilled, net
80.6


102.0

Total receivables under long-term contracts
171.0


170.1

Other receivables
0.5


0.4

Accounts receivable
$
171.5


$
170.5

As of November 30, 2015 and 2014, unbilled receivables included $33.7 million and $30.1 million, respectively, of amounts for overhead disallowances or billing decrements that primarily represent estimates of potential overhead costs which may not be successfully negotiated and collected after one year.
b.  Inventories
 
As of November 30,

2015

2014
 
(In millions)
Long-term contracts at average cost
$
505.8


$
493.6

Progress payments
(349.6
)

(356.9
)
Total long-term contract inventories
156.2


136.7

Total other inventories
1.3


1.3

Inventories
$
157.5


$
138.0

Long-term contract inventories included an allocation of general and administrative costs incurred throughout fiscal 2015 and fiscal 2014 amounting to $240.9 million and $271.1 million, respectively, and the cumulative amount of general and administrative costs in long-term contract inventories is estimated to be $20.8 million and $28.3 million at November 30, 2015 and 2014, respectively.
c.  Other Current Assets, net
 
As of November 30,
 
2015

2014
 
(In millions)
Recoverable from the U.S. government for Rocketdyne Business integration costs (see Note 4(g))
$
11.9

 
$
10.5

Prepaid expenses
10.7

 
11.3

Receivables, net
7.2

 
5.6

Indemnification receivable from UTC, net
15.7

 
0.9

Recoverable from the U.S. government for Competitive Improvement Program severance obligations (see Note 12)
9.5

 

Other
6.5

 
10.3

Other current assets, net
$
61.5

 
$
38.6




39




d.  Property, Plant and Equipment, net
 
As of November 30,
 
2015
 
2014
 
(In millions)
Land
$
71.3


$
67.2

Buildings and improvements
287.6


279.9

Machinery and equipment
509.8


476.0

Construction-in-progress
34.9


35.5


903.6


858.6

Less: accumulated depreciation
(537.8
)

(492.1
)
Property, plant and equipment, net
$
365.8


$
366.5

Depreciation expense for fiscal 2015, 2014, and 2013 was $49.8 million, $48.5 million, and $35.5 million, respectively. The Company had $6.3 million of property, plant and equipment additions included in accounts payable in fiscal 2015.
e.  Goodwill
The goodwill balance at November 30, 2015 and 2014 relates to the Company’s Aerospace and Defense segment. The changes in the carrying amount of goodwill since November 30, 2013 were as follows (in millions):
November 30, 2013
$
152.5

Purchase accounting adjustments in fiscal 2014 related to the Rocketdyne Business acquisition (see Note 5)
5.6

November 30, 2015 and 2014
$
158.1

The purchase accounting adjustments recorded during fiscal 2014 were during the measurement period of the assets acquired and liabilities assumed related to the Rocketdyne Business acquisition and had no impact on the Company’s consolidated statement of operations.
f.  Intangible Assets
 
As of November 30, 2015
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
 
(In millions)
Customer related
$
83.8

 
$
27.6

 
$
56.2

Intellectual property\trade secrets
34.2

 
6.4

 
27.8

Non-compete agreements
0.5

 
0.4

 
0.1

Trade name
20.5

 
1.6

 
18.9

Acquired technology
18.3

 
12.5

 
5.8

Intangible assets
$
157.3

 
$
48.5

 
$
108.8

 
As of November 30, 2014
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
 
(In millions)
Customer related
$
83.8

 
$
18.5

 
$
65.3

Intellectual property\trade secrets
34.2

 
3.7

 
30.5

Non-compete agreements
0.5

 
0.2

 
0.3

Trade name
20.5

 
1.0

 
19.5

Acquired technology
18.3

 
11.7

 
6.6

Intangible assets
$
157.3

 
$
35.1

 
$
122.2

Amortization expense related to intangible assets was $13.4 million, $13.5 million, $6.5 million in fiscal 2015, 2014, and 2013, respectively.


40



Future amortization expense for the five succeeding years is estimated to be as follows:
Year Ending November 30,
Future Amortization Expense
 
(In millions)

2016
$
13.3

2017
13.1

2018
13.1

2019
13.0

2020
12.8

 
$
65.3

g.  Other Noncurrent Assets, net
 
As of November 30,

2015
 
2014
 
(In millions)
Recoverable from the U.S. government for Rocketdyne Business integration costs
$
22.4


$
27.6

Deferred financing costs
13.9


18.5

Recoverable from the U.S. government for conditional asset retirement obligations
17.5


17.7

Grantor trust
10.7


11.2

Note receivable, net
9.0

 

Recoverable from the U.S. government for Competitive Improvement Program severance obligations (see Note 12)
2.8

 

Indemnification receivable from UTC, net

 
6.7

Other
9.4


11.3

Other noncurrent assets, net
$
85.7


$
93.0

The current and noncurrent Rocketdyne Business integration costs incurred and capitalized as of November 30, 2015 and 2014 totaled $34.3 million and $38.1 million, respectively. These integration costs are reimbursable by the U.S. government upon its audit and approval that the Company's planned integration savings will exceed its restructuring costs by a factor of at least two to one. In December 2014, the Company was informed that the Defense Contract Audit Agency had completed its audit of the Company’s restructuring proposal and found that the Company had achieved the required minimum two to one savings to restructuring cost ratio.  Actual recovery of the previously deferred integration costs will take place after the determination from the Under Secretary of Defense that the audited restructuring savings exceed the costs by a factor of two to one and final execution of an Advance Agreement with the Defense Contract Management Agency.  The Company believes these final two actions will be completed in first quarter of fiscal 2016. The Company reviews on a quarterly basis the probability of recovery of these costs.
The Company amortizes deferred financing costs over the estimated life of the related debt. Amortization of deferred financing costs was $2.7 million, $3.6 million, and $4.5 million in fiscal 2015, 2014, and 2013, respectively.
h.  Assets Held for Sale
As of February 28, 2015, the Company classified approximately 550 acres of its Sacramento Land, known as Hillsborough and representing a portion of the 6,000 acre Easton Master Plan, as assets held for sale as a result of its plans to sell the Hillsborough land. The Hillsborough land was reported as real estate held for entitlement and leasing as of November 30, 2014. For operating segment reporting, the Hillsborough land has been reported as a part of the Real Estate segment.
During the second quarter of fiscal 2015, the Company finalized the sale of the Hillsborough land for a total purchase price of $57.0 million which was comprised of $46.7 million cash and $10.3 million of promissory notes. The total acreage covered by the Hillsborough land transaction was approximately 700 acres, of which approximately 550 acres was recognized as a sale in the second quarter of fiscal 2015. At the initial closing, the buyer paid $40.0 million cash and executed a $9.0 million promissory note secured by a first lien Deed of Trust on a portion of the sale property which resulted in a gain of $30.6 million in the second quarter of fiscal 2015. The $9.0 million promissory note secured by a first lien Deed of Trust is divided into two components: (i) a $3.0 million 7% promissory note payable 7 years after close of escrow, which includes a possible $1.0 million reduction in principal if the Company is unable to obtain the necessary road and utility approvals, and (ii) a $6.0 million 7% promissory note payable 7 years after close of escrow and only payable after certain environmental clearances

41



associated with "Area 40" (discussed below) are obtained by the Company. The sale also included a $1.3 million non-interest bearing promissory note secured by a first lien Deed of Trust on a portion of the sale property associated with the location of future city roads. In addition, approximately 150 acres of this land, including a 50-acre portion known as “Area 40,” was held back from the initial closing. Upon receipt of regulatory approvals, a closing will take place for the sale of the developable portions of such holdback acreage for a purchase price of $6.7 million in cash. A summary of the impact of the land sale on the consolidated statement of operations for fiscal 2015 is as follows (in millions):
Net sales from land sale
$
42.0

Cost of sales from land sale
11.4

Income from continuing operations before income taxes from land sale
30.6

Income tax provision related to land sale
12.7

Net income from land sale
$
17.9

In November 2014, the Company classified its energy business (the "Energy Business") as assets held for sale as a result of its plans to sell the business. The Company divested the Energy Business in July 2015 for an insignificant amount of proceeds. The Company incurred approximately $1.8 million of expenses to divest its Energy Business. The assets and liabilities of the Energy Business for all periods presented were insignificant. The plan was a result of management’s decision to focus its capital and resources on its Aerospace and Defense and Real Estate operating segments.  The net sales associated with the Energy Business totaled $0.6 million in fiscal 2015 and 2014. For operating segment reporting, the Energy Business has been reported as a part of the Aerospace and Defense segment. 
In the fourth quarter of fiscal 2014, the Company entered into an asset purchase agreement associated with the sale of certain intellectual property related to a solar power contract.  The related contract was terminated in connection with the sale. The proceeds from the sale were $7.5 million resulting in a gain of $6.8 million which is included in "Other, net" in the consolidated statement of operations.  
i.  Other Current Liabilities
 
As of November 30,
 
2015
 
2014
 
(In millions)
Accrued compensation and employee benefits
$
101.3


$
94.9

Income taxes
15.5

 
16.2

Payable to UTC primarily for Transition Service Agreements
1.9


11.9

Interest payable
11.7


14.6

Contract loss provisions
9.3


12.0

Other
61.6


71.8

Other current liabilities
$
201.3


$
221.4

j.  Other Noncurrent Liabilities
 
As of November 30,
 
2015
 
2014
 
(In millions)
Conditional asset retirement obligations
$
29.3


$
24.4

Pension benefits, non-qualified
17.9


19.1

Deferred compensation
11.9


11.1

Deferred revenue
13.9


7.4

Other
21.4


18.6

Other noncurrent liabilities
$
94.4


$
80.6

k.  Accumulated Other Comprehensive Loss, Net of Income Taxes
Changes in accumulated other comprehensive loss by components, net of income taxes, related to the Company’s retirement benefit plans are as follows:

42




Actuarial
Losses, Net

Prior Service
Credits, Net

Total
 
(In millions)
November 30, 2013
$
(232.1
)
 
$
3.8

 
$
(228.3
)
Actuarial losses arising during the period, net of income taxes
(136.0
)
 

 
(136.0
)
Amortization of actuarial losses and prior service credits, net of income taxes
31.1

 
(0.5
)
 
30.6

November 30, 2014
(337.0
)

3.3


(333.7
)
Actuarial losses and prior service costs arising during the period, net of income taxes
(55.0
)
 
(1.6
)
 
(56.6
)
Amortization of actuarial losses and prior service credits, net of income taxes
49.4

 
(0.8
)
 
48.6

November 30, 2015
$
(342.6
)

$
0.9


$
(341.7
)
The estimated amounts that will be amortized from accumulated other comprehensive loss into net periodic benefit expense in fiscal 2016 are as follows:
 
Pension Benefits
 
Medical and Life Insurance Benefits
 
(In millions)
Actuarial losses (gains), net
$
64.7

 
$
(3.6
)
Prior service costs (credits), net
0.1

 
(1.1
)
 
$
64.8

 
$
(4.7
)
l. Redeemable Common Stock
The Company inadvertently failed to register with the SEC the issuance of certain of its common shares in its defined contribution 401(k) employee benefit plan (the “Plan”). As a result, certain Plan participants who purchased such securities pursuant to the Plan may have the right to rescind certain of their purchases for consideration equal to the purchase price paid for the securities (or if such security has been sold, to receive consideration with respect to any loss incurred on such sale) plus interest from the date of purchase. As of November 30, 2015 and 2014, the Company has classified 0.1 million shares as redeemable common stock because the redemption features are not within the control of the Company. The Company may also be subject to civil and other penalties by regulatory authorities as a result of the failure to register these shares. These shares have always been treated as outstanding for financial reporting purposes. In June 2008, the Company filed a registration statement on Form S-8 to register future transactions in the Company's stock fund in the Plan. During fiscal 2015, 2014 and 2013, the Company recorded less than $(0.1) million, $0.9 million, and $(1.0) million, respectively, for realized (gains)/losses and interest associated with this matter.
Note 5. Acquisition, (As Restated for fiscal 2013)
In July 2012, the Company signed the Original Purchase Agreement with UTC to acquire the Rocketdyne Business from UTC for $550.0 million. On June 10, 2013, the FTC announced that it closed its investigation into the Acquisition under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. On June 12, 2013, the Company entered into an Amended and Restated Purchase Agreement with UTC, which amended and restated the Original Purchase Agreement, as amended. On June 14, 2013, the Company completed the Acquisition of substantially all of the Rocketdyne Business pursuant to the Amended and Restated Purchase Agreement.
The components of the purchase price to UTC are as follows (in millions):
Purchase Price
$
495.0

Advance payments on contracts adjustment
(55.7
)
Capital expenditures adjustment
(28.3
)
Cash payment to UTC
$
411.0


43



The Company incurred substantial expenses in connection with the Acquisition. A summary of the expenses related to the Acquisition recorded in fiscal 2012 ($11.6 million) and fiscal 2013 ($20.0 million) is as follows (in millions):
 
Legal expenses
$
16.4

Professional fees and consulting
8.9

Internal labor
3.4

Costs related to the previously planned divestiture of the Liquid Divert and Attitude Control Systems business, including $0.3 million of internal labor
1.7

Other
1.2

 
$
31.6

The operating results of the Rocketdyne Business are included in the Company’s consolidated financial statements since June 14, 2013, the acquisition date, within the Company’s Aerospace and Defense segment.
The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date (in millions):
Current assets
$
110.9

Property, plant and equipment, net
203.8

Other non-current assets
4.2

Total tangible assets acquired
318.9

Intangible assets acquired
128.3

Deferred income taxes
13.3

Total assets acquired
460.5

Liabilities assumed, current
(105.5
)
Liabilities assumed, non-current
(7.2
)
Total identifiable net assets acquired
347.8

Goodwill (Cash payment less total identifiable net assets acquired)
$
63.2

The purchase price allocation resulted in the recognition of $63.2 million in goodwill, all of which is deductible for tax purposes and included within the Company’s Aerospace and Defense segment. Goodwill recognized from the Acquisition primarily relates to the expected contributions of the Rocketdyne Business to the Company’s overall corporate strategy.
The Company has a $15.7 million and $1.9 million indemnification receivable from and payable to UTC, respectively, as of November 30, 2015. Pursuant to the terms of the Amended and Restated Purchase Agreement, the Company is indemnified for certain matters.
The unaudited pro forma information for fiscal 2013 set forth below gives effect to the Acquisition as if it had occurred at the beginning of the year. These amounts have been calculated after applying the Company’s accounting policies and adjusting the results of the Rocketdyne Business to reflect depreciation and amortization that would have been charged assuming the fair value adjustments to property, plant and equipment and intangible assets had been applied as at the beginning of fiscal 2013, together with the tax effects, as applicable. The pro forma information is presented for informational purposes only and is not necessarily indicative of the results of operations that actually would have been achieved had the Acquisition been consummated as of that time or that may result in the future.

44




Year Ended
 
2013
 
(In millions, except per share amounts)
Net sales:

As reported
$
1,378.1

Pro forma
$
1,757.7

Net income:
 
As reported
$
162.9

Pro forma
$
25.7

Basic income per share
 
As reported
$
2.68

Pro forma
$
0.42

Diluted income per share
 
As reported
$
2.05

Pro forma
$
0.41

Note 6. Income Taxes, (As Restated for fiscal 2014 and 2013)
The Company files a consolidated U.S. federal income tax return with its wholly-owned subsidiaries. The components of the Company’s income tax provision (benefit) from continuing operations are as follows:
 
Year Ended 
 
2015
 
2014
 
2013
 
(In millions)
Current
 
 
 
 
 
   U.S. federal
$
33.0

 
$
19.0

 
$
1.8

   State and local
3.4

 
4.1

 
1.0

 
36.4

 
23.1

 
2.8

Deferred
 
 
 
 
 
   U.S. federal
(41.2
)
 
(5.5
)
 
(150.3
)
   State and local
5.1

 
(1.3
)
 
(50.9
)
 
(36.1
)
 
(6.8
)
 
(201.2
)
Income tax provision (benefit)
$
0.3

 
$
16.3

 
$
(198.4
)

45



A reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate on earnings from continuing operations is as follows:
 
Year Ended 
 
2015
 
2014
 
2013
Statutory U.S. federal income tax rate - provision (benefit)
(35.0
)%
 
(35.0
)%
 
(35.0
)%
State and local income taxes, net of U.S. federal income tax effect
16.2

 
11.4

 
(6.8
)
Changes in state income tax rates
19.0

 
(0.7
)
 
(21.5
)
Reserve adjustments
2.2

 
(0.8
)
 
4.1

Valuation allowance adjustments

 
0.3

 
(501.3
)
Rescindable common stock interest and realized losses (gains)

 
0.9

 
(1.0
)
Non-deductible convertible subordinated notes interest
8.0

 
7.0

 
7.9

Non-deductible premiums on repurchase of convertible subordinated notes

 
64.1

 
4.8

Research credits

 
4.0

 
(3.4
)
Retroactive change in federal tax law
(11.6
)
 

 
(3.9
)
Benefit of manufacturing deductions
(5.8
)
 
(4.3
)
 
(0.8
)
Lobbying costs
3.6

 
1.0

 
0.9

Other, net
5.2

 
1.5

 
0.3

Effective income tax rate - provision (benefit)
1.8
 %
 
49.4
 %
 
(555.7
)%
In fiscal 2015, the Company’s effective tax rate was an income tax expense of 1.8% on a pre-tax loss from continuing operations of $16.8 million. The Company’s effective tax rate differed from the 35.0% statutory federal income tax rate due largely to state income taxes and certain non-deductible interest expense partially offset by the retroactive reinstatement of the federal R&D credit and the benefit related to manufacturing deductions.
In fiscal 2014, the Company’s effective tax rate was an income tax expense of 49.4% on a pre-tax loss from continuing operations of $33.0 million. The Company’s effective tax rate differed from the 35.0% statutory federal income tax rate due largely to the non-deductible premiums paid upon the redemption of portions of the convertible debt, state income taxes, impacts from the final R&D credit study, the benefit related to manufacturing deductions, and certain non-deductible interest expense.
In fiscal 2013, the Company’s effective tax rate was an income tax benefit of 555.7% on a pre-tax loss from continuing operations of $35.7 million. The Company’s effective tax rate differed from the 35% statutory federal income tax rate due largely to the release of a significant portion of the valuation allowance previously recorded against deferred tax assets, the impact of state income taxes, and certain non-deductible interest expense. The Company released approximately $282.4 million of the valuation allowance that existed at the beginning of the year, of which approximately $178.7 million was recorded as an income tax benefit to continuing operations, $1.1 million to discontinued operations, and $102.6 million was recorded in other comprehensive income.
The timing of recording or releasing a valuation allowance requires significant management judgment. The amount of the valuation allowance released by the Company represents a portion of deferred tax assets that was deemed more-likely-than-not that the Company will realize the benefits based on the analysis in which the positive evidence outweighed the negative evidence.
A valuation allowance is required when it is more-likely-than-not that all or a portion of deferred tax assets may not be realized. Establishment and removal of a valuation allowance requires management to consider all positive and negative evidence and to make a judgmental decision regarding the amount of valuation allowance required as of a reporting date. The weight given to the evidence is commensurate with the extent to which it can be objectively verified. In the evaluations as of November 30, 2015 and 2014, management has considered all available evidence, both positive and negative, including but not limited to the following:
Positive evidence
The three year comprehensive cumulative income position as of November 30, 2015;
Continuing positive results of operations from the acquisition of the Rocketdyne Business;
The Company’s recent history of generating taxable income which has allowed for the utilization of tax credit carryforwards, and the expected taxable income position for the current year;
Pension rules that allow the Company to recover pension funding cash contributions through its U.S. government contracts;

46



Establishment and execution of the Competitive Improvement Program evidencing increasing growth and profitability;
Increase in the Company's contract backlog; and
Favorable trends with respect to the market value of certain real estate assets.
Negative evidence
The Company’s exposure to environmental remediation obligations and the related uncertainty as to the ultimate exposure upon settlement;
The significance of the Company’s defined benefit pension obligation and related impact it could have in future years;
The additional indebtedness incurred in fiscal 2013 related to the acquisition of the Rocketdyne Business that continues to generate interest expense; and
Potential three-year cumulative loss position at the end of fiscal 2016.
As of November 30, 2015 and 2014, management believes that the weight of the positive evidence outweighed the negative evidence regarding the realization of the net deferred tax assets. Management will continue to evaluate the ability to realize the Company’s net deferred tax assets and the remaining valuation allowance on a quarterly basis.
The Company is routinely examined by domestic and foreign tax authorities. While it is difficult to predict the outcome or timing of a particular tax matter, the Company believes it has adequately provided reserves for any reasonable foreseeable outcome related to these matters.
A reconciliation of the beginning and ending amount of unrecognized tax benefits consists of the following:
 
Year Ended 
 
2015
 
2014
 
2013
 
(In millions)
Balances at beginning of fiscal year
$
6.8

 
$
7.9

 
$
4.9

  Increases based on tax positions in prior years
1.0

 
0.6

 
3.7

  Decreases based on tax position in prior years
(1.8
)
 
(1.3
)
 

  Increases based on tax positions in current year
0.7

 

 
0.2

  Lapse of statute of limitations

 
(0.4
)
 
(0.9
)
Balances at end of fiscal year
$
6.7

 
$
6.8

 
$
7.9

As of November 30, 2015, the total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate was $5.9 million. The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. As of November 30, 2015, the Company’s accrued interest and penalties related to uncertain tax positions was $0.7 million. It is reasonably possible that a reduction of less than $4.2 million of unrecognized tax benefits and related interest may occur within the next 12 months as a result of the expiration of certain statutes of limitations. During fiscal 2014, the Company completed a study relative to its federal and California R&D credits. Based upon the study results, the Company concluded that no additional reserves were required.
The years ended November 30, 2012 through November 30, 2015 remain open to examination for U.S. federal income tax purposes. In addition, the years ended November 30, 2002 through November 30, 2005 remain open as they relate to selected tax attributes utilized during fiscal years 2010 through 2014. For the Company’s other major taxing jurisdictions, the tax years ended November 30, 2003 through November 30, 2015 remain open to examination.

47



Deferred tax assets and liabilities are as follows:
 
As of November 30, 
 
2015
 
2014
 
(In millions)
Deferred Tax Assets
 
 
 
    Accrued estimated costs
$
112.4

 
$
99.7

    Basis difference in assets and liabilities
7.4

 
18.2

    Tax losses and credit carryforwards
8.2

 
13.0

    Net cumulative defined benefit pension plan losses
222.2

 
192.3

    Retiree medical and life insurance benefits
19.9

 
22.7

    Valuation allowance
(1.7
)
 
(2.6
)
        Total deferred tax assets
368.4

 
343.3

Deferred Tax Liabilities
 
 
 
     Revenue recognition differences
39.7

 
47.6

     Basis differences in intangible assets
13.9

 
14.4

         Total deferred tax liabilities
53.6

 
62.0

         Total net deferred tax assets
$
314.8

 
$
281.3

The deferred tax liabilities considered in the assessment of the realizability of deferred tax assets are of the same character as the temporary differences giving rise to the deferred tax assets. The remaining liabilities will reverse in the same period as the assets, if not sooner.
The changes in the Company's valuation allowance by fiscal year is as follows:
 
Balance at
Beginning of
Period 
Tax
Valuation
Allowance
Charged to
Income
Tax
Provision 
Charged
to Other
Accounts
Tax
Valuation
Allowance
Credited to
Income
Tax
Provision 
Balance at
End of
Period 
 
(In millions)
2015
$
2.6

$
0.6

$

$
(1.5
)
$
1.7

2014
2.6




2.6

2013
288.1

61.2

(100.4
)
(246.3
)
2.6

The year of expiration for the Company’s state net operating loss carryforwards as of November 30, 2015 is as follows (in millions):
2016
$
28.9

2017
26.8

2018
24.2

2019
46.3

 
$
126.2

Approximately $5.5 million of the state net operating loss carryforwards relate to the exercise of stock options the benefit of which will be credited to equity when realized. The Company has approximately $5.9 million of loss carryover in foreign jurisdictions which have no expiration date.
The Company has a California R&D credit carryover of $0.1 million. The state credits have no expiration date.

48



Note  7.    Long-Term Debt
 
As of November 30,
 
2015
 
2014
 
(In millions)
Senior debt
$
93.8

 
$
98.8

Senior secured notes
460.0

 
460.0

Convertible subordinated notes
84.8

 
133.8

Other debt
13.4

 
89.6

Total debt, carrying amount
652.0

 
782.2

Less: Amounts due within one year
(5.3
)
 
(5.3
)
Total long-term debt, carrying amount
$
646.7

 
$
776.9

As of November 30, 2015, the earlier of the Company’s contractual debt principal maturities or the next debt redemption date that could be exercised at the option of the debt holder, are summarized by fiscal year as follows:
 
Total 
 
2016
 
2017
 
2018
 
2019
 
2020
 
2021
 
2022
 
(In millions)
Senior debt
$
93.8

 
$
5.0

 
$
5.0

 
$
5.0

 
$
78.8

 
$

 
$

 
$

Senior secured notes
460.0

 

 

 

 

 

 
460.0

 

Convertible subordinated notes (1)
84.8

 

 

 

 
0.2

 
84.6

 

 

Other debt
13.4

 
0.3

 
0.1

 

 

 

 

 
13.0

Total debt
$
652.0

 
$
5.3

 
$
5.1

 
$
5.0

 
$
79.0

 
$
84.6

 
$
460.0

 
$
13.0

_______
(1)
With respect to the 4 1/16% Debentures holders option to require the Company to repurchase all of the outstanding 4 1/16% Debentures, or any portion thereof that is a multiple of $1,000 principal amount, on December 31, 2019, the Company has the unilateral option to pay the 4 1/16% Debentures holders in shares of its common stock.
a.  Senior Debt:
 
As of November 30,
 
2015
 
2014
 
(In millions)
Term loan, bearing interest at variable rates (rate of 2.33% as of November 30, 2015), payable in quarterly installments of $1.3 million plus interest, maturing in May 2019
$
93.8

 
$
98.8

Senior Credit Facility
In connection with the consummation of the Acquisition, the Company added Pratt & Whitney Rocketdyne, Inc. (“PWR”), Arde, Inc. (“Arde”) and Arde-Barinco, Inc. (“Arde-Barinco”) as subsidiary guarantors under its senior credit facility (the “Senior Credit Facility”) pursuant to that certain Joinder Agreement, dated as of June 14, 2013, by and among PWR, Arde, Arde-Barinco, the Company and Wells Fargo Bank, National Association, as administrative agent. In connection with the consummation of the Acquisition, the name of PWR was changed to Aerojet Rocketdyne of DE, Inc. and the name of Aerojet-General Corporation, an existing subsidiary guarantor at the time of the Acquisition, was changed to Aerojet Rocketdyne, Inc.
On May 30, 2014, the Company, with its wholly-owned subsidiaries Aerojet Rocketdyne, Aerojet Rocketdyne of DE, Inc., Arde, and Arde-Barinco as guarantors, executed an amendment to the Senior Credit Facility with the lenders identified therein and Wells Fargo Bank, National Association, as administrative agent. This amendment to the Senior Credit Facility replaces the Company’s prior credit facility and, among other things, (i) extends the maturity date to May 30, 2019 (which date may be accelerated in certain cases); and (ii) replaces the existing revolving credit facility and credit-linked facility with (x) a revolving credit facility in an aggregate principal amount of up to $200.0 million (with a $100.0 million subfacility for standby letters of credit and a $5.0 million subfacility for swingline loans) and (y) a term loan facility in an aggregate principal amount of up to $100.0 million. The term loan facility will amortize at a rate of 5.0% of the original principal amount per annum to be paid in equal quarterly installments with any remaining amounts due on the maturity date. Outstanding indebtedness under the Senior Credit Facility may be voluntarily prepaid at any time, in whole or in part, in general without premium or penalty.

49



The Company and the guarantors (collectively, the “Loan Parties”) guarantee the payment obligations of the Company under the Senior Credit Facility. Any borrowings are further secured by (i) certain equity interests owned or held by the Loan Parties and 65% of the voting stock (and 100% of the non-voting stock) of all present and future first-tier foreign subsidiaries of the Loan Parties; (ii) substantially all of the tangible and intangible personal property and assets of the Loan Parties; and (iii) certain real property owned by the Loan Parties located in Culpeper, Virginia, Redmond, Washington and Canoga Park, California. All of the Company’s other real property is excluded from collateralization under the Senior Credit Facility.
As of November 30, 2015, the Company had $44.1 million outstanding letters of credit under the $100.0 million subfacility for standby letters of credit and had $93.8 million outstanding under the term loan facility.
In general, borrowings under the Senior Credit Facility bear interest at a rate equal to LIBOR plus 250 basis points (subject to downward adjustment based on the Company's corporate credit ratings and its leverage ratio), or the base rate as it is defined in the credit agreement governing the Senior Credit Facility. In addition, the Company is charged a commitment fee of 50 basis points per annum on unused amounts of the revolving credit facility (subject to downward adjustment based on the Company's corporate credit ratings and its leverage ratio) and 250 basis points per annum (subject to downward adjustment based on the Company's corporate credit ratings and its leverage ratio), along with a fronting fee of 25 basis points per annum, on the undrawn amount of all outstanding letters of credit.
The Company is subject to certain limitations including the ability to incur additional debt, make certain investments and acquisitions, and make certain restricted payments, including stock repurchases and dividends. The Senior Credit Facility includes events of default usual and customary for facilities of this nature, the occurrence of which could lead to an acceleration of the Company’s obligations thereunder. Additionally, the Senior Credit Facility includes certain financial covenants, including that the Company maintain (i) a maximum total leverage ratio, calculated net of cash up to a maximum of $150.0 million, of 4.50 to 1.00 through the fiscal period ended November 30, 2015, 4.25 to 1.00 through fiscal periods ending November 30, 2017, and 4.00 to 1.00 thereafter; and (ii) a minimum interest coverage ratio of 2.40 to 1.00.
Financial Covenant
Actual Ratios as of
November 30, 2015
  
Required Ratios
Interest coverage ratio, as defined under the Senior Credit Facility
4.77 to 1.00
  
Not less than: 2.40 to 1.00
Leverage ratio, as defined under the Senior Credit Facility
2.21 to 1.00
  
Not greater than: 4.50 to 1.00
The Company was in compliance with its financial and non-financial covenants as of November 30, 2015.
b.  Senior Secured Notes:
 
As of November 30,
 
2015
 
2014
 
(In millions)
Senior secured notes, bearing interest at 7.125% per annum, interest payments due in March and September, maturing in March 2021
$
460.0

 
$
460.0

7.125% Second-Priority Senior Secured Notes
On January 28, 2013, the Company issued $460.0 million in aggregate principal amount of its 7 1/8% Notes. The 7 1/8% Notes were sold to qualified institutional buyers in accordance with Rule 144A under the Securities Act and outside the U.S. in accordance with Regulation S under the Securities Act. The 7 1/8% Notes mature on March 15, 2021, subject to early redemption described below. The 7 1/8% Notes pay interest semi-annually in cash in arrears on March 15, and September 15, of each year, beginning on March 15, 2013. In November 2013, the 7 1/8% Notes were registered under the Securities Act.
The gross proceeds from the sale of the 7 1/8% Notes (after deducting underwriting discounts), plus an amount sufficient to fund a Special Mandatory Redemption (as defined in the 7 1/8% Notes indenture), including accrued interest on the 7 1/8% Notes, were deposited into escrow pending the consummation of the Acquisition pursuant to an escrow agreement (the “Escrow Agreement”) by and among the Company and U.S. Bank National Association, as trustee for the 7 1/8% Notes, as escrow agent and as bank and securities intermediary. Pursuant to the Escrow Agreement, the Company continued to deposit accrued interest on the 7 1/8% Notes on a monthly basis until the satisfaction of the conditions to release the proceeds from escrow. On June 14, 2013, the conditions to release the proceeds from escrow were satisfied and escrow funds were released in connection with the consummation of the Acquisition.
The 7 1/8% Notes are redeemable at the Company’s option, in whole or in part, at any time prior to March 15, 2016 at a price equal to 100% of the principal amount, plus any accrued and unpaid interest to the date of redemption, plus an applicable premium (as defined in the 7 1/8% Notes indenture). Thereafter, the Company may redeem the 7 1/8% Notes, at any time on or after March 15, 2016, at redemption prices (expressed as percentages of principal amount) set forth below plus accrued and

50



unpaid interest and additional interest, if any, thereon, to the applicable redemption date, if redeemed during the twelve-month period beginning March 15 of the years indicated below:
 
Year
Redemption Price
2016
105.344
%
2017
103.563
%
2018
101.781
%
2019 and thereafter
100.000
%
In addition, before March 15, 2016, the Company may redeem up to 35% of the original aggregate principal amount of the 7 1/8% Notes at a redemption price equal to 107.125% of the aggregate principal amount of the 7 1/8% Notes, plus accrued interest, with the proceeds from certain types of public equity offerings.
The 7 1/8% Notes are fully and unconditionally and jointly and severally guaranteed on a second-priority senior secured basis by each of the Company’s existing and future subsidiaries that guarantee its obligations under the Company’s existing Senior Credit Facility. These 100% owned subsidiary guarantors are Aerojet Rocketdyne, Aerojet Rocketdyne of DE, Inc. (formerly PWR), Arde and Arde-Barinco. The 7 1/8% Notes are also secured on a second-priority basis by the assets (other than real property) that secure the Company’s and its guarantors’ obligations under the Senior Credit Facility, subject to certain exceptions and permitted liens.
Upon the occurrence of a change of control (as defined in the 7 1/8% Notes indenture), if the Company has not previously exercised its right to redeem all of the outstanding 7 1/8% Notes pursuant to the Special Mandatory Redemption or an optional redemption as described in the indenture, the Company must offer to repurchase the 7 1/8% Notes at 101% of the principal amount of the 7 1/8% Notes, plus accrued and unpaid interest to the date of repurchase.
The 7 1/8% Notes indenture contains certain covenants limiting the Company’s ability and the ability of its restricted subsidiaries (as defined in the 7 1/8% Notes indenture) to, subject to certain exceptions and qualifications: (i) incur additional indebtedness; (ii) pay dividends or make other distributions on, redeem or repurchase, capital stock; (iii) make investments or other restricted payments; (iv) create or incur certain liens; (v) incur restrictions on the payment of dividends or other distributions from its restricted subsidiaries; (vi) enter into transactions with affiliates; (vii) sell assets; or (viii) effect a consolidation or merger.
The 7 1/8% Notes indenture also contains customary events of default, including, among other things, failure to pay interest, failure to comply with certain repurchase provisions, breach of certain covenants, failure to pay at maturity or acceleration of other indebtedness, failure to pay certain judgments, and certain events of insolvency or bankruptcy. Generally, if any event of default occurs, the 7 1/8% Notes trustee or the holders of at least 25% in principal amount of the 7 1/8% Notes may declare the 7 1/8% Notes due and payable by providing notice to the Company. In case of default arising from certain events of bankruptcy or insolvency, the 7 1/8% Notes will become immediately due and payable.
The Company used the net proceeds of the 7 1/8% Notes offering to fund, in part, the acquisition of the Rocketdyne Business, and to pay related fees and expenses.
c.  Convertible Subordinated Notes:
 
As of November 30,
 
2015
 
2014
 
(In millions)
Convertible subordinated debentures, bearing interest at 2.25% per annum, interest payments due in May and November, maturing in November 2024
$
0.2

 
$
0.2

Convertible subordinated debentures, bearing interest at 4.0625% per annum, interest payments due in June and December, maturing in December 2039
84.6

 
133.6

Total convertible subordinated notes
$
84.8

 
$
133.8

2 1/4% Convertible Subordinated Debentures ("2 1/4% Debentures")
As of November 30, 2015 and 2014, the Company had $0.2 million outstanding principal amount of its 2 1/4% Debentures.
4.0625% Convertible Subordinated Debentures
As of November 30, 2015, the Company had $84.6 million outstanding principal of its 4 1/16% Debentures, convertible into 9.4 million of shares of common stock.
In December 2009, the Company issued $200.0 million in aggregate principal amount of 4 1/16% Debentures in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. The

51



4 1/16% Debentures mature on December 31, 2039, subject to earlier redemption, repurchase, or conversion. Interest on the 4 1/16% Debentures accrues at 4.0625% per annum and is payable semiannually in arrears on June 30 and December 31 of each year, beginning June 30, 2010 (or if any such day is not a business day, payable on the following business day), and the Company may elect to pay interest in cash or, generally on any interest payment that is at least one year after the original issuance date of the 4 1/16% Debentures, in shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock, at the Company’s option, subject to certain conditions.
The 4 1/16% Debentures are general unsecured obligations of the Company and rank equal in right of payment to all of the Company’s other existing and future unsecured subordinated indebtedness, including the 2 1/4% Debentures. The 4 1/16% Debentures rank junior in right of payment to all of the Company’s existing and future senior indebtedness, including all of its obligations under its Senior Credit Facility and all of its existing and future senior subordinated indebtedness. In addition, the 4 1/16% Debentures are effectively subordinated to any of the Company’s collateralized debt, to the extent of such collateral, and to any and all debt and liabilities including trade debt of its subsidiaries.
Each holder of the 4 1/16% Debentures may convert its 4 1/16% Debentures into shares of the Company’s common stock at a conversion rate of 111.0926 shares per $1,000 principal amount, representing a conversion price of approximately $9.00 per share, subject to adjustment. In addition, if the holders elect to convert their 4 1/16% Debentures in connection with the occurrence of certain fundamental changes to the Company as described in the indenture, the holders will be entitled to receive additional shares of common stock upon conversion in some circumstances. Upon any conversion of the 4 1/16% Debentures, subject to certain exceptions, the holders will not receive any cash payment representing accrued and unpaid interest.
The Company may at any time redeem any 4 1/16% Debentures for cash (except as described below with respect to any make-whole premium that may be payable) if the last reported sales price of the Company’s common stock has been at least 150% of the conversion price then in effect for at least twenty (20) trading days during any thirty (30) consecutive trading day period ending within five (5) trading days prior to the date on which the Company provides the notice of redemption.
Each holder may require the Company to repurchase all or part of its 4 1/16% Debentures on December 31, 2019, 2024, 2029 and 2034 (each, an “optional repurchase date”) at an optional repurchase price equal to (1) 100% of their principal amount, plus (2) accrued and unpaid interest, if any, up to, but excluding, the date of repurchase. The Company may elect to pay the optional repurchase price in cash, shares of the Company’s common stock, or a combination of cash and shares of the Company’s common stock, at the Company’s option, subject to certain conditions.
If a fundamental change to the Company, as described in the indenture governing the 4 1/16% Debentures, occurs prior to maturity, each holder will have the right to require the Company to purchase all or part of its 4 1/16% Debentures for cash at a repurchase price equal to 100% of their principal amount, plus accrued and unpaid interest, if any, up to, but excluding, the repurchase date.
If the Company elects to deliver shares of its common stock as all or part of any interest payment, any make-whole premium or any optional repurchase price, such shares will be valued at the product of (x) the price per share of the Company’s common stock determined during: (i) in the case of any interest payment, the twenty (20) consecutive trading days ending on the second trading day immediately preceding the record date for such interest payment; (ii) in the case of any make-whole premium payable as part of the redemption price, the twenty (20) consecutive trading days ending on the second trading day immediately preceding the redemption date; and (iii) in the case of any optional repurchase price, the forty (40) consecutive trading days ending on the second trading day immediately preceding the optional repurchase date; (in each case, the “averaging period” with respect to such date) using the sum of the daily price fractions (where “daily price fraction” means, for each trading day during the relevant averaging period, 5% in the case of any interest payment or any make-whole premium or 2.5% in the case of any optional repurchase, multiplied by the daily volume weighted average price per share of the Company’s common stock for such day), multiplied by (y) 97.5%. The Company will notify holders at least five (5) business days prior to the start of the relevant averaging period of the extent to which the Company will pay any portion of the related payment using shares of common stock.
Effective December 21, 2010, in accordance with the terms of the indenture, the restrictive legend on the 4 1/16% Debentures was removed and the 4 1/16% Debentures are freely tradable pursuant to Rule 144 under the Securities Act of 1933 without volume restrictions by any holder that is not an affiliate of the Company at the time of sale and has not been an affiliate during the preceding three months.
Issuance of the 4 1/16% Debentures generated net proceeds of $194.1 million, which were used to repurchase long-term debt and other debt related costs.
During fiscal 2013, $1.6 million of 4 1/16% Debentures were converted to common stock. Additionally, during fiscal 2013, the Company repurchased $5.2 million principal amount of its 4 1/16% Debentures at various prices ranging from 176% of par to 195% of par. During fiscal 2014, the Company repurchased $59.6 million principal amount of its 4 1/16% Debentures at various prices ranging from 195% of par to 212% of par (see Note 14 for additional information).

52



During fiscal 2015, $49.0 million of 4 1/16% Debentures were converted to 5.5 million shares of common stock.
d.  Other Debt:
 
As of November 30,
 
2015
 
2014
 
(In millions)
Delayed draw term loan, bearing interest at variable rates (rate of 9.50% as of November 30, 2015), maturing in April 2022
$
13.0

 
$
89.0

Capital lease, payable in monthly installments, maturing in March 2017
0.4

 
0.6

Total other debt
$
13.4

 
$
89.6

Delayed Draw Term Loan
On April 18, 2014, the Company entered into a subordinated delayed draw credit agreement (the “Subordinated Credit Facility”) with the lenders identified therein, and The Bank of New York Mellon, as administrative agent.
The Subordinated Credit Facility provides a term loan facility in an aggregate principal amount of up to $100.0 million. Outstanding indebtedness under the Subordinated Credit Facility may be voluntarily prepaid at any time, in whole or in part, in general without premium or penalty.
In general, borrowings under the Subordinated Credit Facility bear interest at a rate equal to the sum of (x) the greater of LIBOR and 1.00% per annum plus (y) 8.50%, or in the case of base rate loans, the base rate as it is defined in the credit agreement governing the Subordinated Credit Facility plus 7.50%.
The Company is subject to certain limitations under the Subordinated Credit Facility including the ability to incur additional debt, make certain investments and acquisitions, and make certain restricted payments, including stock repurchases and dividends. The Subordinated Credit Facility does not have any financial maintenance covenants. The Subordinated Credit Facility includes events of default usual and customary for facilities of this nature, the occurrence of which could lead to an acceleration of the Company’s obligations thereunder.
The proceeds from the term loan facility were used to repurchase a portion of the outstanding 4 1/16% Debentures.
During fiscal 2015, the Company retired $76.0 million principal amount of its delayed draw term loan.
Note  8.
Retirement Benefits, (As Restated for fiscal 2014 and 2013)
a.  Plan Descriptions
Pension Benefits
The Company's defined benefit pension plan future benefit accrual was discontinued in fiscal 2009. As of November 30, 2015, the Company’s total defined benefit pension plan assets, total projected benefit obligations, and unfunded pension obligation for the tax-qualified pension plans were approximately $964.1 million, $1,549.5 million, and $566.2 million, respectively.
The Company expects to make cash contributions of approximately $23 million to its tax-qualified defined benefit pension plan in fiscal 2016. The Company estimates that approximately 83% of its unfunded pension obligation as of November 30, 2015 is related to Aerojet Rocketdyne which will be recoverable through its U.S. government contracts.
On July 6, 2012, the Moving Ahead for Progress in the 21st Century Act (“MAP-21”) was signed into law by the U.S. government. MAP-21, in part, provides temporary relief for employers who sponsor defined benefit pension plans related to funding contributions under the Employee Retirement Income Security Act of 1974. Specifically, MAP-21 implemented a 25-year average interest rate corridor around the 24-month interest rate used for purposes of determining minimum funding obligations. This relief deferred minimum required pension funding. On August 8, 2014, the Highway and Transportation Funding Act was signed into law, which enacts the pension provision that delays the widening of the interest corridor under MAP-21. This law increased the interest rates for the plan year beginning December 1, 2013 and decreased the minimum funding requirement for Pension Protection Act ("PPA"). In November 2015, President Obama signed into law the Bipartisan Budget Act of 2015 which further delayed the widening of interest rate corridors and will result in higher interest rates and lower PPA minimum funding requirements in future years than under the prior law.
The PPA requires underfunded pension plans to improve their funding ratios based on the funded status of the plan as of specified measurement dates through contributions or application of prepayment credits. As of the last measurement date at November 30, 2015, the Company has accumulated $8.3 million in prepayment credits as a result of advanced funding.
The funded status of the Company's tax-qualified pension plan may be adversely affected by the investment experience of the plan's assets, by any changes in U.S. law and by changes in the statutory interest rates used by tax-qualified pension plans in the U.S. to calculate funding requirements. Accordingly, if the performance of the Company’s plan's assets does not meet

53



assumptions, if there are changes to the Internal Revenue Service regulations or other applicable law or if other actuarial assumptions are modified, future contributions to the underfunded pension plans could be higher than the Company expects.
In conjunction with the Acquisition, the Company recorded a $5.3 million pension liability associated with Rocketdyne’s bargaining unit employees. Effective November 30, 2014 and December 31, 2014, the Company discontinued benefit accruals for certain Rocketdyne’s bargaining unit employees. Effective April 1, 2016, the Company will discontinue the benefit accrual for the remaining Rocketdyne’s bargaining unit employees.
Medical and Life Insurance Benefits
The Company provides medical and life insurance benefits to certain eligible retired employees, with varied coverage by employee group. Generally, employees hired after January 1, 1997 are not eligible for retiree medical and life insurance benefits. The medical benefit plan provides for cost sharing between the Company and its retirees in the form of retiree contributions, deductibles, and coinsurance. Medical and life insurance benefit obligations are unfunded. Medical and life insurance benefit cash payments for eligible retired employees are recoverable under the Company’s U.S. government contracts.
Defined Contribution 401(k) Benefits
The Company sponsors a defined contribution 401(k) plan and participation in the plan is available to substantially all employees. The Company makes matching contributions in cash equal to 100% of the first 3% of the participants’ compensation contributed and 50% of the next 3% of the compensation contributed. The cost of the 401(k) plan was $24.9 million, $24.4 million, and $14.7 million in fiscal 2015, 2014, and 2013, respectively.

b.  Plan Results
Summarized below is the balance sheet impact of the Company’s pension benefits and medical and life insurance benefits. Pension benefits include the consolidated tax-qualified plan and the unfunded non-qualified plan for benefits provided to employees beyond those provided by the Company’s tax-qualified plan. Plan assets, benefit obligations, and the funded status of the plans were determined at November 30, 2015 and 2014 for fiscal 2015 and 2014, respectively.

54



 
Pension Benefits 
 
Medical and
Life Insurance
Benefits
 
As of November 30,
 
2015
 
2014
 
2015
 
2014
 
(In millions)
Change in fair value of plan assets:
 
 
 
 
 
 
 
Fair value - beginning of year
$
1,163.1

 
$
1,249.2

 
$

 
$

(Loss) gain on plan assets
(64.2
)
 
63.5

 

 

Employer contributions
1.3

 
1.2

 
4.8

 
5.3

Benefits paid (1)
(136.1
)
 
(133.7
)
 
(4.8
)
 
(5.3
)
Lump sum distributions (2)

 
(17.1
)
 

 

Fair value - end of year
$
964.1

 
$
1,163.1

 
$

 
$

Change in benefit obligation:
 
 
 
 
 
 
 
Benefit obligation - beginning of year
$
1,666.3

 
$
1,538.6

 
$
58.1

 
$
66.6

Service cost
10.8

 
8.8

 

 
0.1

Interest cost
63.6

 
67.1

 
1.9

 
2.5

Plan amendments
2.5

 

 

 

Actuarial losses (gains)
(57.6
)
 
202.6

 
(3.7
)
 
(5.8
)
Benefits paid
(136.1
)
 
(133.7
)
 
(4.8
)
 
(5.3
)
Lump sum distributions (2)

 
(17.1
)
 

 

Benefit obligation - end of year (3)
$
1,549.5

 
$
1,666.3

 
$
51.5

 
$
58.1

Funded status of the plans
$
(585.4
)
 
$
(503.2
)
 
$
(51.5
)
 
$
(58.1
)
Amounts recognized in the consolidated balance sheets:
 
 
 
 
 
 
 
Postretirement medical and life insurance benefits, current
$

 
$

 
$
(6.0
)
 
$
(6.4
)
Postretirement medical and life insurance benefits, noncurrent

 

 
(45.5
)
 
(51.7
)
Pension liability, non-qualified current (component of other current liabilities)
(1.3
)
 
(1.3
)
 

 

Pension liability, non-qualified (component of other noncurrent liabilities)
(17.9
)
 
(19.1
)
 

 

Pension benefits, noncurrent
(566.2
)
 
(482.8
)
 

 

Net liability recognized in the consolidated balance sheets
$
(585.4
)
 
$
(503.2
)
 
$
(51.5
)
 
$
(58.1
)
__________ 
(1)
Benefits paid for medical and life insurance benefits are net of the Medicare Part D Subsidy of $0.2 million received in fiscal 2015 and 2014.
(2)
During fiscal 2014, the Company offered and distributed lump sum pension payouts to terminated vested participants in the pension plan with a lump sum present value of less than $25,000.
(3)
Pension benefit obligation includes $19.2 million and $20.4 million as of November 30, 2015 and 2014, respectively, for the non-qualified plan.
The accumulated benefit obligation for the defined benefit pension plans was $1,549.4 million and $1,666.0 million as of the November 30, 2015 and 2014 measurement dates, respectively.
Components of retirement benefit expense (income) are: 

55



 
Pension Benefits
 
Medical and
Life Insurance Benefits 
 
Year Ended
 
 
2015
 
2014
 
2013
 
2015
 
2014
 
2013
 
(In millions)
Service cost
$
10.8

 
$
8.8

 
$
6.3

 
$

 
$
0.1

 
$
0.1

Interest cost on benefit obligation
63.6

 
67.1

 
61.0

 
1.9

 
2.5

 
2.4

Assumed return on plan assets (1)
(88.1
)
 
(92.6
)
 
(96.4
)
 

 

 

Amortization of prior service credits

 

 

 
(1.1
)
 
(0.9
)
 
(0.9
)
Amortization of net losses (gains)
84.0

 
54.4

 
94.6

 
(3.5
)
 
(2.9
)
 
(2.1
)
 
$
70.3

 
$
37.7

 
$
65.5

 
$
(2.7
)
 
$
(1.2
)
 
$
(0.5
)
__________ 
(1)
The actual return and rate of return on plan assets are as follows:
 
 
Year Ended 
 
 
2015
 
2014
 
2013
 
(In millions, except rate of return)
Actual return on plan assets
$
(64.2
)
 
$
63.5

 
$
141.4

Actual rate of return on plan assets
(6.1
)%
 
5.1
%
 
11.8
%
Market conditions and interest rates significantly affect assets and liabilities of the pension plans. Pension accounting permits market gains and losses to be deferred and recognized over a period of years. This “smoothing” results in the creation of other accumulated income or loss which will be amortized to pension costs in future years. The accounting method the Company utilizes recognizes one-fifth of the unamortized gains and losses in the market-related value of pension assets and all other gains and losses including changes in the discount rate used to calculate benefit costs each year. Investment gains or losses for this purpose are the difference between the expected return and the actual return on the market-related value of assets which smoothes asset values over three years. Although the smoothing period mitigates some volatility in the calculation of annual retirement benefit expense, future expenses are impacted by changes in the market value of pension plan assets and changes in interest rates.
c.  Plan Assumptions
The Company used the following assumptions, calculated based on a weighted-average, to determine the benefit obligations for the applicable fiscal year.
 
Pension
Benefits
 
Medical and
Life Insurance Benefits
 
2015
 
2014
 
2015
 
2014
Discount rate
4.26
%
 
3.96
%
 
3.87
%
 
3.54
%
Discount rate (benefit restoration plan)
4.32
%
 
4.01
%
 
*

 
*

Ultimate healthcare trend rate
*

 
*

 
5.00
%
 
5.00
%
Initial healthcare trend rate (pre 65/post 65)
*

 
*

 
7.00
%
 
7.00
%
Year ultimate rate attained (pre 65/post 65)
*

 
*

 
2021

 
2021

______
*
Not applicable
The Company used the following assumptions, calculated based on a weighted-average, to determine the periodic benefit expense (income) for the applicable fiscal year.

56



 
Pension Benefits 
 
Medical and
Life Insurance Benefits 
 
2015
 
2014
 
2013
 
2015
 
2014
 
2013
Discount rate
3.96
%
 
4.54
%
 
3.68
%
 
3.54
%
 
3.98
%
 
3.24
%
Discount rate (benefit restoration plan)
4.01
%
 
4.65
%
 
3.77
%
 
*

 
*

 
*

Expected long-term rate of return on plan assets
8.00
%
 
8.00
%
 
8.00
%
 
*

 
*

 
*

Ultimate healthcare trend rate
*

 
*

 
*

 
5.00
%
 
5.00
%
 
5.00
%
Initial healthcare trend rate (pre 65/post 65)
*

 
*

 
*

 
7.00
%
 
8.50
%
 
8.75
%
Year ultimate rate attained (pre 65/post 65)
*

 
*

 
*

 
2021

 
2021

 
2021

______
*
Not applicable
Certain actuarial assumptions, such as assumed discount rate, long-term rate of return, and assumed healthcare cost trend rates can have a significant effect on amounts reported for periodic cost of pension benefits and medical and life insurance benefits, as well as respective benefit obligation amounts. The assumed discount rate represents the market rate available for investments in high-quality fixed income instruments with maturities matched to the expected benefit payments for pension and medical and life insurance benefit plans.
The expected long-term rate of return on plan assets represents the rate of earnings expected in the funds invested, and funds to be invested, to provide for anticipated benefit payments to plan participants. The Company evaluated the plan’s historical investment performance, its current and expected asset allocation, and, with input from the Company’s external advisors, developed best estimates of future investment performance of the plan’s assets. Based on this analysis, the Company has assumed a long-term rate of return on plan assets of 8.0% for fiscal 2015. As of November 30, 2015, after evaluating the historical investment performance of plan assets, expected asset allocation, and recent input from the Company’s external advisors, the Company decided to change the long-term expected rate of return on plan assets from 8.0% to 7.0% effective December 1, 2015.
The Company reviews external data and its own historical trends for healthcare costs to determine the healthcare cost trend rates for the medical benefit plans. For fiscal 2015 medical benefit obligations, the Company assumed a 7.0% annual rate of increase for pre and post 65 participants in the per capita cost of covered healthcare claims with the rate decreasing over five years until reaching 5.0%.
A one percentage point change in the key assumptions would have the following effects on the projected benefit obligations as of November 30, 2015 and on expense for fiscal 2015:
 
Pension Benefits and
Medical and Life Insurance Benefits Discount Rate
 
Expected Long-term
Rate of Return
 
Assumed Healthcare
Cost Trend Rate
 
Net Periodic
Benefit Expense
 
Projected
Benefit
Obligation
 
Net Periodic Pension
Benefit Expense
 
Net Periodic
Medical and Life
Insurance Benefit Expense
 
Accumulated
Benefit
Obligation
 
(In millions)
1% decrease
$
26.5

 
$
166.1

 
$
11.1

 
$
(0.4
)
 
$
(1.3
)
1% increase
(22.5
)
 
(139.6
)
 
(11.1
)
 
0.4

 
1.5

d.  Plan Assets and Investment Policy
The Company’s investment policy is to maximize the total rate of return with a view toward long-term funding objectives of the plan to ensure that funds are available to meet benefit obligations when due. The plan assets are diversified to the extent necessary to minimize risk and to achieve an optimal balance between risk and return. This return seeking strategy focuses on higher return seeking investments in actively managed investment vehicles with an emphasis toward alternative investments and allows for diversification as to the type of assets, tactical trades, and number of investment managers used to carry out this strategy. This strategy is achieved using diversified asset types, which may include cash, equities, fixed income, real estate, private equity holdings, and derivatives. Allocations between these asset types may change as a result of changing market conditions and tactical investment opportunities.
While the Company does not target specific investment allocations, the Company monitors asset allocations periodically to provide diversification by investment type and investment managers as well as managing overall liquidity to meet the Company’s objective of maximizing the total rate of return. The Company’s pension plan's asset allocations as of November 30,

57



2015 and 2014, by asset category, are as follows:
 
As of November 30,
 
2015
 
2014
Cash and cash equivalents
35
%
 
18
%
Equity securities
35

 
32

Fixed income
13

 
16

Real estate investments

 
2

Private equity holdings
7

 
9

Alternative investments
10

 
23

Total
100
%
 
100
%
The fair value of the Company’s pension plan assets and liabilities by asset category and by level were as follows:
 
Total
 
Quoted Prices in Active Markets for Identical Assets (Level 1)
 
Significant Other Observable Inputs (Level 2)
 
Significant Unobservable Inputs (Level 3)
 
(In millions)
November 30, 2015
 
 
 
 
 
 
 
Cash and cash equivalents
$
101.5

 
$
101.5

 
$

 
$

Equity securities:
 
 
 
 
 
 
 
  Domestic equity securities
361.4

 
352.9

 
8.0

 
0.5

  International equity securities
34.3

 
34.3

 

 

  Derivatives:
 
 
 
 
 
 
 
    Written options
0.2

 
0.2

 

 

  Short sales
(62.8
)
 
(62.8
)
 

 

Fixed income:
 
 
 
 
 
 
 
  Corporate debt securities
27.5

 

 
27.5

 

  Asset-backed securities
96.9

 

 
96.9

 

  Short sales
(3.2
)
 
(2.5
)
 
(0.7
)
 

Real estate investments
0.7

 

 

 
0.7

Total assets at fair value
556.5

 
$
423.6

 
$
131.7

 
$
1.2

Investment measured at NAV
 
 
 
 
 
 
 
  Private equity holdings
62.8

 
 
 
 
 
 
  Alternative investments
97.7

 
 
 
 
 
 
  Common/collective trusts ("CCTs")
245.3

 
 
 
 
 
 
Total investments measured at NAV
405.8

 
 
 
 
 
 
Receivables
3.8

 
 
 
 
 
 
Payables
(2.0
)
 
 
 
 
 
 
Total assets
$
964.1

 
 
 
 
 
 

58



 
Total
 
Quoted Prices in Active Markets for Identical Assets (Level 1)
 
Significant Other Observable Inputs (Level 2)
 
Significant Unobservable Inputs (Level 3)
 
(In millions)
November 30, 2014
 
 
 
 
 
 
 
Cash and cash equivalents
$
166.4

 
$
166.4

 
$

 
$

Equity securities:
 
 
 
 
 
 
 
  Domestic equity securities
418.5

 
412.0

 
6.5

 

  International equity securities
43.3

 
43.3

 

 

  Derivatives:
 
 
 
 
 
 
 
    Purchased options
0.5

 
0.5

 

 

    Written options
(0.6
)
 
(0.6
)
 

 

  Short sales
(96.6
)
 
(96.6
)
 

 

Fixed income:
 
 
 
 
 
 
 
  Corporate debt securities
86.0

 
1.0

 
84.7

 
0.3

  Asset-backed securities
114.0

 

 
114.0

 

  Short sales
(15.4
)
 
(10.4
)
 
(5.0
)
 

Real estate investments
25.3

 

 

 
25.3

Total
741.4

 
$
515.6

 
$
200.2

 
$
25.6

Investment measured at NAV
 
 
 
 
 
 
 
  Private equity holdings
106.8

 
 
 
 
 
 
  Alternative investments
267.7

 
 
 
 
 
 
 CCTs
45.7

 
 

 
 
 
 
Total investments measured at NAV
420.2

 
 
 
 
 
 
Receivables
12.9

 
 
 
 
 
 
Payables
(11.4
)
 
 
 
 
 
 
Total assets
$
1,163.1

 
 
 
 
 
 
The following is a description of the significant investment strategies and valuation methodologies used for the investments measured at fair value, including the general classification of such investments pursuant to the valuation hierarchy. There have been no changes in the methodologies used at November 30, 2015 and 2014.
Cash and cash equivalents
Cash and cash equivalents are held in money market accounts or invested in Short-Term Investment Funds (“STIFs”). Cash and cash equivalents held in money market accounts are classified as Level 1 investments. STIFs are measured at NAV and included in CCTs as a reconciling item to the fair value tables above.
Equity securities
Equity securities are invested broadly in U.S. and non-U.S. companies in a variety of sectors and market capitalizations. These investments are comprised of common stocks, exchange-traded funds (“ETFs”), CCTs, derivatives and other investment vehicles. Common stocks and ETFs are stated at fair value as quoted on a recognized securities exchange and are valued at the last reported sales price on the last business day of the fiscal year and are classified as Level 1 investments. Derivatives include call and put options on common stocks or ETFs, which are all listed on an exchange and active market and classified as Level 1 investments. Short sales are short equity positions which are all listed on an exchange and active market and classified as Level 1 investments. Equity securities that are invested in common stock of private companies are priced using unobservable inputs and classified as Level 3 investments. CCTs invested in equity securities are measured at NAV and included as a reconciling item to the fair value tables above.
Fixed income securities
Fixed income securities are invested in a variety of instruments, including, but not limited to, corporate debt securities, CCTs, asset-backed securities, and other investment vehicles. Corporate debt securities are invested in corporate bonds or ETFs. ETFs are traded in an exchange and active market and classified as Level 1 investments. Corporate bonds that are valued at bid evaluations using observable and market-based inputs are classified as Level 2 investments. Corporate bonds that are priced by

59



brokers using unobservable inputs are classified as Level 3 investments. Asset-backed securities, including government-backed mortgage securities, non-government-backed collateralized mortgage obligations, asset-backed securities, and commercial mortgage-backed securities, are valued at bid evaluations and are classified as Level 2 investments. Short sales are short fixed income positions which are classified as Level 1 investments if they are listed on an exchange and active market, and are classified as Level 2 investments if they are valued at bid evaluation using observable and market-based inputs. CCTs invested in fixed income securities are measured at NAV and included as a reconciling item to the fair value tables above.
Real estate investments
Real estate investments include, but are not limited to, investments in office, commercial, residential and industrial properties and are valued based on either cash flows from future rents or sales of comparable properties, which are estimated based on information provided by the Company to independent appraisers.  Real estate investments are classified as Level 3 investments.
Private equity holdings
Private equity holdings are primarily limited partnerships and fund-of-funds that mainly invest in U.S. and non-U.S. leveraged buyout, venture capital and special situation strategies. Generally, the individual investments within the partnerships or funds are valued at public market, private market, or appraised value. Private equity holdings are valued at total market value or NAV, which are estimated by investment managers using unobservable inputs such as extrapolated data, proprietary data, or indicative quotes and are and included as a reconciling item to the fair value tables above.
Alternative investments
Alternative investments primarily consist of multi-strategy hedge funds that invest across a range of equity and debt securities in a variety of industry sectors. Alternative investments are valued at NAV calculated by investment managers using unobservable inputs such as extrapolated data, proprietary data, or indicative quotes and are included as a reconciling item to the fair value tables above.
Changes in the fair value of the Level 3 investments were as follows:
 
November 30,
2014 
 
Unrealized
Gains (Losses)
on Plan Assets 
 
Realized
Gains (Losses)
on Plan Assets
 
Purchases,
Issuances, and
Settlements 
 
Transfers
out of
Level 3
 
November 30,
2015 
 
(In millions)
Equity securities:
 
 
 
 
 
 
 
 
 
 
 
 Domestic equity securities
$

 
$
(0.3
)
 
$

 
$

 
$
0.8

 
$
0.5

Fixed income:
 
 
 
 
 
 
 
 
 
 
 
 Corporate debt securities
0.3

 
0.1

 
0.3

 
(0.7
)
 

 

Real estate investments
25.3

 
0.2

 

 
(24.8
)
 

 
0.7

Total
$
25.6

 
$

 
$
0.3

 
$
(25.5
)
 
$
0.8

 
$
1.2

 
November 30,
2013 
 
Unrealized
Gains (Losses)
on Plan Assets 
 
Realized
Gains (Losses)
on Plan Assets
 
Purchases,
Issuances, and
Settlements 
 
November 30,
2014 
 
(In millions)
Equity securities:
 
 
 
 
 
 
 
 
 
 Domestic equity securities
$
0.3

 
$
(0.3
)
 
$

 
$

 
$

Fixed income:
 
 
 
 
 
 
 
 
 
 Corporate debt securities
0.4

 
(0.1
)
 

 

 
0.3

Real estate investments
15.7

 
10.0

 

 
(0.4
)
 
25.3

Total
$
16.4

 
$
9.6

 
$

 
$
(0.4
)
 
$
25.6


60



e.  Benefit Payments
The following presents estimated future benefit payments:
 
 
Pension
Benefit
Payments
 
Medical and Life Insurance Benefits 
 
Year Ending November 30,
 
Gross Benefit Payments
 
Medicare D
Subsidy 
 
Net Benefit
Payments 
 
(In millions)
2016
$
123.6

 
$
6.3

 
$
0.3

 
$
6.0

2017
122.0

 
6.1

 
0.3

 
5.8

2018
119.9

 
5.8

 
0.3

 
5.5

2019
117.2

 
5.4

 
0.2

 
5.2

2020
114.5

 
5.1

 
0.2

 
4.9

Years 2021 - 2025
525.2

 
19.6

 
0.8

 
18.8

Note  9.
Commitments and Contingencies
a.  Lease Commitments and Income
The Company and its subsidiaries lease certain facilities, machinery and equipment, and office buildings under long-term, non-cancelable operating leases. The leases provide for renewal options ranging from one to fifteen years and require the Company to pay for utilities, insurance, taxes, and maintenance. Rent expense was $18.5 million in fiscal 2015, $23.7 million in fiscal 2014, and $20.1 million in fiscal 2013.
The Company also leases certain surplus facilities to third parties. The Company recorded lease income of $6.3 million in fiscal 2015, $6.2 million in fiscal 2014, and $5.7 million in fiscal 2013 related to these arrangements, which have been included in net sales.
The future minimum rental commitments under non-cancelable operating leases with initial or remaining terms of one year or more and lease revenue in effect as of November 30, 2015 were as follows:
 
Year Ending November 30,
Future Minimum
Rental Commitments 
 
Future Minimum
Rental Income 
 
(In millions)
2016
$
17.9

 
$
4.3

2017
15.5

 
4.1

2018
11.8

 
3.9

2019
10.6

 
2.2

2020
9.8

 

Thereafter
26.5

 

 
$
92.1

 
$
14.5

b.  Legal Matters
The Company and its subsidiaries are subject to legal proceedings, including litigation in U.S. federal and state courts, which arise out of, and are incidental to, the ordinary course of the Company’s on-going and historical businesses. The Company is also subject from time to time to governmental investigations by federal and state agencies. The Company cannot predict the outcome of such proceedings with any degree of certainty. Loss contingency provisions are recorded for probable losses at management’s best estimate of a loss, or when a best estimate cannot be made, a minimum loss contingency amount is recorded. These estimates are often initially developed substantially earlier than when the ultimate loss is known, and are refined each quarterly reporting period as additional information becomes available. For legal settlements where there is no stated amount for interest, the Company will estimate an interest factor and discount the liability accordingly.
Asbestos Litigation
The Company has been, and continues to be, named as a defendant in lawsuits alleging personal injury or death due to exposure to asbestos in building materials, products, or in manufacturing operations. The majority of cases are pending in Texas and Illinois. There were 83 asbestos cases pending as of November 30, 2015.

61



Given the lack of any significant consistency to claims (i.e., as to product, operational site, or other relevant assertions) filed against the Company, the Company is unable to make a reasonable estimate of the future costs of pending claims or unasserted claims. Accordingly, no estimate of future liability has been accrued.
In 2011, Aerojet Rocketdyne received a letter demand from AMEC, plc, (“AMEC”) the successor entity to the 1981 purchaser of the business assets of Barnard & Burk, Inc., a former Aerojet Rocketdyne subsidiary, for Aerojet Rocketdyne to assume the defense of sixteen asbestos cases, involving 271 plaintiffs, pending in Louisiana, and reimbursement of over $1.7 million in past legal fees and expenses. AMEC is asserting that Aerojet Rocketdyne retained those liabilities when it sold the Barnard & Burk assets and agreed to indemnify the purchaser therefor. Under the relevant purchase agreement, the purchaser assumed only certain, specified liabilities relating to the operation of Barnard & Burk before the sale, with Barnard & Burk retaining all unassumed pre-closing liabilities, and Aerojet Rocketdyne agreed to indemnify the purchaser against unassumed liabilities that are asserted against it. Based on the information provided, Aerojet Rocketdyne declined to accept the liability and requested additional information from AMEC pertaining to the basis of the demand. On April 3, 2013, AMEC filed a complaint for breach of contract against Aerojet Rocketdyne in Sacramento County Superior Court, AMEC Construction Management, Inc. v. Aerojet-General Corporation, Case No. 342013001424718. AMEC contends it has incurred approximately $3.0 million in past legal fees and expenses. Aerojet Rocketdyne filed its answer to the complaint denying AMEC’s allegations as well as a cross-complaint against AMEC for breach of its obligations under the purchase agreement in addition to other claims for relief. Discovery is ongoing. Aerojet Rocketdyne’s motion for summary judgment heard on August 20, 2015 was granted, but the court also granted AMEC leave to amend its complaint. AMEC filed its amended complaint and Aerojet Rocketdyne re-filed its motion for summary judgment which is scheduled for hearing on March 9, 2016. The trial date has been rescheduled to April 11, 2016. As of November 30, 2015, the Company has accrued $0.2 million related to this matter. None of the expenditures related to this matter are recoverable from the U.S. government.
Securities Class Action
On February 11, 2016, a complaint was filed in the United States District Court, Central District of California, by Juliann Travis, purporting to represent a class of purchasers of the Company’s securities during the period from October 15, 2013 through February 1, 2016, against the Company, Eileen Drake, Kathleen Redd and Scott Seymour, Juliann Travis, Individually and on Behalf of All Others Similarly Situated, v. Aerojet Rocketdyne Holdings, Inc., Eileen P. Drake, Kathleen E. Redd, and Scott J. Seymour, Case No. 2:16-cv-00961. The complaint arises out of the announcement of the Restatement by the Company on February 1, 2016. The complaint asserts that the Company's securities traded at artificially inflated prices as a result of such misstatements and alleges a violation of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder by all defendants, and a violation of Section 20(a) of the Exchange Act by the individual defendants, Drake, Redd and Seymour. The complaint seeks a determination that this matter is a proper class action and designating the plaintiff as the lead plaintiff and class representative, an award of compensatory damages in an amount to be determined at trial, an award of reasonable costs and expenses of trial, including counsel and expert fees, an award of rescission or a rescissory measure of damages and an award of such equitable/injunctive or other relief as deemed appropriate by the Court. The Company believes this action is without merit and intends to contest it vigorously.
Inflective, Inc. (“Inflective”) Litigation
On December 18, 2014, Inflective filed a complaint against Aerojet Rocketdyne and Kathleen E. Redd, individually, in the Superior Court of the State of California, Sacramento County, Inflective, Inc. v Aerojet Rocketdyne, Inc., Kathleen E. Redd, et al, Case No. 34-2014-00173068.  Inflective asserts in the complaint causes for breach of contract, breach of implied contract, false promise, inducing breach of contract, intentional interference with contractual relations, negligent interference with prospective economic relations, and intentional interference with prospective economic relations and is seeking damages in excess of $3.0 million, punitive damages, interest and attorney’s costs.  The complaint arises out of the Company’s implementation of ProjectOne, a company-wide enterprise resource planning (“ERP”) system, for which Inflective had been a consultant to the Company.  The Company believes the allegations are without merit and intends to contest this matter vigorously.  On February 6, 2015, Aerojet Rocketdyne and Ms. Redd filed a demurrer to the complaint seeking to have the complaint dismissed for failure to allege facts sufficient to support the causes of action therein.  On June 9, 2015, the Court sustained the demurrer in part and overruled the demurrer in part, with leave to amend.  On June 18, 2015, Inflective filed an amended complaint in which it reiterated all the causes of action dismissed by the Court.  On June 30, 2015, Aerojet Rocketdyne and Ms. Redd filed a demurrer and motion to strike seeking to have (a) all claims and references to a purported “finder’s fee” stricken from the case and (b) the causes of action against Ms. Redd for intentional and negligent interference with prospective business relations dismissed with prejudice.  On October 16, 2015, the Court sustained Aerojet Rocketdyne’s demurrer and motion to strike with respect to the “finder’s fee” claims, dismissing those claims with prejudice, but overruled Ms. Redd’s demurrer with respect to the causes of action asserted against her.  On October 26, 2015, Aerojet Rocketdyne and Ms. Redd answered the amended complaint and denied all material allegations therein.  At the same time, Aerojet Rocketdyne filed a Cross-Complaint against Plaintiff and its principal, Thomas Hensler, for breach of contract, intentional misrepresentation, negligent misrepresentation and negligence.  Inflective and Hensler have filed a demurrer to the intentional misrepresentation, negligent misrepresentation and negligence causes of action, leaving the breach of contract cause of action

62



unchallenged.  Hearing on Inflective and Hensler’s demurrer is set for February 18, 2016.  Aerojet Rocketdyne believes its causes of action have merit and will prevail on the demurrer.
Separately, Satish Rachaiah, a former consultant on ProjectOne (working for Inflective), attempted to intervene in the action and assert claims against Aerojet Rocketdyne arising out of Aerojet Rocketdyne’s alleged interference with his employment with Inflective.  Mr. Rachaiah sought to assert claims against Aerojet Rocketdyne for intentional interference with contractual relations, intentional and negligent interference with prospective economic advantage, inducing breach of contract, intentional and negligent misrepresentation, and declaratory relief.  Aerojet Rocketdyne opposed intervention, and the Court ultimately denied Mr. Rachaiah’s motion to intervene.  After the Court denied Rachaiah’s motion to intervene, on December 30, 2015, Rachaiah filed a separate lawsuit in the Superior Court of the State of California, Sacramento County, Satish Rachaiah v. Aerojet Rocketdyne, Inc., Case No. 34-2015-00188516.  Rachaiah asserts the same claims in his separate lawsuit as he attempted to when he tried to intervene.  The Company believes Rachaiah’s allegations are without merit, and the Company intends to contest the matter vigorously.
The Company has not recorded any liability for either of these matters as of November 30, 2015.
Orbital and ORB-3 Launch Failure
On September 21, 2015, Aerojet Rocketdyne entered into a Settlement and Mutual Release Agreement (the “Agreement”) with Orbital Sciences Corporation (“Orbital”) pursuant to which the parties mutually agreed to a termination for convenience of the contract relating to the provision by Aerojet Rocketdyne of 20 AJ-26 liquid propulsion rocket engines to Orbital for the Antares program (the “Contract”). The Agreement also settles all claims the parties may have had against one another arising out of the Contract and the launch failure that occurred on October 28, 2014 of an Antares launch vehicle carrying the Cygnus ORB-3 service and cargo module (“ORB-3”). The ORB-3 launch vehicle was powered by two AJ-26 engines supplied to Orbital by Aerojet Rocketdyne. Under the terms of the Agreement, Aerojet Rocketdyne made a one-time payment of $50.0 million to Orbital on September 30, 2015, and Orbital transferred to Aerojet Rocketdyne title to the 10 engines remaining to be delivered under the Contract. Aerojet Rocketdyne is seeking reimbursement from its insurers of a portion of the settlement costs.
Socorro
On May 12, 2015, a complaint for personal injuries, loss of consortium and punitive damages was filed by James Chavez, Andrew Baca, and their respective spouses, against Aerojet Rocketdyne and the Board of Regents of New Mexico Tech in the Seventh Judicial District, County of Socorro, New Mexico, James Chavez, et al., vs. Aerojet Rocketdyne, Inc., et al., Case No. D725CV201500047. Messrs. Chavez and Baca were employees of Aerotek, a contractor to Aerojet Rocketdyne, who were injured when excess energetic materials being managed by the Energetic Materials Research and Testing Center, a research division of New Mexico Tech, ignited in an unplanned manner. The complaint alleges causes of action based on negligence and negligence per se, strict liability, and willful, reckless and wanton conduct against Aerojet Rocketdyne, and seeks unspecified compensatory and punitive damages. The Company has filed its answer and discovery has commenced. The Company has alerted its insurance carriers of this action and on September 23, 2015, the Company tendered the defense of the case to Aerotek pursuant to Aerotek’s contract for services with Aerojet Rocketdyne. Aerotek has not yet provided its response. No liability for this matter has been recorded by the Company as of November 30, 2015.
Occupational Safety
On January 16, 2015, the Company received a notice that the State of California, Division of Occupational Safety & Health (“Cal\OSHA”), Bureau of Investigation (“BOI”) is conducting an investigation into an accident that occurred at the Rancho Cordova facility in November 2013.  The accident involved the deflagration of solid rocket propellant following a remote cutting operation and resulted in injuries to two employees, one of whom ultimately died from his injuries.  Cal\OSHA issued nine citations relating to the accident with penalties of approximately $0.1 million, all of which the Company has appealed. The BOI is the criminal investigatory arm of Cal\OSHA and is required by law to investigate any occupational fatality to determine if criminal charges will be recommended. The Company does not believe that circumstances in this matter warrant a criminal recommendation although there can be no assurance on how the BOI will conclude.  
c. Environmental Matters
The Company is involved in over forty environmental matters under the Comprehensive Environmental Response Compensation and Liability Act, the Resource Conservation Recovery Act, and other federal, state, local, and foreign laws relating to soil and groundwater contamination, hazardous waste management activities, and other environmental matters at some of its current and former facilities. The Company is also involved in a number of remedial activities at third party sites, not owned by the Company, where it is designated a potentially responsible party (“PRP”) by either the U.S. Environmental Protection Agency (“EPA”) and/or a state agency. In many of these matters, the Company is involved with other PRPs. In some instances, the Company’s liability and proportionate share of costs have not been determined largely due to uncertainties as to the nature and extent of site conditions and the Company’s involvement. While government agencies frequently claim PRPs are jointly and severally liable at such sites, in the Company’s experience, interim and final allocations of liability and costs are

63



generally made based on relative contributions of waste or contamination. Anticipated costs associated with environmental remediation that are probable and estimable are accrued. In cases where a date to complete remedial activities at a particular site cannot be determined by reference to agreements or otherwise, the Company projects costs over an appropriate time period not exceeding fifteen years; in such cases, generally the Company does not have the ability to reasonably estimate environmental remediation costs that are beyond this period. Factors that could result in changes to the Company’s estimates include completion of current and future soil and groundwater investigations, new claims, future agency demands, discovery of more or less contamination than expected, discovery of new contaminants, modification of planned remedial actions, changes in estimated time required to remediate, new technologies, and changes in laws and regulations.
As of November 30, 2015, the aggregate range of these anticipated environmental costs was $306.1 million to $457.4 million and the accrued amount was $306.1 million. See Note 9(d) for a summary of the environmental reserve activity. Of these accrued liabilities, approximately 98% relates to the Company’s U.S. government contracting business and a portion of this liability is recoverable. The significant environmental sites are discussed below. The balance of the accrued liabilities relates to other sites for which the Company’s obligations are probable and estimable.
Sacramento, California Site
In 1989, a federal district court in California approved a Partial Consent Decree (“PCD”) requiring Aerojet Rocketdyne, among other things, to conduct a Remedial Investigation and Feasibility Study to determine the nature and extent of impacts due to the release of chemicals from the Sacramento, California site, monitor the American River and offsite public water supply wells, operate Groundwater Extraction and Treatment facilities that collect groundwater at the site perimeter, and pay certain government oversight costs. The primary chemicals of concern for both on-site and off-site groundwater are trichloroethylene, perchlorate, and n-nitrosodimethylamine. The PCD has been revised several times, most recently in 2002. The 2002 PCD revision (a) separated the Sacramento site into multiple operable units to allow quicker implementation of remedy for critical areas; (b) required the Company to guarantee up to $75 million (in addition to a prior $20 million guarantee) to assure that Aerojet Rocketdyne’s Sacramento remediation activities are fully funded; and (c) removed approximately 2,600 acres of non-contaminated land from the EPA superfund designation.
Aerojet Rocketdyne is involved in various stages of soil and groundwater investigation, remedy selection, design, and remedy construction associated with the operable units. In 2002, the EPA issued a Unilateral Administrative Order (“UAO”) requiring Aerojet Rocketdyne to implement the EPA-approved remedial action in the Western Groundwater Operable Unit. An identical order was issued by the California Regional Water Quality Control Board, Central Valley (“Central Valley RWQCB”). On July 7, 2011, the EPA issued Aerojet Rocketdyne its Approval of Remedial Action Construction Completion Report for Western Groundwater Operable Unit and its Determination of Remedy as Operational and Functional. On September 20, 2011, the EPA issued two UAOs to Aerojet Rocketdyne to complete a remedial design and implement remedial action for the Perimeter Groundwater Operable Unit. One UAO addresses groundwater and the other addresses soils within the Perimeter Groundwater Operable Unit. Issuance of the UAOs is the next step in the superfund process for the Perimeter Groundwater Operable Unit. Aerojet Rocketdyne submitted a final Remedial Investigation Report for the Boundary Operable Unit in 2010 and a revised Feasibility Study for the Boundary Operable Unit in 2012. A Record of Decision was issued by the EPA on August 4, 2015. A draft Remedial Investigation Report for the Island Operable Unit was submitted in January 2013 and the Final Remedial Investigation Report was issued on September 3, 2015. A portion of the Island Operable Unit, Area 40, a portion of which is related to the Hillsborough sale, is being handled separately and Aerojet Rocketdyne anticipates submitting a draft Feasibility Study to the agencies in the first quarter of fiscal 2016. The remaining operable units are under various stages of investigation.
The entire southern portion of the site known as Rio Del Oro was under state orders issued in the 1990s from the Department of Toxic Substances Control (“DTSC”) to investigate and remediate environmental contamination in the soils and the Central Valley RWQCB to investigate and remediate groundwater environmental contamination. On March 14, 2008, the DTSC released all but approximately 400 acres of the Rio Del Oro property from DTSC’s environmental orders regarding soil contamination. Aerojet Rocketdyne expects the approximately 400 acres of Rio Del Oro property that remain subject to the DTSC orders to be released once the soil remediation has been completed. The Rio Del Oro property remains subject to the Central Valley RWQCB’s orders to investigate and remediate groundwater environmental contamination emanating offsite from such property. Pursuant to a settlement agreement entered into in 2009, Aerojet Rocketdyne and Boeing have defined responsibilities with respect to future costs and environmental projects relating to this property.
As of November 30, 2015, the estimated range of anticipated costs discussed above for the Sacramento, California site was $153.0 million to $253.0 million and the accrued amount was $153.0 million included as a component of the Company’s environmental reserves. Expenditures associated with this matter are partially recoverable. See Note 9(d) below for further discussion on recoverability.
Baldwin Park Operable Unit (“BPOU”)
As a result of its former Azusa, California operations, in 1994 Aerojet Rocketdyne was named a PRP by the EPA in the area of the San Gabriel Valley Basin superfund site known as the BPOU. Between 1995 and 1997, the EPA issued Special

64



Notice Letters to Aerojet Rocketdyne and eighteen other companies requesting that they implement a groundwater remedy. On June 30, 2000, the EPA issued a UAO ordering the PRPs to implement a remedy consistent with the 1994 record of decision. Aerojet Rocketdyne, along with seven other PRPs (the "Cooperating Respondents”) signed a Project Agreement in late March 2002 with the San Gabriel Basin Water Quality Authority, the Main San Gabriel Basin Watermaster, and five water companies (the “Water Entities”). The Project Agreement, which has a term of fifteen years, became effective May 9, 2002 and will terminate in May 2017. In November 2014, the EPA met with representatives from the Cooperating Respondents regarding the end of the Project Agreement and plans for discussions with the Water Entities. The EPA, the Water Entities and Aerojet Rocketdyne and the other Cooperating Respondents have begun settlement discussions regarding the expiration of the Project Agreement in 2017 and the path forward. Discussions have occurred over the summer of 2015 and on September 10, 2015, the parties, including the EPA, met to discuss progress including a new Project Agreement to commence in 2017. At this meeting, Aerojet Rocketdyne and the other Cooperating Respondents proposed a new Project Agreement term limit. That proposal was rejected by the EPA and the Water Entities which want a longer term. Negotiations are ongoing. Pursuant to the Project Agreement, the Cooperating Respondents fund through an escrow account the capital, operational, maintenance, and administrative costs of certain treatment and water distribution facilities to be owned and operated by the water companies. There are also provisions in the Project Agreement for maintaining financial assurance.
Aerojet Rocketdyne and the other Cooperating Respondents entered into an interim allocation agreement, which was renewed effective March 28, 2014, that establishes the interim payment obligations, subject to final reallocation, of the Cooperating Respondents for the costs incurred pursuant to the Project Agreement. Under the interim allocation, Aerojet Rocketdyne is responsible for approximately 70% (increased from approximately 68%) of all project costs. Since entering into the Project Agreement, two of the Cooperating Respondents, Huffy Corporation, and Fairchild Corporation (“Fairchild”), have filed for bankruptcy and are no longer participating in the Project Agreement. The interim allocation accounted for their shares. On September 30, 2014, another of the Cooperating Respondents, Reichhold, Inc. ("Reichhold"), filed for bankruptcy under Chapter 11. Reichhold has stopped paying and Aerojet Rocketdyne increased its contribution for its portion of Reichhold’s share of the financial assurance. Aerojet Rocketdyne and the remaining Cooperating Respondents are completing a final allocation agreement under which Aerojet Rocketdyne’s share of the costs will be 74% provided that Aerojet Rocketdyne assumes the Reichhold share and all currently funding parties participate in the allocation beyond the expiration of the current agreement.
As part of Aerojet Rocketdyne’s sale of its Electronics and Information Systems (“EIS”) business to Northrop in October 2001, the EPA approved a Prospective Purchaser Agreement with Northrop to absolve it of pre-closing liability for contamination caused by the Azusa, California operations, which liability remains with Aerojet Rocketdyne. As part of that agreement, the Company agreed to provide a $25 million guarantee of Aerojet Rocketdyne’s obligations under the Project Agreement.
As of November 30, 2015, the estimated range of anticipated costs was $140.1 million to $183.9 million and the accrued amount was $140.1 million included as a component of the Company’s environmental reserves. The primary reason for the increase in the reserve related to BPOU is to reflect the anticipated costs through the term of a new Project Agreement, and the amount accrued is based on the proposal by Aerojet Rocketdyne. There can be no assurance that the term of the new Project Agreement will not be longer than proposed by the Company and, if so, the Company may be required to make an additional accrual to reflect the longer time period. Expenditures associated with this matter are partially recoverable. See Note 9(d) below for further discussion on recoverability.
Wabash, Indiana Site
The Company owned and operated a former rubber processing plant in Wabash, Indiana from 1937 to 2004. Pursuant to a request from the Indiana Department of Environmental Management (“IDEM”), the Company conducted an initial site investigation of the soil and groundwater at the site and a report was submitted to IDEM. By letter of June 11, 2014, IDEM directed the Company to conduct additional investigation of the site, including a vapor intrusion investigation in areas in and around the site where trichloroethene levels in groundwater were found to exceed screening levels for vapor intrusion. Vapor mitigation systems were installed in one residence and one business where indoor air screening levels were exceeded and efforts are ongoing to install mitigation systems at a third location.  The Company is conducting further investigations of the site in accordance with the IDEM request and approved work plan. The Company sent demands to other former owners/operators of the site to participate in the site work, but no party has agreed to participate as of yet. As of November 30, 2015, the estimated range of the Company's share of anticipated costs for the Wabash, Indiana site was $0.3 million to $0.8 million and the accrued amount was $0.3 million. None of the expenditures related to this matter are recoverable from the U.S. government.
d. Environmental Reserves and Estimated Recoveries
Environmental Reserves
The Company reviews on a quarterly basis estimated future remediation costs and has an established practice of estimating environmental remediation costs over a fifteen year period, except for those environmental remediation costs with a

65



specific contractual term. Environmental liabilities at the BPOU site are currently estimated through the term of a new Project Agreement as proposed by Aerojet Rocketdyne and the other Cooperating Respondents, which the Water Entities and the EPA have rejected. There can be no assurance that the term of the new Project Agreement will not be longer than the term the Company estimated and, if so, the Company may be required to make an additional accrual to reflect the longer term. As the period for which estimated environmental remediation costs lengthens, the reliability of such estimates decreases. These estimates consider the investigative work and analysis of engineers, outside environmental consultants, and the advice of legal staff regarding the status and anticipated results of various administrative and legal proceedings. In most cases, only a range of reasonably possible costs can be estimated. In establishing the Company’s reserves, the most probable estimate is used when determinable; otherwise, the minimum amount is used when no single amount in the range is more probable. Accordingly, such estimates can change as the Company periodically evaluates and revises these estimates as new information becomes available. The Company cannot predict whether new information gained as projects progress will affect the estimated liability accrued. The timing of payment for estimated future environmental costs is influenced by a number of factors such as the regulatory approval process, and the time required to design, construct, and implement the remedy.
A summary of the Company’s environmental reserve activity is shown below:

Aerojet
Rocketdyne-
Sacramento

Aerojet
Rocketdyne-
BPOU

Other
Aerojet
Rocketdyne
Sites

Total
Aerojet
Rocketdyne

Other

Total
Environmental
Reserve
 
(In millions)
November 30, 2012
$
140.5

 
$
31.2

 
$
10.8

 
$
182.5

 
$
7.0

 
$
189.5

Additions
9.8

 
5.1

 
0.1

 
15.0

 
3.8

 
18.8

Expenditures
(22.3
)
 
(9.4
)
 
(2.7
)
 
(34.4
)
 
(2.6
)
 
(37.0
)
November 30, 2013
128.0

 
26.9

 
8.2

 
163.1

 
8.2

 
171.3

Additions
24.0

 
4.5

 
3.3

 
31.8

 
1.9

 
33.7

Expenditures
(21.6
)
 
(9.7
)
 
(3.4
)
 
(34.7
)
 
(4.3
)
 
(39.0
)
November 30, 2014
130.4


21.7

 
8.1

 
160.2

 
5.8

 
166.0

Additions
44.3


129.7

 
2.0

 
176.0

 
0.6

 
176.6

Expenditures
(21.7
)

(11.3
)
 
(2.3
)
 
(35.3
)
 
(1.2
)
 
(36.5
)
November 30, 2015
$
153.0


$
140.1

 
$
7.8


$
300.9


$
5.2


$
306.1

The effect of the final resolution of environmental matters and the Company’s obligations for environmental remediation and compliance cannot be accurately predicted due to the uncertainty concerning both the amount and timing of future expenditures and due to regulatory or technological changes. The Company continues its efforts to mitigate past and future costs through pursuit of claims for recoveries from insurance coverage and other PRPs and continued investigation of new and more cost effective remediation alternatives and associated technologies.
As part of the acquisition of the Atlantic Research Corporation (“ARC”) propulsion business in 2003, Aerojet Rocketdyne entered into an agreement with ARC pursuant to which Aerojet Rocketdyne is responsible for up to $20.0 million of costs (“Pre-Close Environmental Costs”) associated with environmental issues that arose prior to Aerojet Rocketdyne’s acquisition of the ARC propulsion business. ARC is responsible for any cleanup costs relating to the ARC acquired businesses in excess of $20.0 million. Pursuant to a separate agreement with the U.S. government which was entered into prior to the completion of the ARC acquisition, these costs are recovered through the establishment of prices for Aerojet Rocketdyne’s products and services sold to the U.S. government. A summary of the Pre-Close Environmental Costs is shown below (in millions):
Pre-Close Environmental Costs
$
20.0

Amount spent through November 30, 2015
(18.5
)
Amount included as a component of reserves for environmental remediation costs in the consolidated balance sheet as of November 30, 2015
(1.5
)
Remaining Pre-Close Environmental Costs
$

The Company expects that the cumulative clean-up costs will exceed $20 million in fiscal 2017 after which ARC will be responsible for such costs due to contamination existing at the time of the acquisition and still requiring remediation and monitoring.

66



Estimated Recoveries
On January 12, 1999, Aerojet Rocketdyne and the U.S. government implemented the October 1997 Agreement in Principle (“Global Settlement”) resolving certain prior environmental and facility disagreements, with retroactive effect to December 1, 1998. Under the Global Settlement, Aerojet Rocketdyne and the U.S. government resolved disagreements about an appropriate cost-sharing ratio with respect to the clean-up costs of the environmental contamination at the Sacramento and the former Azusa sites. The Global Settlement cost-sharing ratio does not have a defined term over which costs will be recovered. Additionally, in conjunction with the sale of the EIS business in 2001, Aerojet Rocketdyne entered into an agreement with Northrop (the “Northrop Agreement”) whereby Aerojet Rocketdyne is reimbursed by Northrop for a portion of environmental expenditures eligible for recovery under the Global Settlement, subject to an annual and a cumulative limitation. The current annual billing limitation to Northrop is $6.0 million.
Most of the environmental costs are incurred by the Company's Aerospace and Defense segment, and certain of these future costs are allowable to be included in the Company’s contracts with the U.S. government and allocable to Northrop until the cumulative expenditure limitation is reached. The Company currently estimates approximately 24% of its Aerospace and Defense segment environmental costs will not likely be reimbursable and are expensed to the consolidated statements of operations.
Allowable environmental costs are charged to the Company’s contracts as the costs are incurred. Because these costs are recovered through forward-pricing arrangements, the ability of Aerojet Rocketdyne to continue recovering these costs from the U.S. government depends on Aerojet Rocketdyne’s sustained business volume under U.S. government contracts and programs.
Pursuant to the Northrop Agreement, environmental expenditures to be reimbursed are subject to annual limitations and the total reimbursements are limited to a ceiling of $189.7 million. A summary of the Northrop Agreement activity is shown below (in millions):
Total reimbursable costs under the Northrop Agreement
$
189.7

Amount reimbursed to the Company through November 30, 2015
(113.2
)
Potential future cost reimbursements available
76.5

Receivable from Northrop in excess of the annual limitation included in the consolidated balance sheet as of November 30, 2015
(68.7
)
Potential future recoverable amounts available under the Northrop Agreement
$
7.8

Environmental reserves and estimated recoveries impact to the consolidated statements of operations
The expenses associated with adjustments to the environmental reserves are recorded as a component of other expense, net in the consolidated statements of operations. Summarized financial information for the impact of environmental reserves and recoveries to the consolidated statements of operations is set forth below:
 
Year Ended
 
2015
 
2014
 
2013
 
(In millions)
Estimated recoverable amounts under U.S. government contracts and Northrop
$
159.3

 
$
22.9

 
$
10.4

Charge to consolidated statement of operations
17.3

 
10.8

 
8.4

Total environmental reserve additions
$
176.6

 
$
33.7

 
$
18.8

e.  Arrangements with Off-Balance Sheet Risk
As of November 30, 2015, arrangements with off-balance sheet risk consisted of:
 
$44.1 million in outstanding commercial letters of credit expiring through April 2016, the majority of which may be renewed, primarily to collateralize obligations for environmental remediation and insurance coverage.
$45.5 million in outstanding surety bonds to primarily satisfy indemnification obligations for environmental remediation coverage.
Up to $120.0 million aggregate in guarantees by the Company of Aerojet Rocketdyne’s obligations to U.S. government agencies for environmental remediation activities.
Guarantees, jointly and severally, by the Company’s material domestic subsidiaries of their obligations under the Senior Credit Facility and 7 1/8% Notes.
In addition to the items discussed above, the Company has and will from time to time enter into certain types of contracts that require the Company to indemnify parties against potential third-party and other claims. These contracts primarily relate to:

67



(i) divestiture agreements, under which the Company may provide customary indemnification to purchasers of its businesses or assets including, for example, claims arising from the operation of the businesses prior to disposition, and liability to investigate and remediate environmental contamination existing prior to disposition; (ii) certain real estate leases, under which the Company may be required to indemnify property owners for claims arising from the use of the applicable premises; and (iii) certain agreements with officers and directors, under which the Company may be required to indemnify such persons for liabilities arising out of their relationship with the Company. The terms of such obligations vary. Generally, a maximum obligation is not explicitly stated.
Additionally, the Company issues purchase orders to suppliers for equipment, materials, and supplies in the normal course of business. These purchase commitments are generally for volumes consistent with anticipated requirements to fulfill purchase orders or contracts for product deliveries received, or expected to be received, from customers and would be subject to reimbursement if a cost-plus contract is terminated.
The Company provides product warranties in conjunction with certain product sales. The majority of the Company’s warranties are a one-year standard warranty for parts, workmanship, and compliance with specifications. On occasion, the Company has made commitments beyond the standard warranty obligation. While the Company has contracts with warranty provisions, there is not a history of any significant warranty claims experience. A reserve for warranty exposure is made on a product by product basis when it is both estimable and probable. These costs are included in the program’s estimate at completion and are expensed in accordance with the Company’s revenue recognition methodology as allowed under GAAP for that particular contract.
Note  10.
Stockholders’ (Deficit) Equity
a.  Preference Stock
As of November 30, 2015 and 2014, 15.0 million shares of preferred stock were authorized and none were issued or outstanding.
b.  Common Stock
As of November 30, 2015, the Company had 150.0 million authorized shares of common stock, par value $0.10 per share, of which 62.9 million shares were issued and outstanding, and 22.9 million shares were reserved for future issuance for the exercise of stock options (seven and ten year contractual life) and restricted stock (no maximum contractual life), payment of awards under stock-based compensation plans, and conversion of the Company’s Notes. See Note 4(l) for information about the Company’s redeemable common stock.
c.  Treasury Stock
During fiscal 2014, the Company repurchased 3.5 million of its common shares at a cost of $64.5 million. The Company reflects stock repurchases in its financial statements on a “settlement” basis.
d.  Stock-based Compensation
Total stock-based compensation expense by type of award was as follows:
 
 
Year Ended
 
 
2015
 
2014
 
2013
 
(In millions)
SARS
 
$
1.8

 
$
(3.2
)
 
$
9.4

Restricted stock, service based
 
5.6

 
4.3

 
2.3

Restricted stock, performance based
 
0.1

 
4.3

 
2.1

Employee stock purchase plan ("ESPP")
 
0.3

 

 

Stock options
 
0.8

 
0.3

 
0.3

Total stock-based compensation expense
 
$
8.6

 
$
5.7

 
$
14.1

Stock Appreciation Rights: As of November 30, 2015, a total of 0.8 million SARS were outstanding under the 1999 Equity and Performance Incentive Plan (“1999 Plan”) and 2009 Equity and Performance Incentive Plan (“2009 Plan”). SARS granted to employees generally vest in one-third increments at one year, two years, and three years from the date of grant and have a ten year contractual life under the 1999 Plan and a seven year contractual life under the 2009 Plan. SARS granted to directors of the Company typically vest over a one year service period (half after six months and half after one year) and have a ten year contractual life under the 1999 Plan and a seven year contractual life under the 2009 Plan. These awards are similar to the Company’s employee stock options, but are settled in cash rather than in shares of common stock, and are classified as liability awards. Compensation cost for these awards is determined using a fair-value method and remeasured at each reporting date until the date of settlement. Stock-based compensation expense recognized is based on SARS ultimately expected to vest, and therefore it has been reduced for estimated forfeitures.

68



A summary of the status of the Company’s SARS as of November 30, 2015 and changes during fiscal 2015 is presented below:
 
SARS
(In millions) 
 
Weighted
Average
Exercise Price
 
Weighted
Average
Remaining
Contractual
Life (years)
 
Aggregate
Intrinsic
Value
(In millions) 
Outstanding at November 30, 2014
1.3

 
$
10.84

 
 
 
 
Exercised
(0.4
)
 
13.24

 
 
 
 
Canceled
(0.1
)
 
18.64

 
 
 
 
Outstanding at November 30, 2015
0.8

 
$
8.70

 
2.1
 
$
7.4

Exercisable at November 30, 2015
0.8

 
$
8.67

 
2.1
 
$
7.3

The weighted average grant date fair value for SARS granted in fiscal 2013 was $12.08. No SARS were granted in fiscal 2015 and 2014. The total intrinsic value for SARS liabilities paid in fiscal 2015 and 2014 was $3.3 million and $1.0 million, respectively. As of November 30, 2015, there was less than $0.1 million of total stock-based compensation related to nonvested SARS. That cost is expected to be recognized over an estimated weighted-average amortization period of 4 months.
Restricted Stock, service-based: As of November 30, 2015, a total of 0.5 million shares of service-based restricted stock were outstanding which vest based on years of service under the 2009 Plan. Restricted shares are granted to key employees and directors of the Company. The fair value of the restricted stock awards was based on the closing market price of the Company’s common stock on the date of award and is being amortized on a straight line basis over the service period. Stock-based compensation expense recognized is based on service-based restricted stock ultimately expected to vest, and therefore it has been reduced for estimated forfeitures.
The following is summary of the status of the Company’s service-based restricted stock as of November 30, 2015 and changes during fiscal 2015:
 
Service
Based
Restricted
Stock
(In millions)  
 
Weighted
Average
Grant Date
Fair Value 
Outstanding at November 30, 2014
0.7

 
$
13.80

Granted
0.2

 
20.70

Vested
(0.3
)
 
20.90

Canceled
(0.1
)
 
16.94

Outstanding at November 30, 2015
0.5

 
$
18.22

Expected to vest at November 30, 2015
0.4

 
$
18.23

As of November 30, 2015, there was $4.3 million of total stock-based compensation related to nonvested service-based restricted stock. That cost is expected to be recognized over an estimated weighted-average amortization period of 16 months. The intrinsic value of the service-based restricted stock outstanding and expected to vest at November 30, 2015 was $8.3 million and $8.0 million, respectively. The weighted average grant date fair values for service-based restricted stock granted in fiscal 2014 and 2013 was $17.22 and $15.47, respectively.
Restricted Stock, performance-based: As of November 30, 2015, a total of 1.0 million shares of performance-based restricted shares were outstanding under the 2009 Plan. The performance-based restricted stock vests if the Company meets various operations and earnings targets set by the Organization & Compensation Committee of the Board. The fair value of the performance-based restricted stock awards was based on the closing market price of the Company’s common stock on the date of award and is being amortized over the estimated service period to achieve the operations and earnings targets. Stock-based compensation expense recognized for all years presented is based on performance-based restricted stock ultimately expected to vest, and therefore it has been reduced for estimated forfeitures.

69



The following is a summary of the status of the Company’s performance-based restricted stock as of November 30, 2015 and changes during fiscal 2015:
 
Performance
Based
Restricted
Stock
(In millions)
 
Weighted
Average
Grant Date
Fair Value
Outstanding at November 30, 2014
1.2

 
$
14.67

Granted
0.6

 
21.33

Vested
(0.4
)
 
17.69

Canceled
(0.4
)
 
18.63

Outstanding at November 30, 2015
1.0

 
$
18.89

Expected to vest at November 30, 2015
0.4

 
$
19.09

As of November 30, 2015, there was $4.7 million of total stock-based compensation related to nonvested performance-based restricted stock. That cost is expected to be recognized over an estimated weighted-average amortization period of 15 months. The intrinsic value of the performance-based restricted stock outstanding and expected to vest at November 30, 2015 was $17.6 million and $7.1 million, respectively. The weighted average grant date fair values for performance-based restricted stock granted in fiscal 2014 and 2013 was $17.25 and $17.44, respectively.
Employee Stock Purchase Plan: The ESPP initially offered in fiscal 2015 enables eligible employees the opportunity to purchase the Company’s common stock at a price not less than 85% of the fair market value of the common stock on the last day of the respective offering period. A maximum of 1.5 million shares are authorized for issuance under the ESPP under the 2009 Plan. During fiscal 2015, 0.1 million shares were issued under the ESPP at an average price of $20.61 per share.
Stock Options: As of November 30, 2015, a total of 0.6 million stock options were outstanding under the 1999 Plan and 2009 Plan. The 2009 stock option grants are primarily performance-based and vest if the Company meets various operations and earnings targets set by the Organization & Compensation Committee of the Board of Directors. The fair value is being amortized over the estimated service period to achieve the operations and earnings targets.
A summary of the status of the Company’s stock options as of November 30, 2015 and changes during fiscal 2015 is presented below:
 
Stock
Options
(In millions) 
 
Weighted
Average
Exercise
Price 
 
Weighted
Average
Remaining
Contractual
Life (years) 
 
Intrinsic
Value
(In millions) 
Outstanding at November 30, 2014
0.7

 
$
6.64

 
 
 
 
Granted
0.2

 
23.04

 
 
 
 
Exercised
(0.2
)
 
4.88

 
 
 
 
Canceled
(0.1
)
 
22.38

 
 
 
 
Outstanding at November 30, 2015
0.6

 
$
12.29

 
3.8
 
$
4.4

Exercisable at November 30, 2015
0.4

 
$
7.50

 
2.7
 
$
4.4

Expected to vest at November 30, 2015
0.2

 
$
23.02

 
6.3
 
$


70



The total intrinsic value for options exercised in fiscal 2015, 2014, 2013 was $3.9 million, $0.5 million, $0.6 million, respectively. The weighted average grant date fair value for stock options granted in fiscal 2014 was $10.33. No stock options were granted during fiscal 2013.
The following table summarizes the range of exercise prices and weighted-average exercise prices for options outstanding as of November 30, 2015 under the Company’s stock option plans:
 
 
 
 
Outstanding
Year
Granted
 
Range of Exercise Prices
 
Stock
Options
Outstanding
(In millions) 
 
Weighted
Average
Exercise
Price 
 
Weighted
Average
Remaining
Contractual
Life (years) 
2009
 
$4.54
 
0.1

 
$
4.54

 
3.6
2010
 
$4.91 - $7.14
 
0.1

 
$
6.13

 
1.5
2011
 
$6.01
 
0.1

 
$
6.01

 
2.3
2014
 
$16.59 - $17.27
 
0.1

 
$
17.03

 
5.3
2015
 
$20.48 - $23.06
 
0.2

 
$
23.02

 
6.3
 
 
 
 
0.6

 
 
 
 

Valuation Assumptions
The fair value of stock options was estimated using a Black-Scholes Model with the following weighted average assumptions:
 
Year Ended
 
2015
 
2014
Expected life (in years)
7.0

 
7.0

Volatility
58.06
%
 
58.92
%
Risk-free interest rate
1.94
%
 
2.27
%
The fair value of SARS was estimated using a Black-Scholes Model with the following weighted average assumptions:
 
Year Ended
 
2015
 
2014
 
2013
Expected life (in years)
2.1

 
2.6

 
3.6

Volatility
34.00
%
 
28.00
%
 
44.3
%
Risk-free interest rate
0.94
%
 
0.75
%
 
0.84
%
Expected Term: The Company’s expected term represents the period that the Company’s stock-based awards are expected to be outstanding and was determined based on historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards and vesting schedules.
Expected Volatility: The fair value of stock-based payments was determined using the Black-Scholes Model with a volatility factor based on the Company’s historical stock prices. The range of expected volatility used in the Black-Scholes Model was 30% to 50% as of November 30, 2015.
Expected Dividend: The Black-Scholes Model requires a single expected dividend yield as an input. The Senior Credit Facility restricts the payment of dividends and the Company does not anticipate paying cash dividends in the foreseeable future. Accordingly, the Company did not apply an expected dividend yield to the Black-Scholes Model for all periods presented.
Risk-Free Interest Rate: The Company bases the risk-free interest rate used in the Black-Scholes Model on the implied yield currently available on U.S. Treasury zero-coupon issues with an equivalent remaining term. The range of risk-free interest rates used in the Black-Scholes Model was 0.21% to 1.55% as of November 30, 2015.
Estimated Pre-vesting Forfeitures: When estimating forfeitures, the Company considers historical terminations as well as anticipated retirements.

71



Note 11.     Operating Segments and Related Disclosures, (As Restated for fiscal 2014 and 2013)
The Company’s operations are organized into two operating segments based on different products and customer bases: Aerospace and Defense, and Real Estate. The accounting policies of the operating segments are the same as those described in the summary of significant accounting policies (see Note 1).
The Company evaluates its operating segments based on several factors, of which the primary financial measure is segment performance. Segment performance represents net sales from continuing operations less applicable costs, expenses and unusual items relating to the segment operations. Segment performance excludes corporate income and expenses, legacy income or expenses, unusual items not related to the segment operations, interest expense, interest income, and income taxes.
Customers that represented more than 10% of net sales for the periods presented are as follows:
 
Year Ended
 
2015
 
2014
 
2013
Lockheed Martin
29
%
 
28
%
 
23
%
Raytheon
20

 
17

 
33

ULA
19

 
25

 
18

NASA
11

 
11

 
*

________
 * Less than 10%
Selected financial information for each reportable segment is as follows:


72



 
Year Ended
 
2015
 
2014
 
2013
 
(In millions)
Net Sales:
 
 
 
 
 
Aerospace and Defense
$
1,660.0

 
$
1,596.0

 
$
1,372.4

Real Estate
48.3

 
6.2

 
5.7

Total Net Sales
$
1,708.3

 
$
1,602.2

 
$
1,378.1

Segment Performance:
 
 
 
 
 
Aerospace and Defense
$
165.7

 
$
148.6

 
$
138.1

Environmental remediation provision adjustments
(16.6
)
 
(8.8
)
 
(4.6
)
Retirement benefit expense
(50.2
)
 
(25.2
)
 
(44.2
)
Unusual items
(50.0
)
 
(0.9
)
 
(1.6
)
Aerospace and Defense Total
48.9

 
113.7

 
87.7

Real Estate
34.4

 
4.2

 
3.8

Total Segment Performance
$
83.3

 
$
117.9

 
$
91.5

Reconciliation of segment performance to loss from continuing operations before income taxes:
 
 
 
 
 
Segment performance
$
83.3

 
$
117.9

 
$
91.5

Interest expense
(50.4
)
 
(52.7
)
 
(48.7
)
Interest income
0.3

 
0.1

 
0.2

Stock-based compensation expense
(8.6
)
 
(5.7
)
 
(14.1
)
Corporate retirement benefit expense
(17.4
)
 
(11.3
)
 
(20.8
)
Corporate and other
(22.1
)
 
(20.5
)
 
(20.9
)
Unusual items
(1.9
)
 
(60.8
)
 
(22.9
)
Loss from continuing operations before income taxes
$
(16.8
)
 
$
(33.0
)
 
$
(35.7
)
Aerospace and Defense
$
36.8

 
$
43.1

 
$
63.2

Real Estate

 

 

Corporate

 
0.3

 

Capital Expenditures
$
36.8

 
$
43.4

 
$
63.2

Aerospace and Defense
$
64.4

 
$
63.0

 
$
42.8

Real Estate
0.7

 
0.7

 
0.7

Corporate

 

 

Depreciation and Amortization
$
65.1

 
$
63.7

 
$
43.5

 
As of November 30,
 
2015
 
2014
 
(In millions)
Assets:
 
 
 
Aerospace and Defense (1)
$
1,580.2

 
$
1,432.1

Real Estate
124.4

 
120.5

Identifiable assets
1,704.6

 
1,552.6

Corporate
330.3

 
366.0

Total Assets
$
2,034.9

 
$
1,918.6

 _________
(1)
The Aerospace and Defense operating segment had $158.1 million of goodwill as of November 30, 2015 and 2014. In addition, as of November 30, 2015 and 2014 intangible assets balances (other than goodwill) were $108.8 million and $122.2 million, respectively, in the Aerospace and Defense operating segment.


73



Note 12.     Cost Reduction Plan
On January 30, 2014, the Company announced a cost reduction plan (the “Restructuring Plan - Phase I”) which resulted in the reduction of the Company’s overall headcount by approximately 260 employees. In connection with the Restructuring Plan - Phase I, the Company recorded a liability of $10.0 million in the first quarter of fiscal 2014, consisting of costs for severance, employee-related benefits and other associated expenses.
The costs of the Restructuring Plan - Phase I of $6.3 million related to ongoing business volume were recovered as a component of overhead in fiscal 2014. These restructuring costs were a component of the Company’s fiscal 2014 U.S. government forward pricing rates, and therefore, were recovered through the pricing of the Company’s products and services to the U.S. government.
The costs of the Restructuring Plan - Phase I of $3.0 million related to the acquisition of the Rocketdyne Business, as of November 30, 2014, have been capitalized and recorded in other noncurrent assets in the consolidated balance sheet. See Note 4(g) for a discussion of the capitalization of such costs.
As part of the Company's ongoing efforts to optimize business resources, during the fourth quarter of fiscal 2014, the Company determined a cost reduction plan (the “Restructuring Plan - Phase II”) was necessary which resulted in the reduction of the Company's overall headcount by approximately 90 employees and the closing of a facility. In connection with the Restructuring Plan - Phase II, the Company recorded a liability of $4.3 million in the fourth quarter of fiscal 2014, consisting of costs for severance, employee-related benefits and other associated expenses. In the second and third quarters of fiscal 2015, the Company recorded reductions to the liability of $5.1 million and $1.5 million, respectively, primarily for payments made under the cost reduction plan and changes to the expected headcount reduction. These costs are primarily a component of the Company’s fiscal 2015 U.S. government forward pricing rates, and therefore, will be recovered through the pricing of the Company’s products and services to the U.S. government.
During the second quarter of fiscal 2015, the Company initiated a competitive improvement program (the “CIP”) comprised of activities and initiatives aimed at reducing costs in order for the Company to continue to compete successfully. The CIP is composed of three major components: (i) facilities optimization and footprint reduction; (ii) product affordability; and (iii) reduced administrative and overhead costs. Under the CIP, the Company expects an estimated 500 headcount reduction in its total employee population. The Company currently estimates that it will incur restructuring and related costs over the next four years totaling approximately $110 million. A summary of the Company's CIP reserve activity in fiscal 2015 is shown below:
 
Severance
 
Retention
 
Total
 
(In millions)
February 28, 2015
$

 
$

 
$

      Accrual established
12.9

 
2.7

 
15.6

      Payments
(1.8
)
 

 
(1.8
)
November 30, 2015
$
11.1

 
$
2.7

 
$
13.8

The costs associated with the CIP will be a component of the Company’s U.S. government forward pricing rates, and therefore, will be recovered through the pricing of the Company’s products and services to the U.S. government. In addition to the employee-related CIP obligations, the Company incurred non-cash accelerated depreciation expense of $0.8 million in fiscal 2015 associated with changes in the estimated useful life of long-lived assets impacted by the CIP.
In addition, as part of the Company's ongoing effort to optimize business resources and achieve headcount reduction goals established through the CIP, the Company offered a Voluntary Reduction in Force ("VRIF") in July 2015 to its employees. In connection with the VRIF, the Company recorded a liability of $2.6 million in the third quarter of fiscal 2015, consisting of costs for severance, employee-related benefits and other associated expenses. These costs will be a component of the Company’s U.S. government forward pricing rates, and therefore, will be recovered through the pricing of the Company’s products and services to the U.S. government.

74



Note  13.
Quarterly Financial Data (Unaudited)
As discussed in Note 2, the Company has restated its consolidated financial statements for fiscal 2014 and 2013 and its unaudited quarterly financial information for the first three quarters in fiscal 2015 and each of the quarters in fiscal 2014. The quarterly unaudited financial results presented in the table below reflect the impact of the restatement adjustments.
 
First
Quarter 
 
Second
Quarter 
 
Third
Quarter 
 
Fourth
Quarter
 
As Restated
 
As Restated
 
As Restated
 
 
 
(In millions, except per share amounts)
2015
 
 
 
 
 
 
 
Net sales
$
323.0

 
$
457.8

 
$
441.0

 
$
486.5

Cost of sales (exclusive of items shown separately on Statement of Operations)
285.4

 
372.7

 
373.1

 
428.3

(Loss) income from continuing operations before income taxes
(9.3
)
 
37.2

 
(60.2
)
 
15.5

(Loss) income from continuing operations
(3.5
)
 
17.3

 
(38.5
)
 
7.6

Income from discontinued operations, net of income taxes
0.2

 

 
0.6

 
0.1

Net (loss) income
(3.3
)
 
17.3

 
(37.9
)
 
7.7

Basic (loss) income per share from continuing operations
(0.06
)
 
0.28

 
(0.62
)
 
0.12

Basic income per share from discontinued operations, net of income taxes

 

 
0.01

 

Basic net (loss) income per share
(0.06
)
 
0.28

 
(0.61
)
 
0.12

Diluted (loss) income per share from continuing operations
(0.06
)
 
0.25

 
(0.62
)
 
0.12

Diluted income per share from discontinued operations, net of income taxes

 

 
0.01

 

Diluted net (loss) income per share
$
(0.06
)
 
$
0.25

 
$
(0.61
)
 
$
0.12


 
First
Quarter 
 
Second
Quarter 
 
Third
Quarter 
 
Fourth
Quarter
 
(In millions, except per share amounts)
2014, As Restated
 
 
 
 
 
 
 
Net sales
$
331.6

 
$
406.6

 
$
420.4

 
$
443.6

Cost of sales (exclusive of items shown separately on Statement of Operations)
287.5

 
369.0

 
375.8

 
373.9

(Loss) income from continuing operations before income taxes
(0.2
)
 
(48.2
)
 
(11.2
)
 
26.6

(Loss) income from continuing operations
(2.2
)
 
(48.4
)
 
(10.7
)
 
12.0

(Loss) income from discontinued operations, net of income taxes

 
(0.8
)
 
0.2

 
(0.1
)
Net (loss) income
(2.2
)
 
(49.2
)
 
(10.5
)
 
11.9

Basic (loss) income per share from continuing operations
(0.04
)
 
(0.84
)
 
(0.19
)
 
0.20

Basic loss per share from discontinued operations, net of income taxes

 
(0.01
)
 

 

Basic net (loss) income per share
(0.04
)
 
(0.85
)
 
(0.19
)
 
0.20

Diluted (loss) income per share from continuing operations
(0.04
)
 
(0.84
)
 
(0.19
)
 
0.18

Diluted loss per share from discontinued operations, net of income taxes

 
(0.01
)
 

 

Diluted net (loss) income per share
$
(0.04
)
 
$
(0.85
)
 
$
(0.19
)
 
$
0.18


75



Note  14.
Unusual Items
Total unusual items expense, a component of other expense, net in the consolidated statements of operations was as follows:
 
Year Ended
 
2015
 
2014
 
2013
 
(In millions)
Aerospace and Defense:
 
 
 
 
 
        Loss (gain) on legal matters and settlements
$
50.0

 
$
0.9

 
$
(1.0
)
        Rocketdyne Business acquisition related costs

 

 
2.6

        Aerospace and defense unusual items
50.0

 
0.9

 
1.6

Corporate:
 
 
 
 
 
        Rocketdyne Business acquisition related costs

 

 
17.4

        Loss on debt repurchased
1.9

 
60.6

 
5.0

        Loss on legal settlement

 

 
0.5

        Loss on bank amendment

 
0.2

 

        Corporate unusual items
1.9

 
60.8

 
22.9

            Total unusual items
$
51.9

 
$
61.7

 
$
24.5

Fiscal 2015 Activity:
The Company recorded an expense of $50.0 million associated with a legal settlement. See Note 9(b).
The Company retired $76.0 million principal amount of its delayed draw term loan resulting in $1.9 million of losses associated with the write-off of deferred financing fees.
Fiscal 2014 Activity:
The Company recorded a charge of $0.2 million related to an amendment to the Senior Credit Facility.
The Company recorded $0.9 million for realized losses and interest associated with the failure to register with the SEC the issuance of certain of the Company’s common shares under the defined contribution 401(k) employee benefit plan.
A summary of the Company’s loss on the 4 1/16% Debentures repurchased is as follows (in millions):
Principal amount repurchased
$
59.6

Cash repurchase price
(119.9
)
Write-off of deferred financing costs
(0.3
)
Loss on 4 1/16% Debentures repurchased
$
(60.6
)
Fiscal 2013 Activity:
The Company recorded a charge of $0.5 million related to a legal settlement.
The Company recorded ($1.0) million for realized gains net of interest associated with the failure to register with the SEC the issuance of certain of the Company’s common shares under the defined contribution 401(k) employee benefit plan.
The Company incurred expenses of $20.0 million, including internal labor costs of $1.4 million, related to the Rocketdyne Business acquisition in fiscal 2013.
A summary of the Company’s loss on the 4 1/16% Debentures repurchased is as follows (in millions):
Principal amount repurchased
$
5.2

Cash repurchase price
(10.1
)
Write-off of deferred financing costs
(0.1
)
Loss on 4 1/16% Debentures repurchased
$
(5.0
)
Note  15.
Condensed Consolidating Financial Information, (As Restated for fiscal 2014 and 2013)
The Company is providing condensed consolidating financial information for its domestic subsidiaries that have guaranteed the 7 1/8% Notes, and for those subsidiaries that have not guaranteed the 7 1/8% Notes. These 100% owned subsidiary guarantors (Aerojet Rocketdyne, Aerojet Rocketdyne of DE, Inc. (formerly PWR), Arde and Arde-Barinco) have, jointly and severally, fully and unconditionally guaranteed the 7 1/8% Notes subject to release under the following circumstances: (i) to

76



enable the disposition of such property or assets to a party that is not the Company or a subsidiary guarantor to the extent permitted by and consummated in compliance with the indenture governing the 7 1/8% Notes; (ii) in case of a subsidiary guarantor that is released from its subsidiary guarantee, the release of the property and assets of such subsidiary guarantor; (iii) as permitted or required by the intercreditor agreement; (iv) with the consent of the holder of at least a majority in principal amount of the outstanding 7 1/8% Notes; or (v) when permitted or required by the indenture governing the 7 1/8% Notes. Prior to the consummation of the Acquisition and escrow release date, the 7 1/8% Notes were secured by a first priority security interest in the escrow account and all deposits and investment property therein. Following the consummation of the Acquisition and escrow release date on June 14, 2013, the subsidiary guarantees are a senior secured obligation of each subsidiary guarantor and rank (i) effectively junior to all of existing and future first-priority senior secured debt, including borrowings under the Senior Credit Facility, to the extent of the value of the assets securing such debt; (ii) effectively senior to all of the Company’s existing and future unsecured senior debt; (iii) senior in right of payment to all of the Company’s existing and future subordinated debt; and (iv) structurally subordinated to all existing and future liabilities of non-guarantor subsidiaries.
The Company has not presented separate financial and narrative information for each of the subsidiary guarantors because it believes that such financial and narrative information would not provide investors with any additional information that would be material in evaluating the sufficiency of the guarantees. Therefore, the following condensed consolidating financial information summarizes the financial position, results of operations, and cash flows for the Company’s guarantor and non-guarantor subsidiaries.

Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income
Year ended fiscal 2015
Parent
 
Guarantor
Subsidiaries
 
Non-guarantor
Subsidiaries
 
Eliminations
 
Consolidated
 
(In millions)
Net sales
$

 
$
1,667.7

 
$
40.6

 
$

 
$
1,708.3

Cost of sales (exclusive of items shown separately below)

 
1,462.6

 
29.6

 
(0.6
)
 
1,491.6

Selling, general and administrative
23.8

 
23.4

 
1.8

 

 
49.0

Depreciation and amortization
0.1

 
64.0

 
1.0

 

 
65.1

Interest expense
48.0

 
2.4

 

 

 
50.4

Other, net
12.4

 
58.0

 
(2.0
)
 
0.6

 
69.0

(Loss) income from continuing operations before income taxes
(84.3
)
 
57.3

 
10.2

 

 
(16.8
)
Income tax (benefit) provision
(31.1
)
 
27.5

 
3.9

 

 
0.3

(Loss) income from continuing operations
(53.2
)
 
29.8

 
6.3

 

 
(17.1
)
Income from discontinued operations
0.9

 

 

 

 
0.9

(Loss) income before equity income of subsidiaries
(52.3
)
 
29.8

 
6.3

 

 
(16.2
)
Equity income of subsidiaries
36.1

 

 

 
(36.1
)
 

Net (loss) income
$
(16.2
)
 
$
29.8

 
$
6.3

 
$
(36.1
)
 
$
(16.2
)
Comprehensive (loss) income
$
(24.2
)
 
$
21.9

 
$
6.3

 
$
(28.2
)
 
$
(24.2
)


77



Year ended fiscal 2014, As Restated
Parent
 
Guarantor
Subsidiaries
 
Non-guarantor
Subsidiaries
 
Eliminations
 
Consolidated
 
(In millions)
Net sales
$

 
$
1,575.7

 
$
26.5

 
$

 
$
1,602.2

Cost of sales (exclusive of items shown separately below)

 
1,382.8

 
23.9

 
(0.5
)
 
1,406.2

Selling, general and administrative
12.8

 
23.8

 
1.6

 

 
38.2

Depreciation and amortization
0.1

 
62.5

 
1.1

 

 
63.7

Interest expense
50.1

 
2.6

 

 

 
52.7

Other, net
59.1

 
18.5

 
(3.7
)
 
0.5

 
74.4

(Loss) income from continuing operations before income taxes
(122.1
)
 
85.5

 
3.6

 

 
(33.0
)
Income tax (benefit) provision
(8.3
)
 
22.9

 
1.7

 

 
16.3

(Loss) income from continuing operations
(113.8
)
 
62.6

 
1.9

 

 
(49.3
)
Loss from discontinued operations
(0.7
)
 

 

 

 
(0.7
)
(Loss) income before equity income of subsidiaries
(114.5
)
 
62.6

 
1.9

 

 
(50.0
)
Equity income of subsidiaries
64.5

 

 

 
(64.5
)
 

Net (loss) income
$
(50.0
)
 
$
62.6

 
$
1.9

 
$
(64.5
)
 
$
(50.0
)
Comprehensive (loss) income
$
(155.4
)
 
$
(25.0
)
 
$
1.9

 
$
23.1

 
$
(155.4
)

Year ended fiscal 2014, As Reported
Parent
 
Guarantor
Subsidiaries
 
Non-guarantor
Subsidiaries
 
Eliminations
 
Consolidated
 
(In millions)
Net sales
$

 
$
1,570.9

 
$
26.5

 
$

 
$
1,597.4

Cost of sales (exclusive of items shown separately below)

 
1,384.7

 
23.9

 
(0.5
)
 
1,408.1

Selling, general and administrative
12.6

 
23.7

 
1.6

 

 
37.9

Depreciation and amortization
0.1

 
62.5

 
1.1

 

 
63.7

Interest expense
50.1

 
2.6

 

 

 
52.7

Other, net
59.1

 
18.5

 
(3.7
)
 
0.5

 
74.4

(Loss) income from continuing operations before income taxes
(121.9
)
 
78.9

 
3.6

 

 
(39.4
)
Income tax (benefit) provision
(8.4
)
 
19.6

 
1.7

 

 
12.9

(Loss) income from continuing operations
(113.5
)
 
59.3

 
1.9

 

 
(52.3
)
Loss from discontinued operations
(0.7
)
 

 

 

 
(0.7
)
(Loss) income before equity income of subsidiaries
(114.2
)
 
59.3

 
1.9

 

 
(53.0
)
Equity income of subsidiaries
61.2

 

 

 
(61.2
)
 

Net (loss) income
$
(53.0
)
 
$
59.3

 
$
1.9

 
$
(61.2
)
 
$
(53.0
)
Comprehensive (loss) income
$
(164.8
)
 
$
(33.3
)
 
$
1.9

 
$
31.4

 
$
(164.8
)

 

78



Year ended fiscal 2013, As Restated
Parent
 
Guarantor
Subsidiaries
 
Non-guarantor
Subsidiaries
 
Eliminations
 
Consolidated
 
(In millions)
Net sales
$

 
$
1,349.7

 
$
28.4

 
$

 
$
1,378.1

Cost of sales (exclusive of items shown separately below)

 
1,211.0

 
23.9

 
(0.6
)
 
1,234.3

Selling, general and administrative
31.1

 
21.2

 
1.3

 

 
53.6

Depreciation and amortization
0.1

 
42.3

 
1.1

 

 
43.5

Interest expense
46.2

 
2.5

 

 

 
48.7

Other, net
32.8

 
2.9

 
(2.6
)
 
0.6

 
33.7

(Loss) income from continuing operations before income taxes
(110.2
)
 
69.8

 
4.7

 

 
(35.7
)
Income tax benefit
(81.8
)
 
(106.3
)
 
(10.3
)
 

 
(198.4
)
(Loss) income from continuing operations
(28.4
)
 
176.1

 
15.0

 

 
162.7

Income from discontinued operations
0.2

 

 

 

 
0.2

(Loss) income before equity income of subsidiaries
(28.2
)
 
176.1

 
15.0

 

 
162.9

Equity income of subsidiaries
191.1

 

 

 
(191.1
)
 

Net income
$
162.9

 
$
176.1

 
$
15.0

 
$
(191.1
)
 
$
162.9

Comprehensive income
$
420.9

 
$
366.1

 
$
15.0

 
$
(381.1
)
 
$
420.9


Year ended fiscal 2013, As Reported
Parent
 
Guarantor
Subsidiaries
 
Non-guarantor
Subsidiaries
 
Eliminations
 
Consolidated
 
(In millions)
Net sales
$

 
$
1,354.7

 
$
28.4

 
$

 
$
1,383.1

Cost of sales (exclusive of items shown separately below)

 
1,206.3

 
23.9

 
(0.6
)
 
1,229.6

Selling, general and administrative
31.1

 
21.2

 
1.3

 

 
53.6

Depreciation and amortization
0.1

 
42.6

 
1.1

 

 
43.8

Interest expense
46.2

 
2.5

 

 

 
48.7

Other, net
32.8

 
2.8

 
(2.6
)
 
0.6

 
33.6

(Loss) income from continuing operations before income taxes
(110.2
)
 
79.3

 
4.7

 

 
(26.2
)
Income tax benefit
(81.8
)
 
(101.8
)
 
(10.3
)
 

 
(193.9
)
(Loss) income from continuing operations
(28.4
)
 
181.1

 
15.0

 

 
167.7

Income from discontinued operations
0.2

 

 

 

 
0.2

(Loss) income before equity income of subsidiaries
(28.2
)
 
181.1

 
15.0

 

 
167.9

Equity income of subsidiaries
196.1

 

 

 
(196.1
)
 

Net income
$
167.9

 
$
181.1

 
$
15.0

 
$
(196.1
)
 
$
167.9

Comprehensive income
$
431.8

 
$
375.7

 
$
15.0

 
$
(390.7
)
 
$
431.8




79



Condensed Consolidating Balance Sheets
November 30, 2015
Parent
 
Guarantor
Subsidiaries
 
Non-guarantor
Subsidiaries
 
Eliminations
 
Consolidated
 
(In millions)
Cash and cash equivalents
$
221.9

 
$

 
$

 
$
(10.8
)
 
$
211.1

Accounts receivable

 
167.4

 
4.1

 

 
171.5

Inventories

 
150.8

 
6.7

 

 
157.5

Recoverable from the U.S. government, Northrop, and other third parties for environmental remediation costs

 
30.0

 

 

 
30.0

Other current assets, net
3.1

 
57.5

 
0.9

 

 
61.5

Income taxes
44.2

 
0.3

 

 
(41.6
)
 
2.9

Deferred income taxes
6.5

 
20.4

 
1.2

 

 
28.1

Total current assets
275.7

 
426.4

 
12.9

 
(52.4
)
 
662.6

Property, plant and equipment, net
4.7

 
355.3

 
5.8

 

 
365.8

Recoverable from the U.S. government and other third parties for environmental remediation costs
0.7

 
209.7

 

 

 
210.4

Deferred income taxes
66.2

 
203.4

 
17.1

 

 
286.7

Goodwill

 
158.1

 

 

 
158.1

Intercompany receivable

 
192.9

 
34.5

 
(227.4
)
 

Investments in subsidiaries
543.2

 

 

 
(543.2
)
 

Other noncurrent assets and intangibles, net
31.4

 
258.6

 
61.3

 

 
351.3

Total assets
$
921.9

 
$
1,804.4

 
$
131.6

 
$
(823.0
)
 
$
2,034.9

Short-term borrowings and current portion of long-term debt
$
5.0

 
$
0.3

 
$

 
$

 
$
5.3

Accounts payable
1.0

 
112.9

 
2.1

 
(10.8
)
 
105.2

Reserves for environmental remediation costs
0.7

 
31.9

 

 

 
32.6

Postretirement medical and life insurance benefits
4.6

 
1.4

 

 

 
6.0

Other current liabilities and advance payments on contracts
26.8

 
413.4

 
6.4

 
(41.6
)
 
405.0

Total current liabilities
38.1

 
559.9

 
8.5

 
(52.4
)
 
554.1

Long-term debt
646.6

 
0.1

 

 

 
646.7

Reserves for environmental remediation costs
4.5

 
269.0

 

 

 
273.5

Pension benefits
98.8

 
467.4

 

 

 
566.2

Intercompany payable
227.4

 

 

 
(227.4
)
 

Postretirement medical and life insurance benefits
32.9

 
12.6

 

 

 
45.5

Other noncurrent liabilities
19.1

 
62.6

 
12.7

 

 
94.4

Total liabilities
1,067.4

 
1,371.6

 
21.2

 
(279.8
)
 
2,180.4

Commitments and contingencies (Note 9)

 

 

 

 

Redeemable common stock
0.9

 

 

 

 
0.9

Total stockholders’ (deficit) equity
(146.4
)
 
432.8

 
110.4

 
(543.2
)
 
(146.4
)
Total liabilities, redeemable common stock, and stockholders’ (deficit) equity
$
921.9

 
$
1,804.4

 
$
131.6

 
$
(823.0
)
 
$
2,034.9



80



November 30, 2014, As Restated
Parent
 
Guarantor
Subsidiaries
 
Non-guarantor
Subsidiaries
 
Eliminations
 
Consolidated
 
(In millions)
Cash and cash equivalents
$
271.6

 
$

 
$

 
$
(5.7
)
 
$
265.9

Accounts receivable

 
168.0

 
2.5

 

 
170.5

Inventories

 
132.6

 
5.4

 

 
138.0

Recoverable from the U.S. government, Northrop, and other third parties for environmental remediation costs
0.1

 
25.3

 

 

 
25.4

Other current assets, net
3.5

 
34.3

 
0.8

 

 
38.6

Income taxes
31.0

 
1.8

 

 
(30.7
)
 
2.1

Deferred income taxes
5.6

 
13.4

 
0.9

 

 
19.9

Total current assets
311.8

 
375.4

 
9.6

 
(36.4
)
 
660.4

Property, plant and equipment, net
4.7

 
355.9

 
5.9

 

 
366.5

Recoverable from the U.S. government and other third parties for environmental remediation costs
0.7

 
86.5

 

 

 
87.2

Deferred income taxes
57.4

 
186.1

 
17.9

 

 
261.4

Goodwill

 
158.1

 

 

 
158.1

Intercompany receivable

 
97.7

 
29.2

 
(126.9
)
 

Investments in subsidiaries
500.2

 

 

 
(500.2
)
 

Other noncurrent assets and intangibles, net
28.1

 
300.9

 
56.0

 

 
385.0

Total assets
$
902.9

 
$
1,560.6

 
$
118.6

 
$
(663.5
)
 
$
1,918.6

Short-term borrowings and current portion of long-term debt
$
5.0

 
$
0.3

 
$

 
$

 
$
5.3

Accounts payable
1.5

 
103.6

 
4.6

 
(5.7
)
 
104.0

Reserves for environmental remediation costs
1.0

 
30.9

 

 

 
31.9

Other current liabilities and advance payments on contracts
32.1

 
413.9

 
3.5

 
(30.7
)
 
418.8

Postretirement medical and life insurance benefits
5.0

 
1.4

 

 

 
6.4

Total current liabilities
44.6

 
550.1

 
8.1

 
(36.4
)
 
566.4

Long-term debt
776.6

 
0.3

 

 

 
776.9

Reserves for environmental remediation costs
4.8

 
129.3

 

 

 
134.1

Pension benefits
67.0

 
415.8

 

 

 
482.8

Intercompany payable
126.9

 

 

 
(126.9
)
 

Postretirement medical and life insurance benefits
37.7

 
14.0

 

 

 
51.7

Other noncurrent liabilities
19.2

 
49.8

 
11.6

 

 
80.6

Total liabilities
1,076.8

 
1,159.3

 
19.7

 
(163.3
)
 
2,092.5

Commitments and contingencies (Note 9)

 

 

 

 

Redeemable common stock
1.6

 

 

 

 
1.6

Total stockholders’ (deficit) equity
(175.5
)
 
401.3

 
98.9

 
(500.2
)
 
(175.5
)
Total liabilities, redeemable common stock, and stockholders’ (deficit) equity
$
902.9

 
$
1,560.6

 
$
118.6

 
$
(663.5
)
 
$
1,918.6



81



November 30, 2014, As Reported
Parent
 
Guarantor
Subsidiaries
 
Non-guarantor
Subsidiaries
 
Eliminations
 
Consolidated
 
(In millions)
Cash and cash equivalents
$
271.6

 
$

 
$

 
$
(5.7
)
 
$
265.9

Accounts receivable

 
170.4

 
2.5

 

 
172.9

Inventories

 
133.6

 
5.4

 

 
139.0

Recoverable from the U.S. government, Northrop, and other third parties for environmental remediation costs
0.1

 
25.3

 

 

 
25.4

Other current assets, net
3.5

 
31.6

 
0.8

 

 
35.9

Income taxes
31.0

 
1.8

 

 
(30.7
)
 
2.1

Deferred income taxes
5.6

 
18.8

 
0.9

 

 
25.3

Total current assets
311.8

 
381.5

 
9.6

 
(36.4
)
 
666.5

Property, plant and equipment, net
4.7

 
356.9

 
5.9

 

 
367.5

Recoverable from the U.S. government and other third parties for environmental remediation costs
0.7

 
80.5

 

 

 
81.2

Deferred income taxes
57.7

 
183.4

 
17.9

 

 
259.0

Goodwill

 
164.4

 

 

 
164.4

Intercompany receivable

 
97.7

 
29.2

 
(126.9
)
 

Investments in subsidiaries
503.0

 

 

 
(503.0
)
 

Other noncurrent assets and intangibles, net
28.1

 
298.9

 
56.0

 

 
383.0

Total assets
$
906.0

 
$
1,563.3

 
$
118.6

 
$
(666.3
)
 
$
1,921.6

Short-term borrowings and current portion of long-term debt
$
5.0

 
$
0.3

 
$

 
$

 
$
5.3

Accounts payable
1.5

 
103.1

 
4.6

 
(5.7
)
 
103.5

Reserves for environmental remediation costs
1.0

 
30.9

 

 

 
31.9

Other current liabilities and advance payments on contracts
31.5

 
415.9

 
3.5

 
(30.7
)
 
420.2

Postretirement medical and life insurance benefits
5.0

 
1.4

 

 

 
6.4

Total current liabilities
44.0

 
551.6

 
8.1

 
(36.4
)
 
567.3

Long-term debt
776.6

 
0.3

 

 

 
776.9

Reserves for environmental remediation costs
4.8

 
129.3

 

 

 
134.1

Pension benefits
67.0

 
415.8

 

 

 
482.8

Intercompany payable
126.9

 

 

 
(126.9
)
 

Postretirement medical and life insurance benefits
37.7

 
14.0

 

 

 
51.7

Other noncurrent liabilities
19.9

 
48.2

 
11.6

 

 
79.7

Total liabilities
1,076.9

 
1,159.2

 
19.7

 
(163.3
)
 
2,092.5

Commitments and contingencies (Note 8)
 
 
 
 
 
 
 
 
 
Redeemable common stock
1.6

 

 

 

 
1.6

Total stockholders’ (deficit) equity
(172.5
)
 
404.1

 
98.9

 
(503.0
)
 
(172.5
)
Total liabilities, redeemable common stock, and stockholders’ (deficit) equity
$
906.0

 
$
1,563.3

 
$
118.6

 
$
(666.3
)
 
$
1,921.6



82



Condensed Consolidating Statements of Cash Flows
Year ended fiscal 2015
Parent
 
Guarantor
Subsidiaries
 
Non-guarantor
Subsidiaries
 
Eliminations
 
Consolidated
 
(In millions)
Net cash (used in) provided by operating activities
$
(66.3
)
 
$
130.2

 
$
6.3

 
$
(5.1
)
 
$
65.1

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
Capital expenditures

 
(35.8
)
 
(1.0
)
 

 
(36.8
)
Other investing

 
1.0

 

 

 
1.0

Net cash used in investing activities

 
(34.8
)
 
(1.0
)
 

 
(35.8
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
Debt repayments / repurchases
(81.0
)
 
(0.2
)
 

 

 
(81.2
)
Net transfers from (to) parent
100.5

 
(95.2
)
 
(5.3
)
 

 

Other financing activities
(2.9
)
 

 

 

 
(2.9
)
Net cash provided by (used in) financing activities
16.6

 
(95.4
)
 
(5.3
)
 

 
(84.1
)
Net decrease in cash and cash equivalents
(49.7
)
 

 

 
(5.1
)
 
(54.8
)
Cash and cash equivalents at beginning of year
271.6

 

 

 
(5.7
)
 
265.9

Cash and cash equivalents at end of period
$
221.9

 
$

 
$

 
$
(10.8
)
 
$
211.1

Year ended fiscal 2014, As Restated
Parent
 
Guarantor
Subsidiaries
 
Non-guarantor
Subsidiaries
 
Eliminations
 
Consolidated
 
(In millions)
Net cash (used in) provided by operating activities
$
(35.2
)
 
$
194.0

 
$
(2.5
)
 
$
(5.7
)
 
$
150.6

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
Capital expenditures
(0.1
)
 
(42.8
)
 
(0.5
)
 

 
(43.4
)
Other investing activities
0.2

 
7.5

 

 

 
7.7

Net cash provided by (used in) investing activities
0.1

 
(35.3
)
 
(0.5
)
 

 
(35.7
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
Debt repayments / repurchases
(166.1
)
 
(0.2
)
 

 

 
(166.3
)
Proceeds from issuance of debt
189.0

 

 

 

 
189.0

Debt issuance costs
(4.2
)
 

 

 

 
(4.2
)
Net transfers from (to) parent
160.4

 
(163.4
)
 
3.0

 

 

Other financing activities
(65.1
)
 

 

 

 
(65.1
)
Net cash provided by (used in) financing activities
114.0

 
(163.6
)
 
3.0

 

 
(46.6
)
Net increase (decrease) in cash and cash equivalents
78.9

 
(4.9
)
 

 
(5.7
)
 
68.3

Cash and cash equivalents at beginning of year
192.7

 
4.9

 

 

 
197.6

Cash and cash equivalents at end of period
$
271.6

 
$

 
$

 
$
(5.7
)
 
$
265.9

 

83



Year ended fiscal 2014, As Reported
Parent
 
Guarantor
Subsidiaries
 
Non-guarantor
Subsidiaries
 
Eliminations
 
Consolidated
 
(In millions)
Net cash (used in) provided by operating activities
$
(35.4
)
 
$
194.0

 
$
(2.5
)
 
$
(5.7
)
 
$
150.4

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
Capital expenditures
(0.1
)
 
(42.8
)
 
(0.5
)
 

 
(43.4
)
Other investing activities
0.2

 
7.5

 

 

 
7.7

Net cash provided by (used in) investing activities
0.1

 
(35.3
)
 
(0.5
)
 

 
(35.7
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
Debt repayments / repurchases
(166.1
)
 
(0.2
)
 

 

 
(166.3
)
Proceeds from issuance of debt
189.0

 

 

 

 
189.0

Debt issuance costs
(4.2
)
 

 

 

 
(4.2
)
Net transfers from (to) parent
160.4

 
(163.4
)
 
3.0

 

 

Other financing activities
(64.9
)
 

 

 

 
(64.9
)
Net cash provided by (used in) financing activities
114.2

 
(163.6
)
 
3.0

 

 
(46.4
)
Net increase (decrease) in cash and cash equivalents
78.9

 
(4.9
)
 

 
(5.7
)
 
68.3

Cash and cash equivalents at beginning of year
192.7

 
4.9

 

 

 
197.6

Cash and cash equivalents at end of period
$
271.6

 
$

 
$

 
$
(5.7
)
 
$
265.9


Year ended fiscal 2013, As Restated
Parent
 
Guarantor
Subsidiaries
 
Non-guarantor
Subsidiaries
 
Eliminations
 
Consolidated
 
(In millions)
Net cash (used in) provided by operating activities
$
(40.4
)
 
$
105.1

 
$
2.4

 
$
10.3

 
$
77.4

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
Capital expenditures

 
(62.5
)
 
(0.7
)
 

 
(63.2
)
Other investing

 
(411.7
)
 

 

 
(411.7
)
Net cash used in investing activities

 
(474.2
)
 
(0.7
)
 

 
(474.9
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
Debt repayments / repurchases
(12.6
)
 
(0.2
)
 

 

 
(12.8
)
Proceeds from issuance of debt
460.0

 

 

 

 
460.0

Debt issuance costs
(14.9
)
 

 

 

 
(14.9
)
Net transfers (to) from parent
(372.5
)
 
374.2

 
(1.7
)
 

 

Other financing activities
0.7

 

 

 

 
0.7

Net cash provided by financing activities
60.7

 
374.0

 
(1.7
)
 

 
433.0

Net increase in cash and cash equivalents
20.3

 
4.9

 

 
10.3

 
35.5

Cash and cash equivalents at beginning of year
172.4

 

 

 
(10.3
)
 
162.1

Cash and cash equivalents at end of period
$
192.7

 
$
4.9

 
$

 
$

 
$
197.6



84



Year ended fiscal 2013, As Reported
Parent
 
Guarantor
Subsidiaries
 
Non-guarantor
Subsidiaries
 
Eliminations
 
Consolidated
 
(In millions)
Net cash (used in) provided by operating activities
$
(40.2
)
 
$
105.1

 
$
2.4

 
$
10.3

 
$
77.6

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
Capital expenditures

 
(62.5
)
 
(0.7
)
 

 
(63.2
)
Other investing

 
(411.7
)
 

 

 
(411.7
)
Net cash used in investing activities

 
(474.2
)
 
(0.7
)
 

 
(474.9
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
Debt repayments / repurchases
(12.6
)
 
(0.2
)
 

 

 
(12.8
)
Proceeds from issuance of debt
460.0

 

 

 

 
460.0

Debt issuance costs
(14.9
)
 

 

 

 
(14.9
)
Net transfers (to) from parent
(372.5
)
 
374.2

 
(1.7
)
 

 

Other financing activities
0.5

 

 

 

 
0.5

Net cash provided by financing activities
60.5

 
374.0

 
(1.7
)
 

 
432.8

Net increase in cash and cash equivalents
20.3

 
4.9

 

 
10.3

 
35.5

Cash and cash equivalents at beginning of year
172.4

 

 

 
(10.3
)
 
162.1

Cash and cash equivalents at end of period
$
192.7

 
$
4.9

 
$

 
$

 
$
197.6


Note  16.
Subsequent Event
On January 20, 2016, the Company’s board of directors approved a change in the Company’s fiscal year-end from November 30 of each year to December 31 of each year.
Item 9A.
Controls and Procedures
As of November 30, 2015, we conducted an evaluation under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”), means controls and other procedures of a company that are designed to provide reasonable assurance that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures are also designed to provide reasonable assurance that such information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures were not effective as of November 30, 2015 because of the material weaknesses in our internal control over financial reporting described below. In light of the material weaknesses described below, management performed additional analysis and other post-closing procedures, including substantial work performed during the restatement process that identified adjustments resulting in the restatement to our previously issued financial statements to ensure our consolidated financial statements are prepared in accordance with generally accepted accounting principles. Accordingly, management has concluded that the Company's consolidated financial statements included in this Annual Report on Form 10-K fairly present, in all material respects, our financial condition, results of operations and cash flows for the periods presented therein.
Management’s Report on Internal Control Over Financial Reporting (Restated)
Our management is responsible for establishing and maintaining adequate “internal control over financial reporting,” as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. The rules define internal control over financial reporting as a process designed by, or under the supervision of, the Company’s Chief Executive Officer and Chief Financial Officer, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that:

85



Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;
Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and
Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. In addition, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
With the participation of the Chief Executive Officer and the Chief Financial Officer, our management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. In connection with management’s evaluation of the effectiveness of our internal control over financial reporting described above, management has identified control deficiencies that constituted material weaknesses in our internal control over financial reporting as of November 30, 2015, as described below:
(a)We did not adequately design controls related to purchase accounting considerations for long-term customer contracts acquired as part of a business combination. Specifically, we did not have appropriate controls in place to (i) ensure that the estimate of the acquired contracts’ percentage of completion used to recognize revenue was based on our estimate of remaining effort on such contracts at the acquisition date instead of the inception date of the contract; (ii) identify changes to the results of the fair value assessment of acquired customer contracts performed by the Company’s third party valuation expert during the measurement period following the close of the transaction; and (iii) evaluate the long-term contract accounting policies of the acquired business to determine the impact on the fair value of acquired contracts.
The above material weakness resulted in errors in net sales, accounts receivable and goodwill in the consolidated financial statements for the year ended November 30, 2013, and errors in net sales and accounts receivable in the consolidated financial statements for the year ended November 30, 2014, and the unaudited quarterly financial information for the first three quarters in fiscal 2015 and each of the quarters in fiscal 2014. These errors were corrected through restatement of those periods.
(b)We did not maintain effective controls over the integration of the Company’s accounting policies, practices and controls applicable to the acquired Rocketdyne Business, including those over the segmentation criteria applicable to long-term contracts. Specifically, we did not provide oversight to, or fully evaluate the results of an accounting conclusion reached by Rocketdyne management regarding significant customer contract amendments.
This material weakness resulted in errors in net sales and accounts receivable in the consolidated financial statements for the years ended November 30, 2013 and 2014, and the unaudited quarterly financial information for the first three quarters in fiscal 2015 and each of the quarters in fiscal 2014. These errors were corrected through restatement of those periods.
(c) We did not maintain adequate controls over the completeness and accuracy of our accounting for income taxes, including the income tax provision and related tax assets and liabilities. Specifically, we did not design effective controls related to the preparation and review of the financial information used in the calculation of our annual and quarterly income tax provision.
This material weakness resulted in errors to deferred tax assets, income taxes payable, uncertain tax positions and income tax expense accounts in the consolidated financial statements for the year ended November 30, 2015. This material weakness did not result in a material misstatement of the Company’s consolidated financial statements for the year ended November 30, 2015.
Additionally, these material weaknesses could result in a material misstatement of the aforementioned account balances or disclosures that would result in a misstatement to the annual or interim consolidated financial statements that would not be prevented or detected.
In Management’s Report on Internal Control Over Financial Reporting included in our original Annual Report on Form 10-K for the year ended November 30, 2015, our management, including our Chief Executive Officer and Chief Financial Officer, concluded that we did not maintain effective internal control over financial reporting as of November 30, 2015 because of the

86



material weaknesses described in (a) and (b) above. Management subsequently concluded that the material weakness described in (c) above also existed as of November 30, 2015. As a result, we have concluded that we did not maintain effective internal control over financial reporting as of November 30, 2015, based on the criteria in Internal Control-Integrated Framework (2013) issued by the COSO. Accordingly, management has restated its report on internal control over financial reporting to include this additional material weakness.
The effectiveness of our internal control over financial reporting as of November 30, 2015 has been audited by PricewaterhouseCoopers LLP, our independent registered public accounting firm. Their report appears in Item 8 of this Form 10-K.
Remediation Efforts to Address Material Weaknesses
We are currently evaluating the internal controls related to business combinations, and intend to incorporate the following changes into the processes, procedures and internal controls currently in place to:
Ensure the percent complete on all acquired long-term customer contracts is reset to zero upon acquisition;
Verify that all acquired long-term customer contracts are appropriately evaluated for necessary fair value adjustments during the measurement period following the close of the transaction; and
Assess acquiree accounting policies and evaluate the impact of those policies on the fair value of acquired long-term customer contracts upon acquisition.
In addition, with the transition of our Rocketdyne Business from a third party hosted enterprise resource planning (“ERP”) system to the Company’s Oracle ERP system and business processes in 2015, we have also aligned our contract accounting structure under common leadership. In doing so, this resulted in common controls over the application of contract accounting on all of our long-term contracts. Although this change was not applied retrospectively, our management believes the controls over our contract accounting efforts now in place will be sufficient to address the material weakness in future periods.
We are also evaluating the composition of the internal controls in place for our income tax accounting and intend to perform the following:
Hire additional tax resources (either internal or external) with the requisite skillset to supplement the current complement of tax professionals in place; and
Develop and implement controls that will be executed consistently to validate the completeness and accuracy of the financial information utilized in our accounting for income taxes.
As part of our ongoing monitoring effort of the Company’s internal control over financial reporting, we will report progress and status of the above remediation efforts to the Audit Committee on a periodic basis throughout the year.
Remediation of Prior Year Material Weaknesses
We previously identified and disclosed in our Form 10-K for the year ended November 30, 2014, as well as in our Forms 10-Q for each interim period in fiscal 2015, material weaknesses in our internal control over financial reporting regarding the following:
We did not maintain effective controls over information and communications between the Aerojet Rocketdyne parent, the Rocketdyne Business and other third parties performing services for the Company under Transition Service Agreements (“TSA”) associated with the acquisition of the Rocketdyne Business; and
We did not maintain effective controls over the timely capitalization and depreciation of assets placed into service at the acquired Rocketdyne Business.
Throughout fiscal 2015, we implemented changes to our processes to improve our internal control over financial reporting. The following steps have been taken to remediate the conditions leading to the above stated material weaknesses:
Effective January 1, 2015, we transitioned our Rocketdyne Business from a third party hosted ERP system and third party TSAs to our Oracle ERP system and internal shared services business processes and controls.
Assessed the organizational structure of our accounting and finance function and reassigned certain personnel to ensure appropriate oversight maintained across the organization.
Changes in Internal Control Over Financial Reporting
There were no changes to our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the fiscal quarter ended November 30, 2015 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Part IV
Item 15.
Exhibits and Financial Statement Schedules
(a)
The following documents are filed as part of this report:
(1)
FINANCIAL STATEMENTS  
 
Page
Number 
Report of Independent Registered Public Accounting Firm
Consolidated Statements of Operations for each of the three years in the period ended November 30, 2015
Consolidated Statements of Comprehensive (Loss) Income for each of the three years in the period ended November 30, 2015
Consolidated Balance Sheets as of November 30, 2015 and 2014
Consolidated Statements of Stockholders’ (Deficit) Equity for each of the three years in the period ended November 30, 2015
Consolidated Statements of Cash Flows for each of the three years in the period ended November 30, 2015
Notes to Consolidated Financial Statements

(b)
EXHIBITS

Table
Item No.
Exhibit Description
2.1
Stock and Asset Purchase Agreement, dated July 22, 2012, by and between United Technologies Corporation and GenCorp Inc. was filed as Exhibit 2.1 to GenCorp Inc.’s Current Report on Form 8-K dated July 26, 2012 (File No. 1-01520) and incorporated herein by reference.**

87



2.2
Amendment No. 1 to the Stock and Asset Purchase Agreement, dated as of October 16, 2012, by and between GenCorp Inc. and United Technologies Corporation was filed as Exhibit 2.1 to GenCorp Inc.’s Current Report on Form 8-K dated October 22, 2012 (File No. 1-01520) and incorporated herein by reference.**
2.3
Amended and Restated Stock and Asset Purchase Agreement, dated as of June 12, 2013, by and between United Technologies Corporation and GenCorp Inc. was filed as Exhibit 2.1 to GenCorp Inc.’s Current Report on Form 8-K dated June 14, 2013 (File No. 1-01520), and is incorporated herein by reference.**
2.4
Plan of Conversion, dated April 11, 2014 was filed as Exhibit 2.1 to GenCorp Inc.’s Current Report on Form 8-K dated April 11, 2014 (File No. 1-01520), and is incorporated herein by reference.
3.1
Certificate of Conversion, as filed with the Secretary of State of the State of Ohio on April 11, 2014 was filed as Exhibit 3.1 to GenCorp Inc.’s Current Report on Form 8-K dated April 11, 2014 (File No. 1-01520), and is incorporated herein by reference.
3.2
Certificate of Conversion, as filed with the Secretary of State of the State of Delaware on April 11, 2014 was filed as Exhibit 3.2 to GenCorp Inc.’s Current Report on Form 8-K dated April 11, 2014 (File No. 1-01520), and is incorporated herein by reference.
3.3
Certificate of Incorporation, as of April 11, 2014, as amended on April 27, 2015.
3.4
Bylaws, effective April 11, 2014 was filed as Exhibit 3.4 to GenCorp Inc.’s Current Report on Form 8-K dated April 11, 2014 (File No. 1-01520), and is incorporated herein by reference.
4.1
Indenture, dated as of November 23, 2004, between GenCorp Inc. and The Bank of New York Trust Company, N.A., as trustee relating to GenCorp Inc.’s 2  1 / 4 % Convertible Subordinated Debentures due 2024 was filed as Exhibit 4.01 to GenCorp Inc.’s Current Report on Form 8-K dated November 23, 2004 (File No. 1-01520), as amended, and incorporated herein by reference.
4.2
Registration Rights Agreement, dated as of November 23, 2004, by and between GenCorp Inc. and Wachovia Capital Markets, LLC, as representative for the several initial purchasers of the 2  1 / 4 % Convertible Subordinated Debentures due 2024 was filed as Exhibit 4.14 to GenCorp Inc.’s Form S-3 Registration Statement dated January 11, 2005 (File No. 333-121948) and incorporated herein by reference.
4.3
Form of 2  1 / 4 % Convertible Subordinated Debenture was filed as Exhibit 4.02 to GenCorp Inc.’s Current Report on Form 8-K dated November 23, 2004 (File No. 1-01520), as amended, and incorporated herein by reference.
4.4
GenCorp Retirement Savings Plan was filed as Exhibit 4.1 to GenCorp Inc.’s Registration Statement on Form S-8 filed on June 30, 2008 (File No. 333-0152032) and incorporated herein by reference.
4.5
Indenture, dated as of December 21, 2009, between GenCorp Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee, relating to GenCorp’s 4.0625% Convertible Subordinated Debentures due 2039 was filed as Exhibit 4.1 to GenCorp Inc.’s Current Report on Form 8-K filed on December 21, 2009 (File 1-01520) and is incorporated herein by reference.
4.6
Form of 4.0625% Convertible Subordinated Debenture due 2039 was filed as Exhibit 4.2 to GenCorp Inc.’s Current Report on Form 8-K dated December 21, 2009 (File No. 1-01520), as amended, and incorporated herein by reference.
4.7
Third Supplemental Indenture dated as of November 24, 2009, by and among GenCorp Inc., Easton Development Company, LLC, and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A. and successor to The Bank of New York), to the Indenture dated as of August 11, 2003, as amended, between GenCorp Inc. as Issuer, the Guarantors party thereto as Guarantors, and The Bank of New York Mellon Trust Company, N.A., as Trustee was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K filed on November 30, 2009 (File No. 1-01520), and is incorporated herein by reference.
4.8
GenCorp Inc. Amended and Restated 2009 Equity and Performance Incentive Plan was filed as Exhibit 4.1 to GenCorp Inc.’s Form S-8 Registration Statement dated March 28, 2012 (File No. 333-180400), and is incorporated herein by reference.
4.9
Indenture for the Senior Secured Notes, dated as of January 28, 2013, between UR Financing Escrow Corporation, and U.S. Bank National Association, as Trustee was filed as Exhibit 4.1 to GenCorp Inc.’s Current Report on Form 8-K filed on February 1, 2013 (File No. 1-01520), and is incorporated herein by reference.
4.10
First Supplemental Indenture to the Senior Secured Notes, dated as of June 14, 2013, among GenCorp Inc., Aerojet Rocketdyne of DE, Inc., Arde, Inc. and Arde-Barinco, Inc., and U.S. Bank National Association, as Trustee was filed as Exhibit 4.1 to GenCorp Inc.’s Current Report on Form 8-K dated June 14, 2013 (File No. 1-01520), and is incorporated herein by reference.
4.11
Registration Rights Agreement, dated as of January 28, 2013, among GenCorp Inc. and Morgan Stanley & Co. LLC, Citigroup Global Markets Inc., Wells Fargo Securities, LLC, and SunTrust Robinson Humphrey, Inc., as representatives of the purchasers named therein was filed as Exhibit 10.2 of GenCorp Inc.’s Current Report on Form 8-K filed on February 1, 2013 (File No. 1-01520), and is incorporated herein by reference.

88



4.12
Joinder to the Registration Rights Agreement dated as of June 14, 2013 among GenCorp Inc., Aerojet Rocketdyne of DE, Inc., Arde, Inc. and Arde-Barinco, Inc. was filed as Exhibit 10.5 to GenCorp Inc.’s Current Report on Form 8-K filed on June 14, 2013, and is incorporated herein by reference.
4.13
Intercreditor Agreement, dated as of June 14, 2013, among Wells Fargo, National Association as credit agreement agent and U.S. Bank National Association as trustee under the indenture and U.S. Bank National Association as second lien collateral agent, acknowledged by GenCorp and the subsidiary guarantors was filed as Exhibit 10.3 to GenCorp Inc.’s Current Report on Form 8-K filed on June 14, 2013, and is incorporated herein by reference.
4.14
Second Lien Security Agreement, dated as of June 14, 2013, by and among GenCorp Inc., certain subsidiaries of GenCorp Inc. and U.S. Bank National Association, as Note Trustee and Collateral Agent was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K filed on June 14, 2013, and is incorporated herein by reference.
4.15
Form of Common Stock Certificate was filed as Exhibit 4.1 to GenCorp Inc.’s Current Report on Form 8-K dated April 11, 2014 (File No. 1-01520), and is incorporated herein by reference.
4.16
GenCorp Inc. Amended and Restated 2009 Equity and Performance Incentive Plan was filed as Exhibit 4.1 to GenCorp Inc.’s Registration Statement on Form S-8 dated April 9, 2015 (File No. 333-203319), and is incorporated herein by reference.
10.1
Amended and Restated Environmental Agreement by and between Aerojet and Northrop Grumman, dated October 19, 2001 was filed as Exhibit 2.4 to the Company’s Current Report on Form 8-K dated November 5, 2001 (File No. 1-01520), and is incorporated herein by reference.
10.2†
GenCorp 1996 Supplemental Retirement Plan for Management Employees effective March 1, 1996 was filed as Exhibit B to GenCorp Inc.’s Annual Report on Form 10-K for the fiscal year ended November 30, 1996 (File No. 1-01520), and is incorporated herein by reference.
10.3†
2009 Benefit Restoration Plan for the GenCorp Inc. Pension Plan was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K filed on January 7, 2009 (File No. 1-01520), and is incorporated herein by reference.
10.4†
2009 Benefit Restoration Plan for the GenCorp Inc. 401(k) Plan was filed as Exhibit 10.2 to GenCorp Inc.’s Current Report on Form 8-K filed on January 7, 2009 (File No. 1-01520), and is incorporated herein by reference.
10.5†
Deferred Bonus Plan of GenCorp Inc. and Participating Subsidiaries was filed as Exhibit 10.6 to GenCorp Inc.’s Annual Report on Form 10-K for the fiscal year ended November 30, 2008 (File No. 1-01520), and is incorporated herein by reference.
10.6†
GenCorp Inc. Deferred Compensation Plan for Nonemployee Directors, as amended was filed as Exhibit 10.7 to GenCorp Inc.’s Annual Report on Form 10-K for the fiscal year ended November 30, 2008 (File No. 1-01520), and is incorporated herein by reference.
10.7†
GenCorp Inc. 1997 Stock Option Plan effective March 26, 1997 was filed as Exhibit 4.1 to Form S-8 Registration Statement No. 333-35621 dated September 15, 1997 and is incorporated herein by reference.
10.8†
GenCorp Inc. 1999 Equity and Performance Incentive Plan as amended was filed as Exhibit 10.11 to GenCorp Inc.’s Annual Report on Form 10-K for the fiscal year ended November 30, 2007 (File No. 1-01520), and is incorporated herein by reference.
10.9†
Form of Restricted Stock Agreement between the Company and Nonemployee Directors providing for payment of part of Directors’ compensation for service on the Board of Directors in Company stock was filed as Exhibit 10.1 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended February 28, 1998 (File No. 1-01520), and is incorporated herein by reference.
10.10†
Form of Restricted Stock Agreement between the Company and Nonemployee Directors providing for payment of part of Directors’ compensation for service on the Board of Directors in Company stock was filed as Exhibit 10.1 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended February 28, 1999 (File No. 1-01520), and is incorporated herein by reference.
10.11†
Form of Restricted Stock Agreement between the Company and Directors or Employees for grants of time-based vesting of restricted stock under the GenCorp Inc. 1999 Equity and Performance Incentive Plan was filed as Exhibit 10.26 to GenCorp Inc.’s Annual Report on Form 10-K for the fiscal year ended November 30, 2004 (File No. 1-01520), and is incorporated herein by reference.
10.12†
Form of Stock Appreciation Rights Agreement between the Company and Employees for grants of stock appreciation rights under the GenCorp Inc. 1999 Equity and Performance Incentive Plan was filed as Exhibit 10.27 to GenCorp Inc.’s Annual Report on Form 10-K for the fiscal year ended November 30, 2004 (File No. 1-01520), and is incorporated herein by reference.
10.13†
Form of Stock Appreciation Rights Agreement between the Company and Directors for grants of stock appreciation rights under the GenCorp Inc. 1999 Equity and Performance Incentive Plan was filed as Exhibit 10.28 to GenCorp Inc.’s Annual Report on Form 10-K for the fiscal year ended November 30, 2004 (File No. 1-01520), and is incorporated herein by reference.

89



10.14†
Form of Restricted Stock Agreement between the Company and Employees for grants of performance-based vesting of restricted stock under the GenCorp Inc. 1999 Equity and Performance Incentive Plan was filed as Exhibit 10.29 to GenCorp Inc.’s Annual Report on Form 10-K for the fiscal year ended November 30, 2004 (File No. 1-01520), and is incorporated herein by reference.
10.15†
Form of Director Nonqualified Stock Option Agreement between the Company and Nonemployee Directors providing for annual grant of nonqualified stock options prior to February 28, 2002, valued at $30,000 was filed as Exhibit 10.1 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended May 31, 2002 (File No. 1-01520), and is incorporated herein by reference.
10.16†
Form of Director Nonqualified Stock Option Agreement between the Company and Nonemployee Directors providing for an annual grant of nonqualified stock options on or after February 28, 2002, valued at $30,000 in lieu of further participation in Retirement Plan for Nonemployee Directors was filed as Exhibit 10.2 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended May 31, 2002 (File No. 1-01520), and is incorporated herein by reference.
10.17†
Form of Restricted Stock Agreement Version 2 between the Company and Employees for grants of performance-based vesting of restricted stock under the GenCorp Inc. 1999 Equity and Performance Incentive Plan was filed as Exhibit 10.33 to GenCorp Inc.’s Annual Report on Form 10-K for the fiscal year ended November 30, 2005 (File No. 1-01520) and is incorporated herein by reference.
10.18
Second Amended and Restated Shareholder Agreement dated as of March 5, 2008, by and between GenCorp Inc. and Steel Partners II L.P. was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K filed on March 10, 2008 (File No. 1-01520), and is incorporated herein by reference.
10.19†
Director Stock Appreciation Rights Agreement between GenCorp Inc. and Directors for grants of stock appreciation rights under the GenCorp Inc. 2009 Equity and Performance Incentive Plan was filed as Exhibit 10.4 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the third quarter ended August 31, 2009 (File No. 1-01520), and is incorporated herein by reference.
10.20†
Amendment to the Benefits Restoration Plan for Salaried Employees of GenCorp Inc. and Certain Subsidiary Companies, effective October 6, 2009 was filed as Exhibit 10.5 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the third quarter ended August 31, 2009 (File No. 1-01520), and is incorporated herein by reference.
10.21†
Amendment to the 2009 Benefit Restoration Plan for the GenCorp Inc. 401(k) Plan, effective October 6, 2009 was filed as Exhibit 10.6 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the third quarter ended August 31, 2009 (File No. 1-01520), and is incorporated herein by reference.
10.22†
Amendment to the 2009 Benefits Restoration Plan for the GenCorp Inc. Pension Plan, effective October 6, 2009 was filed as Exhibit 10.7 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the third quarter ended August 31, 2009 (File No. 1-01520), and is incorporated herein by reference.
10.23†
Amendment to the Deferred Bonus Plan of GenCorp Inc. and Participating Subsidiaries, effective October 6, 2009 was filed as Exhibit 10.8 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the third quarter ended August 31, 2009 (File No. 1-01520), and is incorporated herein by reference.
10.24†
Amendment to the GenCorp Inc. Deferred Compensation Plan for Nonemployee Directors, as amended, effective October 6, 2009 was filed as Exhibit 10.9 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the third quarter ended August 31, 2009 (File No. 1-01520), and is incorporated herein by reference.
10.25†
Amendment to the GenCorp Inc. 1996 Supplemental Retirement Plan for Management Employees, effective October 6, 2009 was filed as Exhibit 10.10 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the third quarter ended August 31, 2009 (File No. 1-01520), and is incorporated herein by reference.
10.26†
Employment Agreement dated January 6, 2010 by and between Scott Seymour and GenCorp Inc. was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated January 6, 2010 (File No. 1-01520), and is incorporated herein by reference.
10.27
Settlement Agreement by and between Aerojet and United States of America, dated November 29, 1992, was filed as Exhibit 10.52 to GenCorp Inc.’s Annual Report on Form 10-K for the fiscal year ended November 30, 2009 (File No. 1-01520), and is incorporated herein by reference.
10.28
Modification No. 1 to the November 29, 1992 Settlement Agreement by and between Aerojet and United States of America, dated October 27, 1998, was filed as Exhibit 10.53 to GenCorp Inc.’s Annual Report on Form 10-K for the fiscal year ended November 30, 2009 (File No. 1-01520), and is incorporated herein by reference.
10.29
Purchase Agreement dated March 18, 2010 between GenCorp Inc. and Beach Point Capital Management LP, on behalf of certain funds and accounts it manages was filed as Exhibit 10.2 to GenCorp Inc.’s Current Report on Form 8-K filed on March 19, 2010 (File No. 1-01520), and is incorporated herein by reference.
10.30†
Addendum dated as of February 10, 2011 to the Employment Agreement, dated as of January 6, 2010, by and between GenCorp Inc. and Scott Seymour was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated February 9, 2011 (File No. 1-01520), and is incorporated herein by reference.
10.31†
Amendment to the Amended and Restated 2009 Equity and Performance Incentive Plan, was filed as an exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated March 30, 2011 (File No. 1-01520), and is incorporated herein by reference.

90



10.32†
Employment Offer Letter dated July 29, 2011 by and between GenCorp Inc. and Christopher C. Cambria was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated September 12, 2011 (File No. 1-01520), and is incorporated herein by reference.
10.33†
Employment Offer Letter, dated May 21, 2012, by and between Aerojet-General Corporation and Warren M. Boley, Jr. was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated July 23, 2012 (File No. 1-01520), and is incorporated herein by reference.
10.34
Escrow Agreement, dated as of January 28, 2013, by and among GenCorp Inc. and U.S. Bank National Association, as trustee, escrow agent and bank and securities intermediary was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated February 1, 2013 (File No. 1-01520), and is incorporated herein by reference.
10.35
GenCorp Inc. 2013 Employee Stock Purchase Plan (incorporated by reference to Exhibit A of the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on February 15, 2013 (File No. 1-01520)).
10.36†
Amendment to the GenCorp Inc. Deferred Compensation Plan for Nonemployee Directors, as amended, effective April 11, 2013 was filed as Exhibit 10.1 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the second quarter ended May 31, 2013 (File No. 1-01520), and is incorporated herein by reference.
10.37
Joinder Agreement dated as of June 14, 2013 by and among Pratt &Whitney Rocketdyne, Inc., Arde, Inc., Arde-Barinco, Inc., GenCorp Inc. and Wells Fargo Bank, National Association to that certain Second Amended and Restated Credit Agreement, dated as of November 18, 2011 (as amended, restated, amended and restated, supplemented or otherwise modified) by and among GenCorp Inc., the Material Domestic Subsidiaries from time to time party thereto, the Lenders from time to time party thereto and Wells Fargo Bank, National Association was filed as Exhibit 10.2 to GenCorp Inc.’s Current Report on Form 8-K dated June 14, 2013 (File No. 1-01520), and is incorporated herein by reference.
10.38
Purchase Agreement Joinder, dated as of June 14, 2013, by Pratt & Whitney Rocketdyne, Inc., Arde, Inc., Arde-Barinco, Inc. and Morgan Stanley & Co. LLC to that certain Purchase Agreement, dated as of January 18, 2013, by and among GenCorp Inc., Aerojet-General Corporation and the Initial Purchasers named therein was filed as Exhibit 10.4 to GenCorp Inc.’s Current Report on Form 8-K dated June 14, 2013 (File No. 1-01520), and is incorporated herein by reference.
10.39†
Stock Option Cancellation Agreement, dated July 9, 2013, between GenCorp Inc. and Kathleen E. Redd was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated July 12, 2013 (File No. 1-01520), and is incorporated herein by reference.
10.40
Form of Indemnification Agreement was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated April 11, 2014 (File No. 1-01520), and is incorporated herein by reference.
10.41
Credit Agreement, dated as of April 18, 2014, among GenCorp Inc., as Borrower, the lenders from time to time parties thereto, and The Bank of New York Mellon, as Administrative Agent was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated April 18, 2014 (File No. 1-01520), and is incorporated herein by reference.
10.42
Third Amended and Restated Credit Agreement, dated as of May 30, 2014, among GenCorp Inc., as Borrower, each of those Material Domestic Subsidiaries of the Borrower identified as a “Guarantor” on the signature pages thereto and such other Material Domestic Subsidiaries of the Borrower as may from time to time become a party thereto, the several banks and other financial institutions from time to time parties thereto, and Wells Fargo Bank, National Association, as Administrative Agent was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated May 30, 2014 (File No. 1-01520), and is incorporated herein by reference.
10.43
Amended and Restated 2013 Employee Stock Purchase Plan, dated as of June 24, 2014 was filed as Exhibit 10.1 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended August 31, 2014 (File No. 1-01520), and is incorporated herein by reference.
10.44†
Amended and Restated Deferred Compensation Plan for Nonemployee directors, dated as of June 24, 2014 was filed as Exhibit 10.2 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended August 31, 2014 (File No. 1-01520), and is incorporated herein by reference.
10.45†
Amended and Restated 2009 Equity and Performance Incentive Plan, dated as of June 24, 2014 was filed as Exhibit 10.3 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended August 31, 2014 (File No. 1-01520), and is incorporated herein by reference.
10.46†
Form of Restricted Stock Agreement between the Company and Employees for grants of time-based vesting of restricted stock under the GenCorp Inc. Amended and Restated 2009 Equity and Performance Incentive Plan was filed as Exhibit 10.4 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended August 31, 2014 (File No. 1-01520), and is incorporated herein by reference.
10.47†
Form of Unrestricted Stock Agreement between the Company and Directors for grants of common stock under the GenCorp Inc. Amended and Restated 2009 Equity and Performance Incentive Plan was filed as Exhibit 10.5 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended August 31, 2014 (File No. 1-01520), and is incorporated herein by reference.

91



10.48†
Form of Director Nonqualified Stock Option Agreement between the Company and Directors for grants of nonqualified stock options under the GenCorp Inc. Amended and Restated 2009 Equity and Performance Incentive Plan was filed as Exhibit 10.6 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended August 31, 2014 (File No. 1-01520), and is incorporated herein by reference.
10.49†
Offer letter between GenCorp and Eileen Drake, dated March 2, 2015 was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated March 2, 2015 (File No. 1-01520), and is incorporated herein by reference.
10.50†
Separation and General Release Agreement between Aerojet Rocketdyne, Inc. and Warren M. Boley, Jr. dated March 5,2015 was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated March 5, 2015 (File No. 1-01520), and is incorporated herein by reference.
10.51†
Transition and General Release Agreement between Aerojet Rocketdyne Holdings, Inc. and Scott J. Seymour dated July 7, 2015 was filed as Exhibit 10.1 to Aerojet Rocketdyne Holdings, Inc.’s Current Report on Form 8-K dated July 7, 2015 (File No. 1-01520), and is incorporated herein by reference.
10.52†
Executive Employment Agreement, dated as of November 23, 2015, between Aerojet Rocketdyne Holdings, Inc. and Eileen Drake was filed as Exhibit 10.1 to Aerojet Rocketdyne Holdings, Inc.’s Current Report on Form 8-K dated November 23, 2015 (File No. 1-01520), and is incorporated herein by reference.
21.1
Subsidiaries of the Company.
23.1*
Consent of Independent Registered Public Accounting Firm.
24.1
Power of Attorney
31.1*
Certification of Principal Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.
31.2*
Certification of Principal Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.
32.1*
Certification of Principal Executive Officer and Principal Accounting Officer pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 as amended, and 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS
XBRL Instance Document, as filed on February 16, 2016
101.SCH
XBRL Taxonomy Extension Schema, as filed on February 16, 2016
101.CAL
XBRL Taxonomy Extension Calculation Linkbase, as filed on February 16, 2016
101.DEF
XBRL Taxonomy Extension Definition Linkbase, as filed on February 16, 2016
101.LAB
XBRL Taxonomy Extension Label Linkbase, as filed on February 16, 2016
101.PRE
XBRL Taxonomy Extension Presentation Linkbase, as filed on February 16, 2016
 ___________
 
*
Filed herewith. All other exhibits have been previously filed.
**
Schedules and Exhibits have been omitted, but will be furnished to the SEC upon request.
Management contract or compensatory plan or arrangement. 




92



SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
August 16, 2016
 
 
 
Aerojet Rocketdyne Holdings, Inc.
 
 
By:
/s/    EILEEN P. DRAKE
 
 
 
Eileen P. Drake
 
 
 
 
President and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
 
Signature
 
Title
Date
/s/    EILEEN P. DRAKE        
 
Eileen P. Drake
 
President, Chief Executive Officer and Director (Principal Executive Officer)
August 16, 2016
/s/    KATHLEEN E. REDD        
 
Kathleen E. Redd
 
Vice President, Chief Financial
Officer and Assistant Secretary
(Principal Financial Officer and
Principal Accounting Officer)
August 16, 2016
*                                                 
 
Warren G. Lichtenstein
 
Chairman of the Board of Directors
August 16, 2016
*                                                      
 
Thomas A. Corcoran
 
Director
August 16, 2016
*                                                     
 
James R. Henderson
 
Director
August 16, 2016
*                                                     
 
Lance W. Lord
 
Director
August 16, 2016
*                                                   
 
Merrill A. McPeak
 
Director
August 16, 2016
*                                                     
 
James H. Perry
 
Director
August 16, 2016
*                                                   
 
Martin Turchin
 
Director
August 16, 2016
* By:   
/s/    KATHLEEN E. REDD        
 
Kathleen E. Redd
Attorney-in-Fact pursuant to Power of Attorney
August 16, 2016


93



EXHIBIT INDEX
Table
Item No.
Exhibit Description
2.1
Stock and Asset Purchase Agreement, dated July 22, 2012, by and between United Technologies Corporation and GenCorp Inc. was filed as Exhibit 2.1 to GenCorp Inc.’s Current Report on Form 8-K dated July 26, 2012 (File No. 1-01520) and incorporated herein by reference.**
2.2
Amendment No. 1 to the Stock and Asset Purchase Agreement, dated as of October 16, 2012, by and between GenCorp Inc. and United Technologies Corporation was filed as Exhibit 2.1 to GenCorp Inc.’s Current Report on Form 8-K dated October 22, 2012 (File No. 1-01520) and incorporated herein by reference.**
2.3
Amended and Restated Stock and Asset Purchase Agreement, dated as of June 12, 2013, by and between United Technologies Corporation and GenCorp Inc. was filed as Exhibit 2.1 to GenCorp Inc.’s Current Report on Form 8-K dated June 14, 2013 (File No. 1-01520), and is incorporated herein by reference.**
2.4
Plan of Conversion, dated April 11, 2014 was filed as Exhibit 2.1 to GenCorp Inc.’s Current Report on Form 8-K dated April 11, 2014 (File No. 1-01520), and is incorporated herein by reference.
3.1
Certificate of Conversion, as filed with the Secretary of State of the State of Ohio on April 11, 2014 was filed as Exhibit 3.1 to GenCorp Inc.’s Current Report on Form 8-K dated April 11, 2014 (File No. 1-01520), and is incorporated herein by reference.
3.2
Certificate of Conversion, as filed with the Secretary of State of the State of Delaware on April 11, 2014 was filed as Exhibit 3.2 to GenCorp Inc.’s Current Report on Form 8-K dated April 11, 2014 (File No. 1-01520), and is incorporated herein by reference.
3.3
Certificate of Incorporation, as of April 11, 2014, as amended on April 27, 2015.
3.4
Bylaws, effective April 11, 2014 was filed as Exhibit 3.4 to GenCorp Inc.’s Current Report on Form 8-K dated April 11, 2014 (File No. 1-01520), and is incorporated herein by reference.
4.1
Indenture, dated as of November 23, 2004, between GenCorp Inc. and The Bank of New York Trust Company, N.A., as trustee relating to GenCorp Inc.’s 2  1 / 4 % Convertible Subordinated Debentures due 2024 was filed as Exhibit 4.01 to GenCorp Inc.’s Current Report on Form 8-K dated November 23, 2004 (File No. 1-01520), as amended, and incorporated herein by reference.
4.2
Registration Rights Agreement, dated as of November 23, 2004, by and between GenCorp Inc. and Wachovia Capital Markets, LLC, as representative for the several initial purchasers of the 2  1 / 4 % Convertible Subordinated Debentures due 2024 was filed as Exhibit 4.14 to GenCorp Inc.’s Form S-3 Registration Statement dated January 11, 2005 (File No. 333-121948) and incorporated herein by reference.
4.3
Form of 2  1 / 4 % Convertible Subordinated Debenture was filed as Exhibit 4.02 to GenCorp Inc.’s Current Report on Form 8-K dated November 23, 2004 (File No. 1-01520), as amended, and incorporated herein by reference.
4.4
GenCorp Retirement Savings Plan was filed as Exhibit 4.1 to GenCorp Inc.’s Registration Statement on Form S-8 filed on June 30, 2008 (File No. 333-0152032) and incorporated herein by reference.
4.5
Indenture, dated as of December 21, 2009, between GenCorp Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee, relating to GenCorp’s 4.0625% Convertible Subordinated Debentures due 2039 was filed as Exhibit 4.1 to GenCorp Inc.’s Current Report on Form 8-K filed on December 21, 2009 (File 1-01520) and is incorporated herein by reference.
4.6
Form of 4.0625% Convertible Subordinated Debenture due 2039 was filed as Exhibit 4.2 to GenCorp Inc.’s Current Report on Form 8-K dated December 21, 2009 (File No. 1-01520), as amended, and incorporated herein by reference.
4.7
Third Supplemental Indenture dated as of November 24, 2009, by and among GenCorp Inc., Easton Development Company, LLC, and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A. and successor to The Bank of New York), to the Indenture dated as of August 11, 2003, as amended, between GenCorp Inc. as Issuer, the Guarantors party thereto as Guarantors, and The Bank of New York Mellon Trust Company, N.A., as Trustee was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K filed on November 30, 2009 (File No. 1-01520), and is incorporated herein by reference.
4.8
GenCorp Inc. Amended and Restated 2009 Equity and Performance Incentive Plan was filed as Exhibit 4.1 to GenCorp Inc.’s Form S-8 Registration Statement dated March 28, 2012 (File No. 333-180400), and is incorporated herein by reference.
4.9
Indenture for the Senior Secured Notes, dated as of January 28, 2013, between UR Financing Escrow Corporation, and U.S. Bank National Association, as Trustee was filed as Exhibit 4.1 to GenCorp Inc.’s Current Report on Form 8-K filed on February 1, 2013 (File No. 1-01520), and is incorporated herein by reference.
4.10
First Supplemental Indenture to the Senior Secured Notes, dated as of June 14, 2013, among GenCorp Inc., Aerojet Rocketdyne of DE, Inc., Arde, Inc. and Arde-Barinco, Inc., and U.S. Bank National Association, as Trustee was filed as Exhibit 4.1 to GenCorp Inc.’s Current Report on Form 8-K dated June 14, 2013 (File No. 1-01520), and is incorporated herein by reference.

94



4.11
Registration Rights Agreement, dated as of January 28, 2013, among GenCorp Inc. and Morgan Stanley & Co. LLC, Citigroup Global Markets Inc., Wells Fargo Securities, LLC, and SunTrust Robinson Humphrey, Inc., as representatives of the purchasers named therein was filed as Exhibit 10.2 of GenCorp Inc.’s Current Report on Form 8-K filed on February 1, 2013 (File No. 1-01520), and is incorporated herein by reference.
4.12
Joinder to the Registration Rights Agreement dated as of June 14, 2013 among GenCorp Inc., Aerojet Rocketdyne of DE, Inc., Arde, Inc. and Arde-Barinco, Inc. was filed as Exhibit 10.5 to GenCorp Inc.’s Current Report on Form 8-K filed on June 14, 2013, and is incorporated herein by reference.
4.13
Intercreditor Agreement, dated as of June 14, 2013, among Wells Fargo, National Association as credit agreement agent and U.S. Bank National Association as trustee under the indenture and U.S. Bank National Association as second lien collateral agent, acknowledged by GenCorp and the subsidiary guarantors was filed as Exhibit 10.3 to GenCorp Inc.’s Current Report on Form 8-K filed on June 14, 2013, and is incorporated herein by reference.
4.14
Second Lien Security Agreement, dated as of June 14, 2013, by and among GenCorp Inc., certain subsidiaries of GenCorp Inc. and U.S. Bank National Association, as Note Trustee and Collateral Agent was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K filed on June 14, 2013, and is incorporated herein by reference.
4.15
Form of Common Stock Certificate was filed as Exhibit 4.1 to GenCorp Inc.’s Current Report on Form 8-K dated April 11, 2014 (File No. 1-01520), and is incorporated herein by reference.
4.16
GenCorp Inc. Amended and Restated 2009 Equity and Performance Incentive Plan was filed as Exhibit 4.1 to GenCorp Inc.’s Registration Statement on Form S-8 dated April 9, 2015 (File No. 333-203319), and is incorporated herein by reference.
10.1
Amended and Restated Environmental Agreement by and between Aerojet and Northrop Grumman, dated October 19, 2001 was filed as Exhibit 2.4 to the Company’s Current Report on Form 8-K dated November 5, 2001 (File No. 1-01520), and is incorporated herein by reference.
10.2†
GenCorp 1996 Supplemental Retirement Plan for Management Employees effective March 1, 1996 was filed as Exhibit B to GenCorp Inc.’s Annual Report on Form 10-K for the fiscal year ended November 30, 1996 (File No. 1-01520), and is incorporated herein by reference.
10.3†
2009 Benefit Restoration Plan for the GenCorp Inc. Pension Plan was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K filed on January 7, 2009 (File No. 1-01520), and is incorporated herein by reference.
10.4†
2009 Benefit Restoration Plan for the GenCorp Inc. 401(k) Plan was filed as Exhibit 10.2 to GenCorp Inc.’s Current Report on Form 8-K filed on January 7, 2009 (File No. 1-01520), and is incorporated herein by reference.
10.5†
Deferred Bonus Plan of GenCorp Inc. and Participating Subsidiaries was filed as Exhibit 10.6 to GenCorp Inc.’s Annual Report on Form 10-K for the fiscal year ended November 30, 2008 (File No. 1-01520), and is incorporated herein by reference.
10.6†
GenCorp Inc. Deferred Compensation Plan for Nonemployee Directors, as amended was filed as Exhibit 10.7 to GenCorp Inc.’s Annual Report on Form 10-K for the fiscal year ended November 30, 2008 (File No. 1-01520), and is incorporated herein by reference.
10.7†
GenCorp Inc. 1997 Stock Option Plan effective March 26, 1997 was filed as Exhibit 4.1 to Form S-8 Registration Statement No. 333-35621 dated September 15, 1997 and is incorporated herein by reference.
10.8†
GenCorp Inc. 1999 Equity and Performance Incentive Plan as amended was filed as Exhibit 10.11 to GenCorp Inc.’s Annual Report on Form 10-K for the fiscal year ended November 30, 2007 (File No. 1-01520), and is incorporated herein by reference.
10.9†
Form of Restricted Stock Agreement between the Company and Nonemployee Directors providing for payment of part of Directors’ compensation for service on the Board of Directors in Company stock was filed as Exhibit 10.1 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended February 28, 1998 (File No. 1-01520), and is incorporated herein by reference.
10.10†
Form of Restricted Stock Agreement between the Company and Nonemployee Directors providing for payment of part of Directors’ compensation for service on the Board of Directors in Company stock was filed as Exhibit 10.1 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended February 28, 1999 (File No. 1-01520), and is incorporated herein by reference.
10.11†
Form of Restricted Stock Agreement between the Company and Directors or Employees for grants of time-based vesting of restricted stock under the GenCorp Inc. 1999 Equity and Performance Incentive Plan was filed as Exhibit 10.26 to GenCorp Inc.’s Annual Report on Form 10-K for the fiscal year ended November 30, 2004 (File No. 1-01520), and is incorporated herein by reference.
10.12†
Form of Stock Appreciation Rights Agreement between the Company and Employees for grants of stock appreciation rights under the GenCorp Inc. 1999 Equity and Performance Incentive Plan was filed as Exhibit 10.27 to GenCorp Inc.’s Annual Report on Form 10-K for the fiscal year ended November 30, 2004 (File No. 1-01520), and is incorporated herein by reference.

95



10.13†
Form of Stock Appreciation Rights Agreement between the Company and Directors for grants of stock appreciation rights under the GenCorp Inc. 1999 Equity and Performance Incentive Plan was filed as Exhibit 10.28 to GenCorp Inc.’s Annual Report on Form 10-K for the fiscal year ended November 30, 2004 (File No. 1-01520), and is incorporated herein by reference.
10.14†
Form of Restricted Stock Agreement between the Company and Employees for grants of performance-based vesting of restricted stock under the GenCorp Inc. 1999 Equity and Performance Incentive Plan was filed as Exhibit 10.29 to GenCorp Inc.’s Annual Report on Form 10-K for the fiscal year ended November 30, 2004 (File No. 1-01520), and is incorporated herein by reference.
10.15†
Form of Director Nonqualified Stock Option Agreement between the Company and Nonemployee Directors providing for annual grant of nonqualified stock options prior to February 28, 2002, valued at $30,000 was filed as Exhibit 10.1 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended May 31, 2002 (File No. 1-01520), and is incorporated herein by reference.
10.16†
Form of Director Nonqualified Stock Option Agreement between the Company and Nonemployee Directors providing for an annual grant of nonqualified stock options on or after February 28, 2002, valued at $30,000 in lieu of further participation in Retirement Plan for Nonemployee Directors was filed as Exhibit 10.2 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended May 31, 2002 (File No. 1-01520), and is incorporated herein by reference.
10.17†
Form of Restricted Stock Agreement Version 2 between the Company and Employees for grants of performance-based vesting of restricted stock under the GenCorp Inc. 1999 Equity and Performance Incentive Plan was filed as Exhibit 10.33 to GenCorp Inc.’s Annual Report on Form 10-K for the fiscal year ended November 30, 2005 (File No. 1-01520) and is incorporated herein by reference.
10.18
Second Amended and Restated Shareholder Agreement dated as of March 5, 2008, by and between GenCorp Inc. and Steel Partners II L.P. was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K filed on March 10, 2008 (File No. 1-01520), and is incorporated herein by reference.
10.19†
Director Stock Appreciation Rights Agreement between GenCorp Inc. and Directors for grants of stock appreciation rights under the GenCorp Inc. 2009 Equity and Performance Incentive Plan was filed as Exhibit 10.4 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the third quarter ended August 31, 2009 (File No. 1-01520), and is incorporated herein by reference.
10.20†
Amendment to the Benefits Restoration Plan for Salaried Employees of GenCorp Inc. and Certain Subsidiary Companies, effective October 6, 2009 was filed as Exhibit 10.5 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the third quarter ended August 31, 2009 (File No. 1-01520), and is incorporated herein by reference.
10.21†
Amendment to the 2009 Benefit Restoration Plan for the GenCorp Inc. 401(k) Plan, effective October 6, 2009 was filed as Exhibit 10.6 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the third quarter ended August 31, 2009 (File No. 1-01520), and is incorporated herein by reference.
10.22†
Amendment to the 2009 Benefits Restoration Plan for the GenCorp Inc. Pension Plan, effective October 6, 2009 was filed as Exhibit 10.7 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the third quarter ended August 31, 2009 (File No. 1-01520), and is incorporated herein by reference.
10.23†
Amendment to the Deferred Bonus Plan of GenCorp Inc. and Participating Subsidiaries, effective October 6, 2009 was filed as Exhibit 10.8 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the third quarter ended August 31, 2009 (File No. 1-01520), and is incorporated herein by reference.
10.24†
Amendment to the GenCorp Inc. Deferred Compensation Plan for Nonemployee Directors, as amended, effective October 6, 2009 was filed as Exhibit 10.9 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the third quarter ended August 31, 2009 (File No. 1-01520), and is incorporated herein by reference.
10.25†
Amendment to the GenCorp Inc. 1996 Supplemental Retirement Plan for Management Employees, effective October 6, 2009 was filed as Exhibit 10.10 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the third quarter ended August 31, 2009 (File No. 1-01520), and is incorporated herein by reference.
10.26†
Employment Agreement dated January 6, 2010 by and between Scott Seymour and GenCorp Inc. was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated January 6, 2010 (File No. 1-01520), and is incorporated herein by reference.
10.27
Settlement Agreement by and between Aerojet and United States of America, dated November 29, 1992, was filed as Exhibit 10.52 to GenCorp Inc.’s Annual Report on Form 10-K for the fiscal year ended November 30, 2009 (File No. 1-01520), and is incorporated herein by reference.
10.28
Modification No. 1 to the November 29, 1992 Settlement Agreement by and between Aerojet and United States of America, dated October 27, 1998, was filed as Exhibit 10.53 to GenCorp Inc.’s Annual Report on Form 10-K for the fiscal year ended November 30, 2009 (File No. 1-01520), and is incorporated herein by reference.
10.29
Purchase Agreement dated March 18, 2010 between GenCorp Inc. and Beach Point Capital Management LP, on behalf of certain funds and accounts it manages was filed as Exhibit 10.2 to GenCorp Inc.’s Current Report on Form 8-K filed on March 19, 2010 (File No. 1-01520), and is incorporated herein by reference.

96



10.30†
Addendum dated as of February 10, 2011 to the Employment Agreement, dated as of January 6, 2010, by and between GenCorp Inc. and Scott Seymour was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated February 9, 2011 (File No. 1-01520), and is incorporated herein by reference.
10.31†
Amendment to the Amended and Restated 2009 Equity and Performance Incentive Plan, was filed as an exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated March 30, 2011 (File No. 1-01520), and is incorporated herein by reference.
10.32†
Employment Offer Letter dated July 29, 2011 by and between GenCorp Inc. and Christopher C. Cambria was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated September 12, 2011 (File No. 1-01520), and is incorporated herein by reference.
10.33†
Employment Offer Letter, dated May 21, 2012, by and between Aerojet-General Corporation and Warren M. Boley, Jr. was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated July 23, 2012 (File No. 1-01520), and is incorporated herein by reference.
10.34
Escrow Agreement, dated as of January 28, 2013, by and among GenCorp Inc. and U.S. Bank National Association, as trustee, escrow agent and bank and securities intermediary was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated February 1, 2013 (File No. 1-01520), and is incorporated herein by reference.
10.35
GenCorp Inc. 2013 Employee Stock Purchase Plan (incorporated by reference to Exhibit A of the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on February 15, 2013 (File No. 1-01520)).
10.36†
Amendment to the GenCorp Inc. Deferred Compensation Plan for Nonemployee Directors, as amended, effective April 11, 2013 was filed as Exhibit 10.1 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the second quarter ended May 31, 2013 (File No. 1-01520), and is incorporated herein by reference.
10.37
Joinder Agreement dated as of June 14, 2013 by and among Pratt &Whitney Rocketdyne, Inc., Arde, Inc., Arde-Barinco, Inc., GenCorp Inc. and Wells Fargo Bank, National Association to that certain Second Amended and Restated Credit Agreement, dated as of November 18, 2011 (as amended, restated, amended and restated, supplemented or otherwise modified) by and among GenCorp Inc., the Material Domestic Subsidiaries from time to time party thereto, the Lenders from time to time party thereto and Wells Fargo Bank, National Association was filed as Exhibit 10.2 to GenCorp Inc.’s Current Report on Form 8-K dated June 14, 2013 (File No. 1-01520), and is incorporated herein by reference.
10.38
Purchase Agreement Joinder, dated as of June 14, 2013, by Pratt & Whitney Rocketdyne, Inc., Arde, Inc., Arde-Barinco, Inc. and Morgan Stanley & Co. LLC to that certain Purchase Agreement, dated as of January 18, 2013, by and among GenCorp Inc., Aerojet-General Corporation and the Initial Purchasers named therein was filed as Exhibit 10.4 to GenCorp Inc.’s Current Report on Form 8-K dated June 14, 2013 (File No. 1-01520), and is incorporated herein by reference.
10.39†
Stock Option Cancellation Agreement, dated July 9, 2013, between GenCorp Inc. and Kathleen E. Redd was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated July 12, 2013 (File No. 1-01520), and is incorporated herein by reference.
10.40
Form of Indemnification Agreement was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated April 11, 2014 (File No. 1-01520), and is incorporated herein by reference.
10.41
Credit Agreement, dated as of April 18, 2014, among GenCorp Inc., as Borrower, the lenders from time to time parties thereto, and The Bank of New York Mellon, as Administrative Agent was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated April 18, 2014 (File No. 1-01520), and is incorporated herein by reference.
10.42
Third Amended and Restated Credit Agreement, dated as of May 30, 2014, among GenCorp Inc., as Borrower, each of those Material Domestic Subsidiaries of the Borrower identified as a “Guarantor” on the signature pages thereto and such other Material Domestic Subsidiaries of the Borrower as may from time to time become a party thereto, the several banks and other financial institutions from time to time parties thereto, and Wells Fargo Bank, National Association, as Administrative Agent was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated May 30, 2014 (File No. 1-01520), and is incorporated herein by reference.
10.43
Amended and Restated 2013 Employee Stock Purchase Plan, dated as of June 24, 2014 was filed as Exhibit 10.1 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended August 31, 2014 (File No. 1-01520), and is incorporated herein by reference.
10.44†
Amended and Restated Deferred Compensation Plan for Nonemployee directors, dated as of June 24, 2014 was filed as Exhibit 10.2 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended August 31, 2014 (File No. 1-01520), and is incorporated herein by reference.
10.45†
Amended and Restated 2009 Equity and Performance Incentive Plan, dated as of June 24, 2014 was filed as Exhibit 10.3 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended August 31, 2014 (File No. 1-01520), and is incorporated herein by reference.

97



10.46†
Form of Restricted Stock Agreement between the Company and Employees for grants of time-based vesting of restricted stock under the GenCorp Inc. Amended and Restated 2009 Equity and Performance Incentive Plan was filed as Exhibit 10.4 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended August 31, 2014 (File No. 1-01520), and is incorporated herein by reference.
10.47†
Form of Unrestricted Stock Agreement between the Company and Directors for grants of common stock under the GenCorp Inc. Amended and Restated 2009 Equity and Performance Incentive Plan was filed as Exhibit 10.5 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended August 31, 2014 (File No. 1-01520), and is incorporated herein by reference.
10.48†
Form of Director Nonqualified Stock Option Agreement between the Company and Directors for grants of nonqualified stock options under the GenCorp Inc. Amended and Restated 2009 Equity and Performance Incentive Plan was filed as Exhibit 10.6 to GenCorp Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended August 31, 2014 (File No. 1-01520), and is incorporated herein by reference.
10.49†
Offer letter between GenCorp and Eileen Drake, dated March 2, 2015 was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated March 2, 2015 (File No. 1-01520), and is incorporated herein by reference.
10.50†
Separation and General Release Agreement between Aerojet Rocketdyne, Inc. and Warren M. Boley, Jr. dated March 5,2015 was filed as Exhibit 10.1 to GenCorp Inc.’s Current Report on Form 8-K dated March 5, 2015 (File No. 1-01520), and is incorporated herein by reference.
10.51†
Transition and General Release Agreement between Aerojet Rocketdyne Holdings, Inc. and Scott J. Seymour dated July 7, 2015 was filed as Exhibit 10.1 to Aerojet Rocketdyne Holdings, Inc.’s Current Report on Form 8-K dated July 7, 2015 (File No. 1-01520), and is incorporated herein by reference.
10.52†
Executive Employment Agreement, dated as of November 23, 2015, between Aerojet Rocketdyne Holdings, Inc. and Eileen Drake was filed as Exhibit 10.1 to Aerojet Rocketdyne Holdings, Inc.’s Current Report on Form 8-K dated November 23, 2015 (File No. 1-01520), and is incorporated herein by reference.
21.1
Subsidiaries of the Company.
23.1*
Consent of Independent Registered Public Accounting Firm.
24.1
Power of Attorney
31.1*
Certification of Principal Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.
31.2*
Certification of Principal Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.
32.1*
Certification of Principal Executive Officer and Principal Accounting Officer pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 as amended, and 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS
XBRL Instance Document, as filed on February 16, 2016
101.SCH
XBRL Taxonomy Extension Schema, as filed on February 16, 2016
101.CAL
XBRL Taxonomy Extension Calculation Linkbase, as filed on February 16, 2016
101.DEF
XBRL Taxonomy Extension Definition Linkbase, as filed on February 16, 2016
101.LAB
XBRL Taxonomy Extension Label Linkbase, as filed on February 16, 2016
101.PRE
XBRL Taxonomy Extension Presentation Linkbase, as filed on February 16, 2016
_____ 
*
Filed herewith. All other exhibits have been previously filed.
**
Schedules and Exhibits have been omitted, but will be furnished to the SEC upon request.
Management contract or compensatory plan or arrangement. 





98